{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Illustrate comparisons to Sicklick 2019\n",
    "We investigated how highlights made by the Molecular Oncology Almanac compare to those made in the trial I-PREDICT. We create the following figures:\n",
    "\n",
    "1. Counts of therapies administered per patient (custom figure)\n",
    "2. Therapies by evidence for those (stacked bar charts)\n",
    "    * administered to patients in I-PREDICT\n",
    "    * highlighted by the Molecular Oncology Almanac\n",
    "3. Counts of (scatter plots)\n",
    "    * therapies\n",
    "    * thearpeutic strategy\n",
    "    * molecular features targeted\n",
    "    \n",
    "Lastly, we'll generate some summary statistics and findings which are of particularly of note."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Import"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import glob\n",
    "import math\n",
    "import matplotlib.pyplot as plt\n",
    "import matplotlib.gridspec as gridspec\n",
    "from matplotlib.patches import Patch\n",
    "from matplotlib.lines import Line2D\n",
    "import numpy\n",
    "import pandas\n",
    "\n",
    "import sys\n",
    "sys.path.append('../../common/')\n",
    "import settings\n",
    "settings.set_arial_as_font()\n",
    "\n",
    "from matplotlib import colors\n",
    "%matplotlib inline\n",
    "\n",
    "features = pandas.read_csv('merged-features.annotated.txt', sep='\\t')\n",
    "therapies = pandas.read_csv('therapies.annotated.txt', sep='\\t')\n",
    "\n",
    "def normalize_rgb(dictionary):\n",
    "    for color in dictionary.keys():\n",
    "        r, g, b = dictionary[color]\n",
    "        dictionary[color] = (r / 255., g / 255., b / 255.)\n",
    "    return dictionary\n",
    "def return_cmap_norm(normalized_rgb, bounds):\n",
    "    cmap = colors.ListedColormap(normalized_rgb)\n",
    "    norm = colors.BoundaryNorm(bounds, cmap.N)\n",
    "    return cmap, norm\n",
    "\n",
    "tableau = normalize_rgb({\n",
    "    'red': (198, 4, 4), 'blue': (48, 100, 147), 'purple': (167, 136, 168),\n",
    "    #'red': (221, 76, 78), 'purple': (166, 111, 151), 'blue': (68, 109, 157)\n",
    "})\n",
    "\n",
    "purple = '#A788A8'\n",
    "blue = '#306493'\n",
    "red = '#CC0000'\n",
    "green = '#49ae3e'\n",
    "orange = '#ec7b22'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['feature', 'feature_type', 'alteration_type', 'alteration',\n",
       "       'patient_id', 'ipredict_targeted', 'score_bin',\n",
       "       'sensitive_predictive_implication', 'resistance_predictive_implication',\n",
       "       'prognostic_predictive_implication', 'sensitive_score_bin',\n",
       "       'sensitive_therapy_name', 'sensitive_therapy_type',\n",
       "       'sensitive_description', 'sensitive_citation', 'sensitive_url',\n",
       "       'resistance_score_bin', 'resistance_therapy_name',\n",
       "       'resistance_therapy_type', 'resistance_description',\n",
       "       'resistance_citation', 'resistance_url', 'prognostic_score_bin',\n",
       "       'favorable_prognosis', 'prognostic_description', 'prognostic_citation',\n",
       "       'prognostic_url'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "features.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['patient_id', 'therapy', 'study-evidence-strongest',\n",
       "       'almanac-evidence-strongest', 'included-in-overlapping-strategy',\n",
       "       'strategy', 'study-gave-as-matched-therapy',\n",
       "       'study-citations-used-for-patient', 'comment-on-study-citation',\n",
       "       'substrategy'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def display_label(data, ax, min_x, min_y, index_value, fontsize=16, add_x=0, add_y=0):\n",
    "    x = data.loc[index_value, 'label_x']\n",
    "    y = data.loc[index_value, 'label_y']\n",
    "    \n",
    "    if (((x > 5) & (y > 5)) | (x > min_x) | (y > min_y)):\n",
    "        ax.annotate(index_value, (x + add_x, y + add_y), fontsize=fontsize)\n",
    "\n",
    "def label_by_height(data, ax, fontsize=16):\n",
    "    labels = []\n",
    "    count = 0\n",
    "    \n",
    "    for index in data.index:\n",
    "        labels.append('')\n",
    "    for index in data.index:\n",
    "        labels.append(data.loc[index, 'percent agree'])\n",
    "        \n",
    "    for i in ax.patches:\n",
    "        if count >= 6:\n",
    "            ax.text(i.get_x() + 0.1, i.get_y() + i.get_height() + 2, labels[count], \n",
    "                    fontsize=fontsize, color=purple, fontweight='semibold')\n",
    "        count += 1\n",
    "        \n",
    "def remove_spines(ax):\n",
    "    ax.spines['top'].set_visible(False)\n",
    "    ax.spines['bottom'].set_visible(False)\n",
    "    ax.spines['right'].set_visible(False)\n",
    "    ax.spines['left'].set_visible(False)\n",
    "\n",
    "def remove_ticks(ax,\n",
    "                 bottom=False, top=False, left=False, right=False,\n",
    "                 labelbottom=False, labeltop=True, labelleft=False, labelright=False):\n",
    "    ax.tick_params(\n",
    "        axis=\"both\", which=\"both\", \n",
    "        bottom=bottom, top=top, left=left, right=right,\n",
    "        labelbottom=labelbottom, labeltop=labeltop, labelleft=labelleft, labelright=labelright) \n",
    "    \n",
    "def roundup(x, n):\n",
    "    return int(int(math.ceil(x / n)) * n)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Counts of therapies administered per patient (custom figure)\n",
    "We will process the therapies dataframe to create a dataframe that shows: \n",
    "1. the number of therapies administered per patient by I-PREDICT on the left (blue)\n",
    "2. the number of therapies highlighted per patient by Molecular Oncology Almanac on the right (red)\n",
    "3. the number of these therapies that were involved in overlapping strategy for both sides (purple)\n",
    "\n",
    "This will be labeled as `data_s`. This was originally Figure 4A but was moved to the supplement."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "series_list = []\n",
    "for label, group in therapies.groupby('patient_id'):\n",
    "    total_therapies = group.shape[0]\n",
    "    idx_study = group['study-gave-as-matched-therapy'].notnull()\n",
    "    idx_almanac = group['almanac-evidence-strongest'].notnull()\n",
    "    idx_overlap = group['included-in-overlapping-strategy'].fillna(0).astype(int).eq(1)\n",
    "    \n",
    "    sum_overlap = group['included-in-overlapping-strategy'].fillna(0.0).astype(float).sum()\n",
    "    \n",
    "    study_overlap = group[idx_study & idx_overlap].shape[0]\n",
    "    almanac_overlap = group[idx_almanac & idx_overlap].shape[0]\n",
    "    \n",
    "    dictionary = {\n",
    "        'total': total_therapies,\n",
    "        'study': group[idx_study].shape[0],\n",
    "        'almanac': group[idx_almanac].shape[0],\n",
    "        'study_overlap': study_overlap,\n",
    "        'almanac_overlap': almanac_overlap,\n",
    "        'overlap': sum_overlap\n",
    "    }\n",
    "    series = pandas.Series(dictionary, name=label)\n",
    "    series_list.append(series)\n",
    "\n",
    "data = pandas.concat(series_list, axis=1).T.reset_index().rename(columns={'index': 'patient_id'})\n",
    "data['study_not_overlap'] = data['study'].subtract(data['study_overlap'])\n",
    "data['almanac_not_overlap'] = data['almanac'].subtract(data['almanac_overlap'])\n",
    "\n",
    "sort_columns = ['overlap', 'study', 'almanac']\n",
    "data = data.sort_values(sort_columns, ascending=True)\n",
    "\n",
    "data_s = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAhIAAAJpCAYAAAD42Nu9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDMuMC4yLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvOIA7rQAAIABJREFUeJzsnXl8VNX5/z8nOyGEQICwiEBB+SG4UHetslS0lqpYUVxQsa7liyIWRSsqYt1asNpSRdFqBdrab1Erdd+w/boviHtEwYgRMBAiJGFIJjm/P86dMJlMlrl3ztz7mTzv12teMDd3zn3Pnefeeeae89yjtNYQBEEQBEFwQ4bfAoIgCIIg8CKJhCAIgiAIrpFEQhAEQRAE10giIQiCIAiCaySREARBEATBNZJICIIgCILgGkkkLKCUuk0p9XbU88uVUhuT1LZSSt2ulNqqlKpRSk1vY90+SqmuUc9XKaW+SoZHKlFKPaSUClydslJqrFJKK6Wm+e2SbCSGk0tQYzgVKKXmOcfJYIvbyEhm+0qpaY7zWC/rdBYkkbDDaACrY56/l6S2JwK4CsDrAGYCeDHeSkqp4wGUAuidpO36yb0AzvZbIg6fwnj9x28RC0gMJ5egxnAqeBTmvVfYaFwpVQjgDQDTbLQvtE+W3wJpymgAj8c8/1eS2t7P+fcarfWHbax3KICiJG3TV7TWr8N86QQKrfVmAMv89rCExHASCWoMpwKt9QcAPrC4iZ4ADgbwlMVtCG0gVySSjFJqAMwvqNXO81wAI5C8X3M5zr87ktSeIDRDYlgQhITQWssjCQ8AXwHQ7TxWtdPGUQBeAFDtPF4CcHQb2/iqlXYeirddAKucNo4F8A6AEICvAcwFkBHTxj4AHgNQBaAWwKsAjotZZxWAZwD8xvH9DsC+zt9OBfAKgO8B1AFYD+C3AHJjXv8CgBMAfAJgJ8yX1ynx3k/Msj0APAxzuTTkvO6smHUUgOthLo+HAGwGsBTAwA58nv2ddSuc97AUwEnO/hzrrDPWeT4NQC6AbQCeiNPWNGe9o53nGQB+BeAzALsAlAO4C0Bh1GsibU8A8Cdn39bCdAPsLzEsMdzO5zDPWX8vAP+GSdq2AfgLgOKYdYsB3O3E4S5nW1cDyIxpr9rZp88DqHHWv8pxnO18Djuc/Tk45rU6sixBtx8CWOG873rn8/krgD1ijpPoR2Q7ec7nut75/NYBmA8gJ2YbfQA8iN3H+p9hutyajvVW9vE0Z50zYeKsxvH8I5xjGUB3Jyb+Eef1lzivH2njeE7lw3eBdHkAmARgKoAnnMCd6jyWwpzIpgKY0MbrTwTQAOBzAHOcxxfOwXNi1DYedYLvcgCTWmnr8Jj1JjjLVzkH8A6YE+IlAP4bWS/q9fs6B1Spc6KYBeAtx29K1HqrYE4uawH80mkzE8AFTpv/crZxmbOuBvDbmNd/C3PyusdZ793IwRm13kOIOgnDfMmXO6+9DsAMmJObBnBl1HrXOs53ATgf5qSyA2ZsQ2Ybn0U3Z9/XALjZef8fA9gafXJBVCLhPL/f2b/dY9p7GkAZAOU8fxBAGMADAC4GcKezD94BkBfTdhnMJfFLAdyA3SfwLIlhieE2Pot5zn7/BsDfnDi732n/H1Hr9XD20S5nG9NhurQ0gEdi2qsDsMl5n5c4+1PDJA6fOZ/Tb5ztvhzz2thEoiNu+8IkgGucti+CSTYaAbzlrFPi/E3DxMtUAF2dz/AFmC/xuxzf+519uRK7j8U8Z1+GANzutPW+s487mkhUw8TgpQDuc/xeitrGCpjjNj/m9a8AWJPs49iPh+8C6fZwgnl51PO70f6vuCwAG2Ay+uhfpUXOwfYNgGxnWbODso02W6yH3SfCk6OWdYM54f4nZr0vAHSNcfyPcyLJiWnv0JhtfwrgtciBFPMeP4jjE/0F0AXmpF4O5xcmWp6EH4L5Uu8XtUzB/FIJAejjLPsEwL9j3C52ThRD29h31zlex8TspzK0nUiMc56fHfW6YpiT5m0xr7k4ZpvHOstnxqz3Fpr/MpzjLG/1C11iWGI4at8tjFn+tBOP+c7z25z1JsWs9ydn+U9j2lsQtc4+zrLtAHpHLV8G82WaG+9zTMDtHpgv4J4x6/3NeX1P5/lg5/m8qHWmOctir0Bd5Cw/yXk+I/b9wyQiH6PjicSriErsYRJ+DeAE5/nPneenRa3THyapmWPrOE7lQ8ZIJJ/9YTLo6Ofvt/OaH8Jc5lyktd4eWai1rgKwCMAAAAclya8W5hdnZBs7YH5N9AUApVQxgDEwA5e6KKV6KaV6wXwhPAbzC+DgqPZ2AngbzdkP5gSko5b1gbl8WRCz7vcwX1QRn50wJ5D+AA6MlVdKZcD8qv0PgPoov2KYzD8XpjsAMF9e45RSM5VSJU7792qtD9Baf9nqHgJOBvCh1vqFKK8d0Z6t8ArMl8dpUctOgfkCWh71XAN4KuLu+L8H8wX3s5g2V2itG6KeR2KpbzsuXpAY5o/hCP+Ief4+TDwWO89PBPCp1vrxmPVucv49KWb5Y1H//9z591WtdXRFxnqYpKjEo9t0mOSjMrKCU6ERcp7Gfg7RnALTVfFuzHH2FMwXeOQ4Ox7A5uj3r7Wugbl60VF+r7UORz3/g/PvROffJ2FiJPq8MAVmH/09ge0EFkkkkoRSqodSak8AQwCURQXuvgDWOc+7t/LyIc6/pXH+9qnz76AkqW6N+WICzIk0MgBuqPPvpTAHYvTjDudve8a01xjdmNa6HsBBSqkHlFKvKqU2w3zB7ouWMfel1rouZtla59/Bcfx7wfQ7Torj988Yv9kAtsB0HWxUSr2tlLpOKdXel/BeUQ7RfNbWi5z98DcAx0Z91lMAfKR3VycMhTmBfB3Hvy+a71ugZcncLuffzHbeQ8JIDO8mDWI4QnvxMwRxPjOt9SaY7qzYz2xz1DqRL8/vYtaJfDbtfb+06eYkccVKqTuUUi8opdY7TtM60P5QmAHDsft3g9N+ZP8Ohhk7EUubx3pb62qtt8EknIOd57tgEsSfRt0T5XQAr2mtyxLYTmCR8s/ksRq7D7rYLPMu5/EKzCXrWFQb7UYOltgTlVsa2/l75ATzJzQv/4vm46j/x57QoZT6I8wlw9Uw/ftLYS4TL0LLL8p47yvi0KLtqL/9E6Y2Px7rAFN2ppTaC8BPYAbD/QRmsNWvlFKHaa1bO1lkY/dJLZpQnGWx/BXm5H+SUupZmF/Gc2P8d8Bc7ozHzpjn7X1eyURi2CENYjhCe/uqvc8t9r2F46yn4yzrCG26KaVOgzmevoUZc/A0zDii4wBc007bmTDJXGs3O9vm/KthuqJiSeRHdrz3r9D8s/8rgF8A+JlS6i0Ah8DEV1ogiUTyOAsmU/4pgHOdZRNgfhWd6Dzf1vJlAMwodAD4f2hZqz/c+XdDMiQ7QMQlHH1pHwCUUvvA/IKpbe3FSqlBMAfIUq31OTF/i/craohSSsVcQt7L+TfeVYEKZ/vZcfz2hLnEXqOUyoS5JL9da/0EnEvhzsnpEQAXwlROxGMdgL3jLN8rzrJmaK1XK6U+hfm1WQBzQvpr1Cpfwak4cC77R/tPhuk39wuJYaRNDHeUr7D784n26AugEKn7zOJxG8z+O8jpbgAAKKXO6sBrv4LpSnsp+mqTUiobJomPvK91AI5WSmXFdE/8IAHPwYhKTJVSvWG60aK7nl4GsBHmOOoLk5DFdu3QIl0bSUJr/SqAfABvaq1fcE4QmQDejzzXWr/bysvfhQmy6U4fIICm/sDpzt9ae21rdPTyYuz72AiT9U9TSvWPcsmGKYv6J9pOQHs6/34SvVAp9VOYk2vsa0sQ1XfoXPr7JYC1Os7NipyD/SkAE5VS+8f8+Q6YPtxeMPv+ZZhLwtG86fwb75dihMcA/FApdViUVy7MqPmOsBzmC/g0AP+ntf466m+Rvv1ro1+glDoBwP/ClJL5gsRwE+kQwx1lJYARSqlJMcuvdv79dxK24ZZiAGUxScRA7L6aF/kc4sXJEzCf4y9j2rwE5mrbMc7zR2G6mS6I2kY2zKDMjnJBzPPZzr/R4y4ane0eBzM+48WYcSXUyBWJ5HIwzGjsCAfCnNDaRGtdr5S6DOZXxjtKqchAnwtgBmxNju3D7QCRIL1SKfW084umo1wGcynxXaXU3TC/ks+AudPgNVrrtn41fwLT//9rpVQezGCxQ2B+6YZgRthHUw/gQaXUD2EuYf4CZtBe7KDDaK4GMB7Af5RSf4KppviZ87hXa/0xACil/gBgrlLqMZgStXyYE0QtzBdKayyAuaXv80qpu2D25Tkwv7aB9i/l/hWmDG4MzIkrmqdgfrHPVkoNgSlRGwzzC/hrZ9t+IjGcHjHcUW6FGZj4iFLqHpgBlD+G+bJ+VGv9dBK24ZanAUxRSi2GGQz7A5irMJFxBpHPYStMN8lJSqmvYcYj3A9zVe2PzufyFsz4lothBjY/6Lx2qdPmIudq1ecwJaSJDGY+Sin1OMyxfSTMueIfWuuXYtb7K0wZ8jHYfcUvPfCjVCQdHzBZbSOAY53nCmak7jkJtPFjmHKyGphBRc8COCpmnXnoWOlcEUxdeghmVDactr+Ks26L5TCXV1c6HjUwB9+57b3OWT7Scd/mvP5dmF8GlznuB0a/HqYbIHLfhv8g6gZGznoPoeXNfIbBHJgVMOMKPoY5SKNLJTOcZR/C1HpXwYygPrADn8VgmF8r253P8UGYy8gawGHOOmMRVf4Z8/pXYfqXe8b5WzbMFYlI/f43MPXxe0atE7fttrYpMSwx3N4+jrcc5orKEpiqoRBMIjUbLW9IFa89DeChtrbR3vM2XtcDJiHYCJM4lcIk2kc46/0q6rVXwyQUtdhdnt0NwO+cz2eX8+8f0PKmVwUwN5Ha5Ozjf8AMku5o+ecxTqzshDmWb4JT6hznNaXOet2Sffz6+YjcMEMQUo5SahXMSWOwzyrNcCoVtumYygCl1K9gTmRDtdbxRnoLnYygxrAQTJzxUx9oraf47ZJMZIyEILRkIYAKpVTTaG5n4NupML8ev/LJSxAEUpRSY2C6Rx9sb102ZIyEILRkGcwYiZeVUstgLl+eAtO/fqFOvK9fEIROilLqHJixL8fC3OjtWX+Nko9ckRCEGLTWz8OUQIZgavZvg7kn/yla60TueCcIghCGuYPmlzDzvKTdeAIZIyEIgiAIgmvkioQgCIIgCK6RREIQBEEQBNdIIkGEUmqVUuqrJLU1VimllVLzOrDuNGfd2MdOpdRnSqkbnRv3tLd+vVLqO6XUk0qpg2K2Ma+V10Q/3m9n/Tql1Eal1KNKqSMSec9KqRyl1IXKTNC0VSkVUkp9oJSa49zVMhFP7ZQFCiQopR5yPrcG5xbHra33vrPeQzHLc5VSVyil3lJKbVdKfa+Uek8pdaVqfaKzyGvHOW1uVUrltLLOVxJTQlCRqg0ubsbuu7r5wX0A/hv1PB/mBknXAxiN3fMxtLZ+LszcARcDGKOU2l+3nAr5FuyeLTKWyjjLotfvAjOh0rkA/quUOltr/dc4r2mGMvMKPA5z98IVMLeqboAZZX0bgOOUUsdrM4vfozA3HoowAsCvYW5r/GjU8s0QGMmAGWHfokTPuRNp7C2toZQaAHPXyZEwcfQXmJt5HQFz58iLlVITtdbxZkYFzBwnNTC3dD4Ru2cAFQQKJJEgwqkm8JPXtdbLYpbd59xj4TRlZiN8o531oZT6P5hbKf8KLWfne15rvSoBpxbrK6UWwszU+IBSKnaui1gXBTP19/4wd3SMnkTpj0qpqwDcDvOFcIXW+gMAH0S9fixMIvFBvPcq0LEewEmIX+t/Msx9RJquWDhXEP4FcyfUY3Tz2yIvUuYW608BeEopta/WutlkYc7VrlMAPAwzz8o0SCIhkCFdG0IyeMT5t0V3Qiv8L8ytbA9rb0U3aDOr5kUwJZuXt7P6yTBXVW6NSSIibf0WwGcAzo2+QZWQtvwLwIRWPuuTsXvStQjnwsxHMlu3nFsBWus3YW6r/QMAV8Zp86cwtwJ/Geb+Asep+DOMCkJgkUSCiNgxEs7zZ5RSP1FKveP0629w+vFT+dlGbtDUoStcTh31TpjLv1bQWv8fzMRLP2ln1dOdf+9rY53jAQzUWu9MhpsQaB6H6bI7JnqhUqoPTKL8aMz658DMz/CXNtr8K8w8DvGmvz4L5oZn/4HpHsuCuRlamzhjJhYppS5QSn3ujFd6Wyl1iFKqr1LqH0qpHUqpcqXULdHnA6VUtlLqGqXUGqVUrfPaNUqpX8RsQyulrnbGfnyplNqllPpQKXVqzHodas9Z93il1CuO2yal1N+VUoPbe79CsJFEgp99YSaZWQXzy+dLADeg5ayTNvmx8+97HVlZmYGWxQBWx/lzd6VUr1YecQeitcFHMFMkt/W6A2GmKt7U2gpa669iL0kLacv/AdgC070RzUkw4xhejCxwuvQOBrBaax1qrUEncX4ZwF7RVxuUmWJ9IkwX4GaYLpBd6PjMkJNgbph2P4AbYW6/vAJmRtlGmK7DjwBcg+bJyYPO616BOWfcCDNx1QPKTJUezS9hJg1bAnNFpSvMTKGjEm1PKXU6zIRjPWAm6LoLJmF7USlV1MH3LAQQGSPBT38AJ2qtVwKAUuphmKmMzwJwd5K3VaDMhFaAuZrQH+ZkdgnM7IgvtrE+YAZD/hBmLoudMAMZY3m8je2f3M7fY9nm/NsT5hdhPPoiasyD0LnRWjcopf4N4ASlVEbU7dBPBvCk1nqXGVYDwMRVLszslO3xrfNvf+yOxVNgut8edba9XSn1AoCJSqmDtdZvt9NmfwD7a60/BAClVE+YL/tXtdanO8uWwwxSPhbAX5xE5kwAt2utr4k0pMw05Z/BXMF7KmobxQCGRRJtpdSbAN6AmZL92o6251wRuQNmFtPDIlf3lFJvw8zweiaSf74SUoQkEvzUwmT5AACtdUgpVQrzBZls/ug8otEwfbvnx7n1a7z1G2Gm2J6stf48zjZmw9yPPh6tLW+N7CjH1mgAkJlgu0J68zjMoMfDALzmXDn4MVp2OUQyinAH2qyPeQ1gvjyB5t0lj8JcpTgPQHuJxJeRJMIhcjw9Flmgta5RSn0HoJ/zfJPzfprmi3EGHEeOlYKYbfw35mpdpAS7b4LtHeg43BLdRai1fkEpdQjM9NoCKZJI8LM1ziRSu5Dgl6Nz+b9nzOKdWuvvo57/DsBzzv81TN/wWq11vLLM6PUzYKoirgGwFsDUNiop3k2waqMtimEShW1trLMJQJ8kbU9ID56HuWJ2Ikz1z09hviifilmvAiZBKOlAm/2df78FAKVUPwDjYb78ddQ4gTUwx9bpSqlZTslxa8SWGEcSmu9iljegeTf2LgBTlVLHAdgbwDAA3Zy/xXZ3V0Q/iboiE31+6Uh7g51/18a+iQ5ceRECjoyR4CdZM1EeAXOJNvpxV8w6n2itX3AeL2qt32wjiYhe/zmt9e9gLq/uD2BVTJdH0nF+Fe0P4FOtdV0bq74GYFBbI+WVUv+jlHpMKTUi2Z5C8HDGwzyH3eMkToYpM66OWU/DXF07WEXdkC0WJxZ/BGCd1jrSDXI6zPl3b5iS08jjHZirFj3QcpxGLK1dCWn1Cpzj+RrMmIdimPEU02HuvxKPNs8vCbQXSTxkcqc0RK5ICBHWAJgQs+zbeCu6RWv9jlLqagC/hxkgNimZ7ccwDkAvAPe2s96jMIPbLgDwm9g/On27FwLYB6kdwCr4y+MAHnQGFR4PYGYr6z0MUz58EYA/tLLOSTDlnzdFLTsT5kv1XAA7YtbfH2Yw4jSYgdTJ5DQAB8F0Rf45slAp1b/1lySlvcgVyKGxDSil/gzgNZlZlxdJJAQAgNZ6G8yvCdvcBWAygJOUUlO01o+094JEcfps74AZZf+ndlZfCTN47Gplbl61KubvN8Kc2P/kjKwXOgcrYboEFsCUg8bePyLCX2ASzduUUp9prZ+L/qNS6gCY0uL1AH7rLNsb5sv3Za310tgGlVJPwiStxyql+mutk5nQFzv/fhKzPJIoJfqd0NH23oHpJjlPKfVA5CqhUupImPEgiY5/EgKEJBJCStFaa6XUxTCln3cppZ5zkpgIE5RSe7TRxGNa65pW1s+F+eU3FaZP+syoS8lt+ZwOU3HyglLqnzC39c6HuVXy0c7zOR1/lwI7WuutytyB9TiYL/ytrazXqJSK3KjqGaXUowBegklCDoOpnvoawElRXSORQZYPtNJmvfMr/dcwAzxvT9LbAsz4jzCApUqpRTBjPE6AeZ912D22Iantaa3rlFJXwFzBeVUptcz520yYW9zL1QhiJJEQUo7W+mOl1G8BXAtTChp945pft/PyITBXGuKtH4YZgPZ/ABZord/poE+ZM3J8OszVkp/AJCWfwdTi/1FrXd9GE0J68jiAMWh5E6pmaK03K6WOhrk51XkwXRhZMPd0mQvg3phBy2cC+L6ddu8DcDVM90bSEgmt9UdKqVNguk5uhelW+QimW3M6gLFKqeyOxnsi7Wmtlymlvoc57m+DGQS9EsA1MT8OBDJUy4o9QRAEQRCEjiFVG4IgCIIguEYSCUEQBEEQXCOJhCAIgiAIrukMiYRO9uPdd9/VEyZM0F27dtWFhYX6hBNO0KWlpUnfTrIfFRUV+sILL9QlJSW6sLBQjx07Vr/xxhu+eyXy+OCDD3ROTo6eN2+e7y4deTz77LP6qKOO0vn5+bqgoEAfc8wxdPuc7ZEO+5wtzpnPLSk6n6c1UrWRIKWlpRg7dizy8/Nx/fXXAwAWLlyIH/3oR1izZg3693d7Xxe77NixA0cffTS+/fZbzJo1Cz169MCiRYswfvx4vPXWWxg1alT7jfhMOBzGtGnTUF/PUUDxyiuv4Pjjj8fIkSNx8803IxwO4+6778aYMWPw3//+F4cccojfimlHOuxztjhnPrewns8Dh9Y63R9J5ZJLLtEA9Hvvvde07K233tIA9OzZs5O9uaRx7bXXaqWUfuWVV5qWbdy4UXfp0kWfffbZPpp1nPnz5+ucnBwNQN9www1+67TLAQccoPfcc09dU1PTtGzTpk26R48e+phjjvHRLH1Jh33OFufM55YUns/9/h60+ugMXRtJZd26dejVqxdGjx7dtOzggw9GcXExPvzwwzZe6R9aazz00EOYOHEijj766Kblffv2xYIFC3DUUUf5aNcxPvzwQ/zmN7/Bdddd57dKh9i2bRvWrFmD0047Dfn5+U3LS0pKMGbMGLz22ms+2qUn6bDP2eKc/dzCeD4PIpJIJMhee+2FyspKVFTsnhSvsrISVVVV6Nevn49mrfPVV1+hvLwcEyaYqTS01qiuNjfZmz59Oi688EI/9dolHA7jvPPOw4QJEzB16lS/dTpEYWEhSktLMWvWrBZ/27JlC7KypFcx2bDvc8Y4Zz+3MJ7Pg4gkEgly1VVXYY899sAZZ5yBDz74AB9++CHOOOMM5OTk4LLLLvNbLy5r15qZe/v06YMrr7wSRUVF6NatG4YNG4aVK1f6bNc+t99+O9auXYvFixf7rdJhMjMzsddee7XoY/3ggw/w6quv4ogjjvDJLH1h3+eMcc5+bmE8nwcSv/tWUvBIOosXL9ZZWVlNI3IzMzP1Y489ZmNTSeGRRx7RAPSwYcP0iBEj9IMPPqgffvhhve++++qMjAz9/PPP+63YKh999JHOycnR9913n9Za6/Xr19P0HceyY8cOvf/++2ullF61apXfOp0Cln3OGufM55YIKTqf+/09aPXhu0AKHkll7ty5GoAeM2aMXr58uX744Yf14YcfrrOzs/UTTzyR7M0lhYcfflgD0L169dKVlZVNy7dt26Z79uypDzroIB/tWiccDuuDDjpIjx8/vmkZywk2lpqaGj1u3DgNQF9zzTV+63QKWPY5c5yznlsipPB87vf3oCQSHh9JY9u2bTo3N1cfdNBBOhwONy2vq6vT+++/vy4pKdGhUCiZm0wKK1as0AD0RRdd1OJv06ZN00opvWPHDh/M2ubWW2/VOTk5+q233tIVFRW6oqJCv/feexqAvvLKK3VFRYVuaGjwW7Ndtm3bpo888kgNQP/iF7/QjY2NfiulPUz7nDnOWc8tWqf8fO7396DVh4yRSIC1a9di165dOOOMM5CZmdm0PDs7G2eddRY2b96Mzz77zEfD+AwYMACA6ceMpU+fPtB69wCpIPHMM8+grq4OhxxyCHr37o3evXvjhz/8IQDgd7/7HXr37o2vv/7aZ8u2+e677zBu3Di8+uqruOiii3D//fdDKeW3VlrDts+Z45z13ALwns+DSLCHMQeM3NxcAEBDQ0OLv0WWNTY2ptSpI4waNQq5ubn4+OOPW/xt/fr1yMvLQ+/evX0wa5uFCxdi27ZtzZZt3rwZU6dOxdlnn41zzjkHffv29cmufXbs2IHjjjsO77//PmbNmoU77rjDb6W0h3GfM8c567kF4D2fBxK/L4mk4JE0wuGw7t+/v95nn330zp07m5bv3LlTjxgxQvfq1UvX1dUlc5NJ49RTT9XZ2dn6o48+alq2bt06nZubq6dMmeKjWWKw9B1rrfXZZ5+tAeiZM2f6rdJpSJd9zhTnrOeWFJ/P/f4etPqQKxIJkJmZiUWLFmHy5Mk45JBDcP7556OhoQF//vOf8dlnn2Hp0qXIzs72WzMuv/3tb7Fq1SqMGzcOM2fORE5ODu666y506dIFt9xyi996acenn36KpUuXoqioCAcccACWLVvWYh2WewWwIPvcH1jPLczn88DhdyaTgkfSefHFF/WYMWN0fn6+zs/P1z/60Y/0008/bWNTSeXLL7/UkydP1t27d9eFhYV64sSJ+pNPPvFbKyFYfqndc8897U7kIySXdNrnLHEegfnckqLzud/fg1YfSuu0n5gs7d+gIAiCEGiCO9o3CUjVhiAIgiAIrpFEQhAEQRAE10giIQiCIAiCaySREARBEATBNZJICIIgCILgGkkkBEEQBEFwjSQSgiAIgiC4RhIJQRAEQRBcI4mEIAiCIAiukUTCA7W1tX4ruIbVndUb4HZnhXWfs3oDvO6s3kFAEgkPbNiwwW8F17C6s3oD3O6ssO5zVm+A153VOwjnKbUXAAAgAElEQVRIIuGBoqIivxVcw+pu03tXfdha2wAweMhQq+3boiHc4LeCa4YPH+63giuG7bmntbYbQyFrbQNybumMyDTiguCQm52F0Rcustb+6iUz8PfbH7HWvi1OnzOF0puZ0+dMwbvKzjxPB6b/RI1CipErEh6oqqryW8E1rO6s3oLQWWA9Rlm9g4AkEh4YOHCg3wquYXVn9RaEzgLrMcrqHQQkkfBAeXm53wquYXVn9RaEzgLrMcrqHQQkkfBARgbv7mN1Z/UWhM4C6zHK6h0ElE7/gTfW3mB1dTUKCgpsNW8VVneb3rvqwsjNsTf+2Hb7tmhsaERGppxkU0njzp3I6NLFTtuhEDLy8qy0Dci5pRXsjJwNCHxntQBRXl5OW17G6m7TOzcnS6oT4iBVG6nn9DlTrLVtM4kA5NzSGZGfGR7o2bOn3wquYXVn9RaEzgLrMcrqHQQkkfBAOGz3BkY2YXVn9RaEzgLrMcrqHQQkkfDA9u3b/VZwDas7q7cgdBZYj1FW7yAgiYQHBg0a5LeCa1jdWb0FobPAeoyyegcBqdrwQGlpKe3gHFZ3m97Wqzbqw8jN5hvfzFy1YbNCwWbbu0K7kJuXa6Vt28i5JS5StSHEJycnx28F17C62/TOzZG5NuLBXLXBOmfFtxu/xZAhQ6y1bxM5t3Q+OH9mBITi4mK/FVzD6s7qLQiJwBznrO6s3kFAEgkPbNy40W8F17C6s3oLQiIwxzmrO6t3EJBEwgO9evXyW8E1rO6s3oKQCMxxzurO6h0EJJHwQCgU8lvBNazurN6CkAjMcc7qzuodBKRqwwOso5MBXnerVRuWqypY59oI14eRRVhtAnDPWcFKXXU1cgjn2pCqDfdIIuGBUCiEPNITCas7q3cExuoHqdoQEsFmNYtNLJ9b0joIpWvDA2VlZX4ruIbVndVbEIRgI+cW90gi4QHmX8as7qzegiAEGzm3uEcSCQ8UFRX5reAaVndWb0EQgo2cW9wjiYQHNm3a5LeCa1jdWb0FQQg2cm5xjwy29EBlZSXtHPas7qzeAG/1A6s3YLdqQ4hPuLYWWfn5fmskjOVzS1oPtuQ8OwSEmpoa2i81VndWbwDIys6irH6Qqo30wnZVxcatWzGQMJFgPrf4jXRteKC2ttZvBdewurN6C0JngfUYZfUOApJIeIB5/npWd1ZvQegssB6jrN5BQBIJDzDXHbO6s3oLQmeB9Rhl9Q4CMkbCA/mE/YARWN1ZvQEzaPH0OVP81kgYVm/ADLZkvdOiLWzf2pv1GGX1DgKSSHiga9eufiu4htWd1RuQwZZ+YHOwpc0ExWYFge35QViPUVbvICBdGx6oqKjwW8E1rO6s3oKQCMxxzurO6h0EJJHwQN++ff1WcA2rO6u3ICQCc5yzurN6BwFJJDxQVVXlt4JrWN1ZvQUhEZjjnNWd1TsISCLhgVAo5LeCa1jdWb0FIRGY45zVndU7CMgtsj1gef56q7C6s3oDvLeabmxoREYm528Om7fItln9wBznrO6WvdP69qp8Z7UAUVZWhuHDh/ut4QpWd1ZvQKo2/MBm2arN6gfmOGd1Z/UOApw/MwJCQUGB3wquYXVn9RaERGCOc1Z3Vu8gIImEBxgv30VgdWf1FoREYI5zVndW7yAgiYQHtmzZ4reCa1jdWb0FIRGY45zVndU7CEgi4YF+/fr5reAaVndWb0FIBOY4Z3Vn9Q4CMtjSA1u3bkVhYaHfGq5gdWf1BnjnrNCNmtIb4K2UYY5zVndW7yDAd4QFiLq6Or8VXMPqzuoNSNWGH7AmQMxxzurO6h0EpGvDA8zz17O6s3oLQiIwxzmrO6t3EJBEwgPM89ezurN6C0IiMMc5qzurdxCQRMIDzP1prO6s3oKQCMxxzurO6h0EJJHwQFYW7xATVndWb0FIBOY4Z3Vn9Q4Csuc8UFlZid69e/ut4QpWd1ZvQKo2/IC1aoM5zlndWb2DgEza5YHq6mra26qyurN6R2CsfpCqjdTDHOes7pa903rSLuna8MDmzZv9VnANqzurtyAkAnOcs7qzegcBSSQ80NjY6LeCa1jdWb0FIRGY45zVndU7CEgi4YEBAwb4reAaVndWb0FIBOY4Z3Vn9Q4Ckkh4YMOGDX4ruIbVndVbEBKBOc5Z3Vm9g4AMtvTA5s2bUVJSYqt5q7C62/TeVR9GLuEIf8Cue2NDIzIyOX9zNO7ciYwuXey0HQohw9LU06zHJ8Drbtk7rQdbcp41BcECudlZGH3hIr81XLF6yQxrlRXsVRvvKjvn8APT/0eYIHQIzp8ZAaGqqspvBdewurN6C0IiMMc5qzurdxCQRMIDAwcO9FvBNazurN6CkAjMcc7qzuodBCSR8EB5ebnfCq5hdWf1FoREYI5zVndW7yAgiYQHMjJ4dx+rO6u3ICQCc5yzurN6BwGp2vAA661gAV53m97UVRt1YeTm2HFnna8C4K3aEOJjc5/LLbLdw3l2CAjl5eUYPny43xquYHW36Z2KJIKx+kGqNoSgYLNShvWcGATkWo4Hevbs6beCa1jdWb0FQQg2cm5xjyQSHgiHw34ruIbVndVbEIRgI+cW90gi4YHt27f7reAaVndWb0EQgo2cW9wjiYQHBg0a5LeCa1jdWb0FQQg2cm5xj1RteKC0tJR2cA6rO6s3wFv9YNPbduWDVFakFzY/T8vnlrQe8ct3VgsQOTk5fiu4htWd1RsAsrKzKKsfbFZtMFdV2KwgWL9+PYYMGWKtfZvYdLeZFDKfW/xGujY8UFxc7LeCa1jdWb0FIRGY45zVndU7CEgi4YGNGzf6reAaVndWb0FIBOY4Z3Vn9Q4Ckkh4oFevXn4ruIbVndVbEBKBOc5Z3Vm9g4AkEh4IhUJ+K7iG1Z3VWxASgTnOWd1ZvYOADLb0QHV1td8KrmF1Z/UGgFBdPU6fM8VK2zbnCQnXh615N+7caXXQok1szuPBHOes7qzeQUDKPz0QCoWQR1paxurO6h1h9IWLrLS7eskMq5UVjNUmgN2qEJsJEHOcs7pb9uYsTeog0rXhgbKyMr8VXMPqzuotCInAHOes7qzeQUASCQ8wZt0RWN1ZvQUhEZjjnNWd1TsISCLhgaKiIr8VXMPqzuotCInAHOes7qzeQUASCQ9s2rTJbwXXsLqzegtCIjDHOas7q3cQkMGWHqisrKSdw57VndUbAHbVhZGbY6eywmbbjQ2NyMjk/M1hs7LC5rwPzHHO6m7ZO60HW0r5pwdqamooDxiA153VGwByc2SujVRjq2wVsDvvA3Ocs7qzegcBzp8ZAaG2ttZvBdewurN6C0IiMMc5qzurdxCQRMIDzPPXs7qzegtCIjDHOas7q3cQkETCA8x1x6zurN6CkAjMcc7qzuodBCSR8EB+fr7fCq5hdWf1FoREYI5zVndW7yAgVRseYB2dDPC6s3oDZs6KLEvzYdhEN2qoDM5B5/V19cjOyfZbI2GY45zVXao23MN3VgsQFRUVlAcMwOvO6g0AWdlStRGvbZusW78Ow4cPt7oNGzDHOas7q3cQkK4ND/Tt29dvBdewurN6C/7AGi+s3gCvO6t3EJBEwgNVVVV+K7iG1Z3VW/AH1nhh9QZ43Vm9g4AkEh4IhUJ+K7iG1Z3VW/AH1nhh9QZ43Vm9g4AkEh5grjtmdWf1FvyBNV5YvQFed1bvICBVGx4oLS2lHMgF8LqzegNStREP2/uENV5YvQFed8veUrUhxKegoMBvBdewurN6A1K10VrbNmGNF1ZvgNed1TsISNeGB/IsTtpjG1Z3Vm/BH1jjhdUb4HVn9Q4Ckkh4YMuWLX4ruIbVndVb8AfWeGH1BnjdWb2DgCQSHujXr5/fCq5hdWf1FvyBNV5YvQFed1bvICCJhAe2bt3qt4JrWN1ZvQV/YI0XVm+A153VOwjIYEsP1NXV+a3gGlZ3Vm8A2BXaZX1woQ10o7bm3RBuQGZWppW2AaB/v/7W2rYJc5yzurN6BwEp//RAKBSiHaDD6s7qDdh3t1lZwVhtAtivCrGFxHnqseyd1uWf0rXhAeb561ndWb0BbnchtTDHCqs7q3cQkETCA4WFhX4ruIbVndUb4HYXUgtzrLC6s3oHAUkkPJCVxTvEhNWd1RvgdhdSC3OssLqzegcBSSQ8UFlZ6beCa1jdWb0BbnchtTDHCqs7q3cQkMGWHqiurqa9rSqru03vXfVh5BLOhQEAu+rCyM2x497Y0IiMTDu/ORpDIWRYHJjXuHMnMrp0sda+LViPT4DX3bJ3Wg+25DxrBoTNmzdTHjAAr7tN79zsLIy+cJGVtm2zeskMyqqN0+dMwbvK3jn2QNIfSqzHJ8DrzuodBKRrwwONjY1+K7iG1Z3VWxASgTnOWd1ZvYOAJBIeGDBggN8KrmF1Z/UWhERgjnNWd1bvICCJhAc2bNjgt4JrWN1ZvQUhEZjjnNWd1TsIyGBLD2zevBklJSW2mrcKq7tNb+bBlqG6MPIsDbYM14eRZWm/2B4MaXswpy3CNTXI6trVbw1XyLklLjLYUhA6A6lIImwN5pTBlukF6yBRoXMiXRseqKqq8lvBNazurN6C0FlgPUZZvYOAJBIeGDhwoN8KrmF1Z/UWhM4C6zHK6h0EJJHwQHl5ud8KrmF1Z/UWhM4C6zHK6h0EJJHwQEYG7+5jdWf1FoTOAusxyuodBKRqwwOst4IFeN1ZvQG7lRVStZFeMO8X1mNUbpHtHqna8EB5eTmGDx/ut4YrWN1ZvQEgL8feLbhZqzZsw1oVwly1wXqMsnoHAbmW44GePXv6reAaVndWb0HoLLAeo6zeQUASCQ+Ew2G/FVzD6s7qLQidBdZjlNU7CEgi4YHt27f7reAaVndWb0HoLLAeo6zeQUASCQ8MGjTIbwXXsLqzegtCZ4H1GGX1DgJSteGB0tJS2sE5rO6s3gAQqqtHXk62lbZ31YWRS1i1YRvW6oe66mrkEFY+ALzHqGVvvhG/CcB5dggIOTk5fiu4htWd1RsA8nKyKasfpGojPjYrK8orKjCENJFgPUZZvYOAdG14oLi42G8F17C6s3oLQiIwxzmrO6t3EJBEwgMbN270W8E1rO6s3oKQCMxxzurO6h0EJJHwQK9evfxWcA2rO6u3ICQCc5yzurN6BwFJJDwQCoX8VnANqzurtyAkAnOcs7qzegcBGWzpgerqar8VXMPqzuoNmKqN0+dMsdL2rvowci1VVoTrw9a8G0MhZOTlWWkbMFUbtgZF2nRnjnNWd1bvICDlnx4IhULIs3gStAmrO6t3BJlro2XbNufCYJ2zgjnOWd0te6d1+ad0bXigrKzMbwXXsLqzegtCIjDHOas7q3cQkETCA4xZdwRWd1ZvQUgE5jhndWf1DgKSSHigqKjIbwXXsLqzegtCIjDHOas7q3cQkETCA5s2bfJbwTWs7qzegpAIzHHO6s7qHQRksKUHKisraeewZ3Vn9QaAUF0YeZbmw7DZts25NmzPhcE61wZznLO6W/ZO68GWUv7pgZqaGsoDBuB1Z/UGgLycLKnaiNO2VG20hDnOWd1ZvYOAdG14oLa21m8F17C6s3oLQiIwxzmrO6t3EJBEwgPM89ezurN6C0IiMMc5qzurdxCQRMIDzHXHrO6s3oKQCMxxzurO6h0EJJHwQH5+vt8KrmF1Z/UWhERgjnNWd1bvICBVGx5gHZ0M8LqzegO8VRuNDY3IyLTzm8N2VUW4thZZhF8QzHHO6i5VG+6Rqg0PVFRUUB4wAK87qzcgVRuttW2TLzdswPDhw61uwwbMcc7qzuodBKRrwwN9+/b1W8E1rO6s3oI/sMYLqzfA687qHQQkkfBAVVWV3wquYXVn9Rb8gTVeWL0BXndW7yAgiYQHQqGQ3wquYXVn9Rb8gTVeWL0BXndW7yAgiYQHmOuOWd1ZvQV/YI0XVm+A153VOwhI1YYHSktLKQdyAbzurN4AEKqrR15OtqW27VVt6EYNlWFn0LnNeTwA3nhh9QZ43S17S9WGEJ+CggK/FVzD6s7qDQB5OdlStRGnbZuwxgurN8DrzuodBKRrwwN5eXl+K7iG1Z3VW/AH1nhh9QZ43Vm9g4AkEh7YsmWL3wquYXVn9Rb8gTVeWL0BXndW7yAgiYQH+vXr57eCa1jdWb0Ff2CNF1ZvgNed1TsISCLhga1bt/qt4BpWd1ZvwR9Y44XVG+B1Z/UOAjLY0gN1dXV+K7iG1Z3VGzBVG6uXzLDUdtjawEXdqK21bbtqgzVeWL0BXndW7yAg5Z8eCIVCtAN0WN1ZvSNI1UbLtm3CGi+s3gCvu2XvtC7/lK4NDzDPX8/qzuot+ANrvLB6A7zurN5BQBIJDxQWFvqt4BpWd1ZvwR9Y44XVG+B1Z/UOApJIeCAri3eICas7q7fgD6zxwuoN8LqzegcBSSQ8UFlZ6beCa1jdWb0Ff2CNF1ZvgNed1TsIyGBLD1RXV9PeVpXVndUbsDsfhsy1ER/WeGH1BnjdLXun9WBLuZbjgc2bN1MeMACvO6s3AOTlZEnVRpy2bcIaL6zeAK87q3cQkK4NDzQ2Nvqt4BpWd1ZvwR9Y44XVG+B1Z/UOApJIeGDAgAF+K7iG1Z3VW/AH1nhh9QZ43Vm9g4AkEh7YsGGD3wquYXVn9Rb8gTVeWL0BXndW7yAgiYQHioqK/FZwDas7q7fgD6zxwuoN8LqzegcBqdrwwObNm1FSUmKreauwurN6A8DOUB265OVYaXtXXRi5lqo2GhsakZFp5zdH486dyOjSxUrbtmkMhZBh6ZbKzHHO6m7ZW6o2hPhUVVVRHjAArzurNwB8XbYew4cPt9J2bk4WbdXGu4rzHHugxR9hzHHO6s7qHQSka8MDAwcO9FvBNazurN4At7uQWphjhdWd1TsISCLhgfLycr8VXMPqzuoNcLsLqYU5VljdWb2DgCQSHsjI4N19rO6s3gC3u5BamGOF1Z3VOwjInvMAc38aqzurN8DtLqQW5lhhdWf1DgJSteGB0tJSa4PnbMPqzuoN2HW3OWeFzbapqzYsukucpx7L3pwjijuIVG14oGfPnn4ruIbVndUbsOuelS1VG6nGZtWGxHnqYfUOAtK14YFwOOy3gmtY3Vm9AW53IbUwxwqrO6t3EJBEwgPbt2/3W8E1rO6s3gC3u5BamGOF1Z3VOwhIIuGBQYMG+a3gGlZ3Vm+A211ILcyxwurO6h0EJJHwQFlZmd8KrmF1Z/UGuN2F1MIcK6zurN5BQAZbeiAnx868CamA1Z3VG7DrHq4P4/Q5U6y03djQaK/tnTutDlq0ic25NiTOUw+rdxCQRMIDxcXFfiu4htWd1Ruw685ctWGT7du3o7Cw0ErbtpIIQOLcD1i9g4B0bXhg48aNfiu4htWd1RvgdmeFdZ+zegO87qzeQUASCQ/06tXLbwXXsLqzegPc7qyw7nNWb4DXndU7CEgi4YFQKOS3gmtY3Vm9AW53Vlj3Oas3wOvO6h0EZIyEB6qrq/1WcA2rO6s3ABT1tNcHu6uOd7ClzVtkDxgwwFrbNundvbvfCq5hPUZZvYOAzLXhgVAohDyLA65swurO6h1h9IWLrLS7eskM2sGWrLfItglrJQvAe4xa9k7rIJeuDQ8w1x2zurN6C0JngfUYZfUOApJIeIAx647A6s7qLQidBdZjlNU7CEgi4YGioiK/FVzD6s7qLQidBdZjlNU7CEgi4YFNmzb5reAaVndWb0HoLLAeo6zeQUAGW3qgsrKSdg57VndWbwAI1YWRl2OnUMpm2+H6MLKy7bRtu2qDlXBtLbLy8/3WcAXrMWrZO60HW0r5pwdqamooDxiA153VGwDycrKkaiNO26xVGzYrKzZu3YqBpIkE6zHK6h0EpGvDA7W1tX4ruIbVndVbEBKBOc5Z3Vm9g4AkEh5gnr+e1Z3VWxASgTnOWd1ZvYOAJBIeYK47ZnVn9RaERGCOc1Z3Vu8gIImEB/JJ+zABXndWb0FIBOY4Z3Vn9Q4CUrXhAdbRyQCvO6s3IFUb8WCu2mgMhZBh6SZGzHHO6i5VG+6Rqg0PVFRUUB4wAK87qzcgVRuttW2zasNmZYWtJALgjnNWd1bvICBdGx7o27ev3wquYXVn9RaERGCOc1Z3Vu8gIImEB6qqqvxWcA2rO6u3ICQCc5yzurN6BwFJJDwQCoX8VnANqzurtyAkAnOcs7qzegcBSSQ8wFx3zOrO6i0IicAc56zurN5BQKo2PFBaWorhw4fbat4qrO6s3gBQszOErl3sDNDbVRdGrlRttGzfYmWFkHpsfp6Wzy1StSHEp6CgwG8F17C6s3oDQFXlVnQdMMBK27k5WVK1IaQ9NqtwmM8tfiNdGx7II/6lw+rO6g1wuwtCuiPHp3skkfDAli1b/FZwDas7qzfA7S4I6Y4cn+6RRMID/fr181vBNazurN4At7sgpDtyfLpHEgkPbN261W8F17C6s3oD3O6CkO7I8ekeGWzpgbq6Or8VXMPqzuoN2HUP14dx+pwpdG037txpdQCdkF7YrNpgPrf4jZR/eiAUCtEO0GF1Z/UG7LtL1YbQEWwnbqzHqGXvtA5y6drwAPP89azurN4At7sgdBTWOGf1DgKSSHigsLDQbwXXsLqzegPc7oLQUVjjnNU7CEgi4YGsLN4hJqzurN4At7sgdBTWOGf1DgKSSHigsrLSbwXXsLqzegPc7oLQUVjjnNU7CMhgSw9UV1fT3laV1Z3VG7DrbnM+DOa5NoSW2J5/hPUYteyd1oMt5VqOBzZv3kx5wAC87qzegF33rGyZayMerKWlX375JYYOHWqlbduTmLEeo6zeQUC6NjzQ2Njot4JrWN1ZvQFudyG1MMcKqzurdxCQRMIDAyzN5JgKWN1ZvQFudyG1MMcKqzurdxCQRMIDGzZs8FvBNazurN4At7uQWphjhdWd1TsISCLhgaKiIr8VXMPqzuoNcLsLqYU5VljdWb2DgAy2FIQ0QObaaKX92lpk5Odba18QBEkkPFFVVYWSkhK/NVzB6s7qDdh1l6qN+LBWbUicpx5W7yAgXRseGDhwoN8KrmF1Z/UGuN2F1MIcK6zurN5BQBIJD5SXl/ut4BpWd1ZvgNtdSC3MscLqzuodBCSR8EBGBu/uY3Vn9Qa43YXUwhwrrO6s3kFA9pwHmPvTWN1ZvQFudyG1MMcKqzurdxCQuTY8UFpaiuHDh9tq3iqs7qzegF13q/NhNDQiI9PObw7bc23UVVcjh/C2xxLnqceyt8y1IcSnZ8+efiu4htWd1Ruw685ctWGT73fuRG/CRELiPPWwegcB6drwQDgc9lvBNazurN4AtzsrrPuc1RvgdWf1DgKSSHhg+/btfiu4htWd1RvgdmeFdZ+zegO87qzeQUASCQ8MGjTIbwXXsLqzegPc7qyw7nNWb4DXndU7CEgi4YGysjK/FVzD6s7qDXC7s8K6z1m9AV53Vu8gIIMtPZCTk+O3gmtY3QcOGuy3gmtsj2S3NXBR19dbHxRpix+QTg3NenwCvO6s3kFAEgkPFBcX+63gGlb3/LxcjL5wkd8anYrVS2ZYnQ/DJqxzbbAenwCvO6t3EJCuDQ9s3LjRbwXXMLsLQrrDfHyyurN6BwFJJDzQq1cvvxVcw+wuCOkO8/HJ6s7qHQQkkfBAKBTyW8E1zO6CkO4wH5+s7qzeQUASCQ9UV1f7reAaZndBSHeYj09Wd1bvICBzbXggFAohLy/PVvNWYXUP1dUjLyfbb41Ohe35MGzSGAohw1Kc22yb9fgEeN0te3OOVu4gUrXhgbKyMsrJaQBe97L166x6S0VIS5irNmxisyKE9fgEeN1ZvYOAdG14gDHrjsDqzuotCInAHOes7qzeQUASCQ8UFRX5reAaVndWb0FIBOY4Z3Vn9Q4Ckkh4YNOmTX4ruIbVndVbEBKBOc5Z3Vm9g4AkEh7o3bu33wquYXVn9RaERGCOc1Z3Vu8gIIMtPVBTU4OePXv6reEKVneb3qG6MFYvmWGlbWYad+6kvdW0TWxWs7AenwCvO6t3EJBEwgO1tbV+K7iG1d2md15OllRtxEGqNuJjM7liPT4BXndW7yAgXRseYJ6/ntWd1VsQEoE5zlndWb2DgCQSHmCev57VndVbEBKBOc5Z3Vm9g4AkEh7Iz8/3W8E1rO6s3oKQCMxxzurO6h0EJJHwQNeuXf1WcA2rO6u3ICQCc5yzurN6BwEZbOmBiooK2lG+rO42vaVqIz5StREfm3NtsB6fAK87q3cQkETCA3379vVbwTWs7ja9pWojPjarNmwnKN9//z26d+9upW1bSQTAe3wCvO6s3kFAujY8UFVV5beCa1jdWb0Ff2CNF1ZvgNed1TsISCLhgVAo5LeCa1jdWb0Ff2CNF1ZvgNed1TsISCLhAea6Y1Z3Vm/BH1jjhdUb4HVn9Q4CSqf/ICprb7C0tJR2/npWd5veobow8nJk2FAsNm8FbbNtQOLcD1jdLXun9a1h5azpgYKCAr8VXMPqbtNbBlvGh3mwpcR56mF1Z/UOAtK14YE8i6O2bcPqzuot+ANrvLB6A7zurN5BQBIJD2zZssVvBdewurN6C/7AGi+s3gCvO6t3EJBEwgP9+vXzW8E1rO6s3oI/sMYLqzfA687qHQQkkfDA1q1b/VZwDas7q7fgD6zxwuoN8LqzegcBGWzpgbq6Or8VXMPqbtN7V73cIjseNm+RbfM20wAwZMgQa23bZEDv3n4ruEbOLZ0PKf/0QCgUoh2gw+rO6h2BsSrEZtWGEB/muU1Yj1HL3ml9AEnXhgeY569ndWf1FoTOAusxyuodBCSR8EBhYaHfCq5hdWf1FoTOAusxyuodBCSR8EBWFu8QE1Z3Vm9B6CywHqOs3kFAEgkPVFZW+q3gGlZ3Vm9B6CywHqOs3kFABlt6oLq6mva2qqzurN4A71wetufDEFrSUFuLzPx8vzVcwXqMWvZO68GWfGe1ALF582bKAwbgdc80V5MAACAASURBVGf1Bnjn8pCqjfjYrKz4auNGDB061Fr7NmE9Rlm9g4B0bXigsbHRbwXXsLqzegtCIjDHOas7q3cQkETCAwMGDPBbwTWs7qzegpAIzHHO6s7qHQQkkfDAhg0b/FZwDas7q7cgJAJznLO6s3oHAUkkPFBUVOS3gmtY3Vm9BSERmOOc1Z3VOwjIYEtBSBGhOs65PGzOtcGMVLMIgkESCQ9UVVWhpKTEbw1XsLqzegNStZFu2EyumOOc1Z3VOwhI14YHBg4c6LeCa1jdWb0FIRGY45zVndU7CEgi4YHy8nK/FVzD6s7qLQiJwBznrO6s3kFAEgkPZGTw7j5Wd1ZvQUgE5jhndWf1DgKy5zzA3J/G6s7qLQiJwBznrO6s3kFA5trwQGlpKYYPH26reauwurN6A0Corh55Odl+aySMVCfEx+Z+YY5zVnfL3mk9WlmqNjzQs2dPvxVcw+rO6g0AeTnZUrWRRtis2mCOc1Z3Vu8gIF0bHgiHw34ruIbVndVbEBKBOc5Z3Vm9g4AkEh7Yvn273wquYXVn9RaERGCOc1Z3Vu8gIImEBwYNGuS3gmtY3Vm9BSERmOOc1Z3VOwhIIuGBsrIyvxVcw+rO6i0IicAc56zurN5BwI/BlscBuAFAX5AnMj/4wQ/8VnANqzurN2CqNmSujfShMRRCRl6elbZzcnKstJsKWN1ZvYNAqhOJ4wAsAlAHYBsslmZGYe16FfMNTFjdWb0BqdrwA5sJkK0kAgCKi4uttW0bVndW7yCQ6rPyDTBJxE6kJomwSn19vd8KrmF1Z/UWhETYuHGj3wquYXVn9Q4CqU4k+gIIpXib1sjK4r0NB6s7q7cgJEKvXr38VnANqzurdxBIdSKRgTS4EhGhsbHRbwXXsLqzegtCIoRCvL+3WN1ZvYMAb4dzAGD+UmN1Z/UWhESorq72W8E1rO6s3kEg1XNtfAVgSyo3CODAZDY2bdo0fPPNN3jhhRfQ2NjYYvDf2LFj8corrzQ9V0qha9euGD16NObPn4+xY8fGXQ8AcnNz0b9/f5xxxhmYP38+MjMzAQCDBw9utTRp5MiR+Oijj5q2FdvekCFDcNZZZ+Gqq65qNipZKYWlS5di6tSpTcs2btyI22+/HStXrsS3336LkpISHH/88bjuuuvQv3//uNuI5YYbbsC8efPaXMcL8fY5C6G6MPJy+LpmmOfaYHUPhULIsziY0yas7pa9OUcrdxC+s1qAqKurixt4Z555JhYuXAgA0FqjsrISc+fOxfHHH49PP/0UgwcPbrEeAHz//ff45z//iblz56KwsBBz5sxp+tucOXNw+eWXt9hWdnbzSaAWLVqEU045BVpr7NixA6+88gquvPJKrFmzBv/7v//b6nv55JNPMH78eIwYMQKLFy/GXnvthXXr1uHaa6/Fj370I7z66qvo169fswFJCxYswIoVK/D66683LSsoKGhnr3mjtX3OQF5OllRtpBjWstWysjLKia8AXndW7yAgiYQHWvt13qVLF/Tt27fpeb9+/XD33Xejf//++Ne//oWZM2fGXa9v37649tpr8dJLL+GRRx5plkgUFBQ0W7c1unfv3rRev379sPfee6NXr174+c9/jmeeeQY/+clP4r5u6tSpGDZsGJ577rmm5GTw4MF49tlnsffee2P+/Pm45557mjkUFBQgMzOzQ17Jor0rIoKQDrAmywCvO6t3EJBEwgORroeOEKk2yM3NbXfd3NzcpFYnTJo0CXvuuSf+/ve/x00k3n77baxevRorV65scYWjsLAQTz75JPr06ZM0Hy8kss8FgZWioiK/FVzD6s7qHQQ4O5sDQkdni9u4cSMuu+wy5Ofn4/jjj291vbq6OixduhTPPfdcs7ELXlFKYdSoUfjwww/j/v3dd98FABx22GFx/37ggQdi4MCBSfPxgszQJ3QGNm3a5LeCa1jdWb2DgCQSHmjtqsFf/vIXFBQUoKCgAHl5eejfvz9Wr16NRx55pNnEMNHrFRQUoEuXLrj55pvx+9//HpdeemmzNm+66aZm60Ye9913X4dce/To0ersdtu2bQPAkZHLfSSEzkDv3r39VnANqzurdxCQs7JLli9fjosvvrjp+dSpU7F48WIAwMknn4xbbrkFgLkU36NHj7hf0pH1Ghsb8Z///AezZ8/GpEmTWiQRAPA///M/mD59eovlHQ3+7du3t5ooRG7EUllZGZgujNZgLv+UuTZST31NDbK7dvVbI2FqamrQs2dPvzVcwerO6h0EJJFwyYknnogDDjigacxDYWFh098KCwsxbNiwdtuIXm/vvfdGUVERTj31VBQVFeHqq69utm7Pnj071GY8tNZYvXp1q90qhx9+OADgjTfewIknntji7wsXLsTatWubEiU/YU4kZK6NlthOUNZ98w3lSPza2lq/FVzD6s7qHQSka8Ml3bp1w4gRIzBs2DAMGzYsKb/kJ0+ejDPPPBPXX399q+MZ3LBy5Up88803OOuss+L+fdSoUTjkkENw2223tRiDsHXrVixcuDAwYxNkhj4hEaK7Eplg9QZ43Vm9g4AkEh6oq6tLept33nknCgsLcdFFFzX79V1dXY1NmzbFfUTfVOz7779vWv7555/j/vvvx3nnnYepU6dizJgxrW53yZIlKC0txbHHHosXX3wR69evx5NPPonx48c3jd0IAjb2uZC+tHYjt6DD6g3wurN6B4FAdG2MvnBRUu8+2VG89lfbuMNi7969cccdd+Dcc8/FokWLcNlllwEAbr/9dtx+++1xX1NRUdE0zmHGjBmYMcO8r6KiIgwdOhQ33ngjfvnLX7a53f322w9vvvkmbrnlFpx33nn47rvv0L9/f0ycOBFz585FSUlJEt+le1jvain4Q35+vt8KrmD1BnjdWb2DQCBukc2aSITDYdoqAlZ3Vu8IMkaiObbHSFRWVlIOoGP1BnjdLXun9Z30eM/IAYD5S43VndUbkKqN1tq2ORdGRUUF5ZcaqzfA687qHQQ4z8gBgfULDeB1Z/UGpGojHravSKTy9u3JhNUb4HVn9Q4C0uHsgYaGBr8VXMPqzuot+ENVVZXfCq5g9QZ43Vm9g4AkEh5I8fiSpMLqzuot+EMoFPJbwRWs3gCvO6t3EJBEwgV1dXU44IADsG7duqS0t2rVKiil8M033ySlvY6Q6P0YXn/9dbz66quetllZWYk///nPntpIxPvjjz/GwQcfHJh7YAiph/XeAKzeAK87q3cQkETCBb/5zW9w5JFH4gc/+EFS2jviiCOwceNG9O/fPyntdYRE78dw9NFHY+3atZ62OWfOHDz88MOe2kjEe+TIkTjggANaLZsV0h/WewOwegO87qzeQYB35JpPVFZW4o477sCaNWuSdk+DnJyclA/0SdQ9GV0KyWgjUe8rrrgChx56KGbMmIHu3bt73r4XQnVhqdqI07bNqo2CggJrbduE1RvgdWf1DgKSSCTIvffei+HDh2Po0KFNl8yVUli6dGmzqb+jl02bNg2ZmZno2rUrli9fjl27duHEE0/Evffei27dumHVqlUYN24cNmzYgD322APbtm3DpZdeipUrV6Jr166YO3cu/vCHP+Dqq6/GtGnTMG/ePCxbtgxffPFF0/Zil23YsAGzZs3Cc889hy5dumDcuHG44447mq56xH4hl5aW4tJLL8Ubb7wBpRTGjRuHO++8E4MHD8bgwYPR0NCA8847Dw899FBTV8x1113X1FXxzjvvYPPmzbjmmmvw2muvoba2FkOGDMG1116Lc845B/PmzcMDDzzQtG/Wr1+PwYMHY8mSJViwYAG+/vprDBs2DLNnz8a5557b5PXmm29i1qxZWL16NQYPHoxZs2bh4osvxvr16/H4449j/vz52LRpU1OXR3V1NUpKSrB8+XJMmjQJI0aMwKBBg7BkyRLMnj072eGQEHk5WVK1EYPtqo28vDyr7duC1RvgdWf1DgKBSCRWL5nxrsXmk3qzqyeeeAITJ04EkNg9DZYtW4YLLrgAr7/+Or744gucdtpp2GeffTB37twW606ePBmbNm3CM888g4yMDFxyySVYv359hx1ramowduxYHHHEEXjttdcQDocxf/58jB8/Hh988AFycnJauJ955pn44Q9/iLvvvhu1tbWYPn06fvGLX+Cll17C22+/jX79+mHhwoU4++yzm16zZMkSPP3006irq0O3bt2w//7744QTTsCbb74JrTUWLlyICy+8EMcddxxmz56NtWvXYv369Xj00UfRu3dv3HPPPbjhhhtw9913Y/To0Xj99deb7sp57rnnory8HBMmTMCUKVPwwAMP4OOPP8Yll1zSzPnKK6/Ek08+iZNPPhkAsGLFCnTt2rXpMwKAiRMn4oknnvA9kRBSz5YtW1BcXOy3RsKwegO87qzeQSAQiQQLjY2NeOedd3D55ZcDALKzszv82uLiYvzhD39AZmYm9t57b0yYMAGvv/56i/U++eQTvPTSS1i1alXTrJzLly/HyJEjO7ytv/3tb6ipqcFDDz2EzMzMpmW9evXCihUrcMYZZ7Rw/+KLL3Dsscdi8ODByMrKwrJly7Bp0yYAu6cq7969e7MbtkybNg0HHHAAAOC7777DFVdcgUsvvbTpVrO//vWvcf/99+Pzzz/HUUcdhS5dujTrxrn55ptxww03YPLkyQCAoUOHoqysDLfccgvOPfdc3HfffejVqxcWL16MzMxMjBgxAt9++y1mzpwJAOjTpw9++tOfYtmyZU2JxNKlS3HmmWc2e3+jRo3C73//+w7vPyF96Nevn98KrmD1BnjdWb2DgAy2TICtW7ciHA43zWuRSDXA0KFDm77UAfOlHG/g4McffwwAOPjgg5uW7bPPPk3b7AirV69GRUUFunfvjoKCAhQUFKC4uBg1NTX49NNP47rfdNNNWLBgAYqLi3HyySfjxRdfxL777tvmdqIHm/bp0we//OUv8fDDD+Piiy/G+PHjceCB5mJQvHs/VFRUoLy8HLNnz25yLCgowE033YQvv/wSdXV1eO+993DwwQc322+HHXZYs3amTZuGJ598ElVVVSgvL8fLL7/crGsEMIlQXV0dtm3b1oG9J6QTW7du9VvBFazeAK87q3cQkCsSCaCcfuLIF2NrgwfjJRi5ubktlsV7feTXfOzf2it7jN5mTk4ORo4ciUcffbTFekVFRXHbv+yyyzBlyhT8+9//xvPPP49Zs2ZhwYIFeP/99+O6A0CXqEFy3377LQ4//HAMGDAAJ5xwAn72s5+hf//+OOigg+K+NvJ+/vjHP2Ls2LEt/p6VlYWsrKxmM6DG8/7Zz36Gbt26YcWKFaisrMSoUaMwevToZutEPi+Z8KvzwTpbLKs3wOvO6h0EJJFIgOLiYuTk5KCiogLA7i/D7OxsbN++vWk9L2WSI0eOhFIKr732GiZMmAAA+Oabb5q6GSLb3bFjR7PXRW9z5MiRuP/++1FcXIwePXoAALZv346pU6di1qxZGDduXLPEZOvWrZg3bx7mzJmD888/H+effz7eeustHHrooVizZg0OOeSQpiSqNf72t79hx44d+O9//9t0BeHZZ58FsPvLP7qN7t27Y8CAAfjqq68wbNiwpuWLFy/G+++/j8WLF2O//fbD0qVL0dDQ0NTme++912y72dnZOPPMM/HYY4+hsrKyxdUIwFz9yM/Pl6oNlzBXbbDeG4DVG+B1Z/UOApJIJIBSCgcddBBWr16Ns846C3V1dcjLy8Phhx+O++67D0ceeSQaGhowa9asVn/Ft8fgwYNx9tlnY/r06ViyZAl69OiBmTNnNvtlfvjhh+Paa6/FnXfeiUmTJuHpp5/G008/jT59+gAAzjrrLNx888047bTTcOuttyIvLw9XX3013nrrraaxFhF3AOjRoweefvpprFu3Drfeeivy8/Px0EMPoaioCMOHDwcAdOvWDZ988gm+++67pu1EM3DgQGzfvh0rVqxoSkAiU6Dv2rWrqY3y8nKsX78eAwcOxNy5c3HFFVdgzz33xI9//GO8+eabuOKKK3DVVVcBAKZPn46FCxdi+vTpmDVrFj7//HPccMMNTZ9FhGnTpuHwww+H1hqPP/54C7fVq1fj0EMPdfV5JBOp2miJ7aqNsrKyphhmgtUb4HVn9Q4Ccq03QU488US8/PLLAHZfKr/nnnvQvXt3HHrooZg8eTIuuugi7LHHHq63cc899+DHP/4xJk2ahGOOOQYTJ05sNk5g3LhxuPHGG3Hbbbdhn332wQsvvIAbb7yx6e9dunTB888/j/z8fIwfPx5HHnkkwuEwXnrppaYkIPoyf0ZGBp588kkAwJgxY7Dffvvh448/xrPPPtv0K/7qq6/G3XffjeOOOy6u86mnnorLL78cl156KfbZZx9cd911uP766zFs2DC8/fbbAIDzzjsPDQ0NGDFiBFavXo1LLrkEt956K373u981VbBcd911TclCSUkJnnrqKbz99tvYf//9cc011+Diiy8G0LyrZ/To0dhrr71w7LHHxk1yXn75ZZx00kmJfxACPYWFhX4ruILVG+B1Z/UOAirFcxd8BWBLKjeIJJd/VlRUYMiQIXjjjTcwfPjwhCo3vJCVlYX7778f06ZNS0p79fX1KXN3yyeffILvv/++qXoF2F1GW11d3VS+Gg6HMXDgQPzpT3/Cz3/+82ZtrFmzBkcffTTKysqaxof4iVyRaI7tKxIVFRVNVUdMsHoDvO6Wve0cQAFBrkgkSO/evTFz5kzcdddd1DNRMrhv2LAB48aNwyOPPIKvv/4ar7zyCubPn48pU6YgKysLdXV1+Oc//4lLLrkEubm5OOGEE1q0ceedd+JXv/pVIJIIIfVUVlb6reAKVm+A153VOwjIGAkXXHfddTj44IPxxRdfYNSoUX7ruCLoVyMA4LjjjsOCBQtw/fXXo6ysDMXFxZg8eTJuvfVWAOY9zJgxA7m5uVi+fHmL9/TRRx9hzZo1uPfee/3QFwLAgAED/FZwBas3wOvO6h0EpGvDA6FQiPa2qqzurN4AEKqrR15O8BO4WGxWVtiu2vjyyy8xdOhQa+3bgtUb4HW37J3WXRtyRUIQUkReTraMkYjB9hiJ2PuQsMDqDfC6s3oHARkj4QGG7oHWYHVn9Rb8gfVyNas3wOvO6h0EJJHwQH19vd8KrmF1Z/UW/GHDhg1+K7iC1RvgdWf1DgKSSHgg+t4ObLC6s3oL/sBarcPqDfC6s3oHARkjIQgpQm6RHb9tm4MtBUGwjyQSHmhoaKDts2d1Z/UG5BbZ8bA92LKqqgolJSVWt2EDVm+A153VOwhI14YHWL/QAF53Vm/BHwYOHOi3gitYvQFed1bvICCJRIJMmzYNxxxzDIDUDPwbO3YsLrjggqS3G3G/4IIL4k7jHUEphWXLliV9+26RwZZCIpSXl/ut4ApWb4DXndU7CEjXhtAmGzdu/P/snXd4FNXegN8JpFcSQjEgkRK6NGNExNBDFa70mkhTqlKjKAZp4kVFUUBR7s2liCJNBAGVoiBFQECRXo0IGBKKIYSQ5Hx/hB2zyQaSXTa7P795n2cfyOyZM++cObv7mznN6IRkIJaci9NJQqo3yHWX6u0MGIGEDUh+zF5Q9zJlytjZpHBILnODokdqm7dUb5DrLtXbGTACCRu4ffs2lSpVYsSIEWzdupVNmzbh5+fHkCFDiIuL48yZM1SqVInNmzebNR+0a9eOEiVKsHjxYpKSkpgwYQJr167lypUrNGzYkDfffJN69eqZHSslJYUyZcrw/vvvm60AOmzYMA4ePMj27du5desWEyZM4JNPPuHGjRvUq1ePN954g8cee0xPP2fOHN58800uXbrE008/fc/Z3DRNY9GiRfTp04eYmBiKFSuGt7c3S5Ys4datWzz11FN8+OGH+Pr6Wtx/69atxMXFsW/fPm7fvk316tWZMWMGrVu3BiA0NDTf8suvzKUOAU1Lv22M2rCQtz1HbZw/f56qVavaLX97IdUb5LpL9XYGjEDCBkw/aBMnTuSdd97h3XffZfny5cTGxtK8eXOeeOIJGjduzNKlS/VAIjExka+//pp169aRmZlJy5YtAVi2bBl+fn5MnTqVyMhIfv75Z0JDQ/Vj+fj40LlzZ5YuXaoHEhkZGSxbtoxp06YB0K9fP06fPs2yZcsoXbq0ftyff/6ZsLAwFi1axOjRo3n//fdp2LAhixcv5o033iAyMrLA52xaxnvnzp2cPHmSbt26UaNGDV555ZU8aRMSEmjTpg1jxozhv//9LykpKbzyyiv069eP33//HTc3t3uWX35lLhFjiuy82HvURmBgoF3ztxdSvUGuu1RvZ8BoFLIB04JnHTp0YPDgwVSsWJHx48cTEBDAzp07AYiOjmb58uV6J0HTj3yLFi3YuHEj+/fv59NPP6VRo0bUrl2bRYsWERAQwJw5c/IcLzo6mk2bNvHnn38CsHHjRlJSUujWrRsnT55k2bJlxMfH07hxY8LCwoiLi6Nx48a89dZbALz//vv06dOHQYMGERYWxowZMwgPDy/UOQcFBTF79mzCwsJo27YtLVu21M81N+np6UyZMoUpU6ZQsWJFHn74YUaNGkViYiKXLl3S092t/PIrcwODgpCRkeFoBauQ6g1y3aV6OwNGIGEDpmaBsLAws+3+/v6kp6cD0LVrV9LS0vj6668BWLJkCb1798bFxYVDhw4RFBRktr+bmxsREREcOnQoz/GaNm1KSEgIn3/+uZ7XU089RUBAAPv37wcgIiICHx8f/bV161aOHDkCZC+r3aBBAzP3nM0eBaFSpUpmTwVynqultP369eOdd96hf//+NG7cmA4dOgDZ80GYuFv55cZYWMegMFy/ft3RClYh1Rvkukv1dgaMpg0bMD2ad3d3z/Oe6c7Z19eXf/3rXyxdupQaNWqwc+dOPv74YwA882kbzm/SJU3T6Nu3r9688cUXX+hBhcll586defI1+WmapnuZ0pv+LSh3O9fcHDp0iMaNG/PYY4/RvHlzunfvzu3bt/Vgwpo8C+tr8P+bChUqOFrBKqR6g1x3qd7OgPFEwgbyu2vOTXR0NF9++SVLliyhQYMG1KhRA4AaNWqQlJTEsWPHzPLcs2ePniY3/fr104MRX19foqKiAKhZsyYAly5donLlyvpr1qxZfPHFFwDUrVuXHTt2mLnv3bvXijMvGB9++CEPPvgg69evZ+zYsURFReljta1toihomRsYAJw7d87RClYh1Rvkukv1dgaMJxI2oBWwA1rz5s3x9fXl3//+t94xEqBZs2Y0bNiQXr16MXv2bPz9/Zk+fTpXr15l8ODBFvMKCwsjIiKCiRMnMmjQIL2ZoXLlynTv3p3BgwczZ84cwsLC+M9//sMHH3ygN6uMHTuWLl268Oijj9K8eXNWr17N9u3bLXZqvB+UL1+es2fP8s033xAWFsa2bduYMGECALdu3bIqz4KWuTMidtRGWpr9Rm2kpeHi4WGXvEHuEyyp3iDXXaq3M+AUgcSnb3zWwBHH7RHb3ab9ixcvWPG5uLjQt29f3nrrLXr27Klv1zSNVatWMXr0aNq1a0dGRgaNGjVi27ZtVKxYMd/8oqOjee655+jXr5/Z9o8//pgXX3yRZ555hmvXrlG9enVWrlxJ8+bNAejUqRPx8fFMnjyZ2NhYWrRowaBBg/Q+FPebkSNHcvjwYbp3705mZibVq1fnww8/JCYmhj179lCtWrVC51nQMndGJI/asBf2DCIgu3OwRKR6g1x3qd7OgFbEveDPApdzb5QaSKSlpeFh5y9CeyHVXaq3CSOQKFqOHTsmcm4Aqd4g193O3nIfpRYAo4+EDUi+O5bqLtXbwDGULFnS0QpWIdUb5LpL9XYGjEDCBiQPRZTqLtXbwDGkpaU5WsEqpHqDXHep3s6AEUjYgOQfNanuUr0NHENKSoqjFaxCqjfIdZfq7QwYz4ltQHIvX6nuUr0B0tIzRPc3kIjUuQGkeoNcd6nezoARSNhAenp6kXT8Cw0NZeDAgRbXs7CWu7lPmjSJxYsXc/Lkyft2vMKQnJzM6tWr6d+/f573ClrmSikWLVpE69atKVWqlD00C42HW3Gjs2URc+7cOZEd/6R6g1x3qd7OgNG0YQOS5zS4m/vYsWPZtWtXEdqYExsby8KFCy2+V9Ay37FjB9HR0aSmpt5PNQNhSB3hI9Ub5LpL9XYGjCcSNiB5Jcq7uZvW6XAUdxuSXNAyNxb3MgAICAhwtIJVSPUGue5SvZ0B44lEIUlKSuLZZ58lJCQEPz8/mjdvri+YFR8fj7e3Nzdu3NDTp6enExgYqK+vcejQIaKiovDy8qJcuXI8++yzXL16VU8fGhrK2LFjqVq1KsHBwfz0009mx8/KymLq1KlUqVIFNzc3AgIC6Ny5M4mJiQBs3bqV4sWLs3z5ckJDQ/Hx8aF9+/YkJCSYHWPGjBk0b94cT09PatSowcqVK/X3J02aROXKlQE4e/YsmqaxYsUK6tevj7u7O1WrVmX16tV6+oyMDGJjYyldujS+vr7079+fXr166cud5yYzM5OxY8cSEhKCu7s7Dz/8sL5myKRJk1iwYAHfffcdmqZx9uxZYmJi6N69O02bNiUoKIh58+aRlpbG6NGjqVChAm5ubgQHB9O/f39SU1M5e/YsjRs3BuChhx5i0qRJBSr7lJQUBg4cSGBgIIGBgYwbN46mTZsyadIkEhMTcXNz0z1N9OvXj06dOuVXXQwczMWLFx2tYBVSvUGuu1RvZ8Apnkj0iO2+z47Z37fJrjIzM2nZsiWQvRy4l5cXM2bMIDIykp9//pkuXbowfPhw1qxZo89g+dVXX3Hz5k26du3K+fPniYyMpH///syePZsrV64wbtw4nn76aTZv3qwfZ968eXz11Vd4eHhQt25dM4e3336bd999l0WLFlG9enUOHz5MTEwM06ZN45133tE9X3zxRT7+kDB1RQAAIABJREFU+GOCgoIYNmwYrVu35uDBg/o8DFOnTmXSpEnMnTuXpUuX0qVLF7Zt20ajRo0snvu4ceOYO3culStX5uWXXyY6Opo//vgDb29vYmNjWbJkCQsWLOChhx5i2rRpfPrpp3lm3jQxd+5cVq1axYoVKyhTpgyLFi2iZ8+ePPLII4wdO5YTJ05w5swZVq5cSXBwsF7e7777Lu+99x4lS5Zk7NixbNy4kSVLllCuXDl2795NTEwMDz/8MCNGjOCLL76gY8eO/Pjjj1SvXr1AZR8dHc2hQ4dYtWoV/v7+jBkzhu+++47IyEiCg4Np06YNixcvpmvXrgDcuHGDlStXsnjxYqvqk4H9MdUfaUj1BrnuUr2dAqVUUb7OKqX2FvHrvrFu3ToFqGPHjimllLp165a6deuWKl++vBo7dqxSSqm+ffuqDh066Pt06dJF9ejRQyml1Msvv6weeeQRszx///13BagdO3YopZSqUKGCnt5EhQoV1JQpU5RSSq1Zs0atW7fO7P1+/fqpZs2aKaWU2rJliwLUmjVr9PdPnjypALVhwwY9v06dOpnl0bhxY/24cXFxqlKlSkoppc6cOaMANXfuXD3tgQMHFKB+/PFHdePGDeXp6akWLFigv5+WlqYeeOABFR0dbbEcR44cqWrVqqUuXLiglFIqKytLbdiwQV29elUppdSAAQNUZGSknj46OlqVKVNGKZVd5koptWjRIrV9+3azfJ988knVv39/pZRS27ZtU4A6c+aMUureZX/69GkFqE2bNunv//nnn8rT01PFxcUppZRauXKlcnV1VUlJSbpDyZIlVXp6usXzzM3NWwVLZ3D/+O233xytYBVSvZWS625n76L+rS3Sl1M8kZDCoUOHCAoKIiwsDMhuZvDw8CAiIoJDhw4B2Xe1bdu25cqVKxQrVoy1a9fqzQb79+9n//79FvsfHDlyhIYNGwLcdZ2NDh06sHPnTl5++WWOHTvG0aNHOXLkiP4o30RkZKT+/0qVKhEcHMwvv/yirxaae6Guxx57jK+++irf45rOGcDf3x/IbrY5cuQIN2/e1N0he1nw8PDwfPMaOnQoK1euJCQkhEceeYTWrVvTu3dvPV9LmMrENI9Enz59+Prrrxk/fjzHjx/n119/5dSpUzz00EMW979X2f/xxx9AdjmYCA4ONjvv9u3b4+/vz2effcaQIUNYtGgRvXr1srjkuyWMtTaKHqmdbaV6g1x3qd7OgNFHohB4enqa/W2a0yAzM1P/MWnatCmlS5dmxYoVrFy5koCAAFq1aqWnb9WqFQcOHDB7nThxgs6dO+d7nJxMnTqVli1bcv36ddq0acPChQvp06dPnnS5f9wyMzNxcfn7cufuoZz7/dy4u7vn2aaU0ptKCjNRVNWqVTl9+jTr1q2jUaNGLF26lJo1a7Jp06Z89zGVianMBw4cSO/evcnKyuLpp59m9erVZsFTbu5V9qbzUHfppOnq6kqvXr345JNPuHjxIps2bcq3H4iBcyB1bgCp3iDXXaq3M2AEEoWgRo0aJCUlcezYMSD7jjw9PZ09e/ZQo0YN4O+VPlesWMGyZcvo3bu3PtKgZs2aHDlyhAoVKlC5cmUqV65MsWLFeOGFF8w6Q96NN954g8mTJ/Pee+8xYMAA6tevz4kTJ/L8AO7du1f///Hjx0lOTqZevXr6tj179pil37Vrl9n7BaVKlSp4enqye/dufdvt27fzdBLNydy5c1mxYgWtW7fm7bff5ujRo1StWpUVK1YAdx/imZ6eTlJSEgsWLODDDz/kzTffpF+/flStWpVTp07p5ZA7j3uVfe3atdE0zew8kpOTOXHihFk+MTEx7Nixg48//pgaNWpYVWYGRce5c+ccrWAVUr1BrrtUb2fACCQKQbNmzWjYsCG9evXihx9+4MiRI8TExHD16lUGDx6sp4uOjmbLli1s2rSJ6Ohoffvw4cO5cuUKMTEx/PLLL+zdu5cePXpw4sQJs0fod6N8+fJs3LiRo0eP8uuvvzJ8+HB27tzJrVu3zNINHTqUHTt2sHfvXvr27Ut4eLjZHfsnn3zC/PnzOX78OC+//DI//vgjL7zwQqHLxMvLi2HDhvHKK6+wbt06jhw5wuDBg0lISMg3ILh8+TIjRoxg7dq1nDt3ji+++IIzZ84QEREBgK+vL+fPn+fMmTNkZGSY7evi4oKfnx9+fn588cUXnDp1iv3799OrVy8SEhL0cvD19QWymzSuXbt2z7KvWLEinTt3ZtiwYXz//ff88ssv9OnTh9TUVLPzqFevHrVq1WL69OnG0wgBeHl5OVrBKqR6g1x3qd7OgBFIFAJN01i1ahXVqlWjXbt2NG7cmKSkJLZt22bWryEsLIx69epRo0YNateurW8vU6YM3377LRcvXiQiIoKoqCgefPBBvvnmmwJP/bxw4UKuXr1KvXr1aNmyJUlJScyYMYPDhw+btfFFR0fTrVs3mjVrRqVKlfjqq6/Mmi769evHkiVLePjhh9mwYQPr16+3+u562rRpdO7cmb59+/Loo4/i6upKw4YN8z2nCRMmMGDAAIYOHUpYWBjjxo3jtdde04OuZ555hszMTKpXr64PrTXh4uKCq6sry5YtY9++fdSqVYuOHTsSGBjImDFj9CcxNWrUoHPnzvTo0YO4uLgClf1HH31EgwYNaN++PZGRkdSrV08fXpqTfv36cfv2bXr37m1VeRkUHd7e3o5WsAqp3iDXXaq3M6DdrU3YDpwFLhflAbmPwz9zk5aW5nSzoW3dupWmTZuSkJBAuXLlLKYJDQ0lJiZGn1/BVlavXk3jxo0JCgrSt1WrVo3evXszceLE+3IME/Yq87S0NDZs2EDLli31L5Tbt28TFBTEnDlz6Nu3r5527NixHD9+nDVr1hTuGOm38XArWMdMg/vDsWPHRE57LNUb5Lrb2VvuNMgFwBi1YQOmDnoSuVvHysLyxhtvsGDBAl5//XU8PT2Jj4/nzJkz+nwL9xN7lbm7uztDhw6lTZs2xMbGkpWVxVtvvYWrqytt2rQBYPv27Rw+fJgPPviAVatWFfoYxqiNoqdMmTKOVrAKqd4g112qtzNgNG3YQGZmpqMVrOZ+Lse9ZMkSXFxcePLJJ3n44YfZvHkzGzZsoFq1avftGCbsVeaaprF27VrOnj1LeHg44eHhnDt3jk2bNlGyZEkg+8nLqFGjGDFihD4xmYFzk3PmUklI9Qa57lK9nQGjacMGnLFpo6BIdZfqbcJ4IlG0GI/Zix6p7kbThvUYTyRsoKAdJJ0Rqe5SvQ0cg9S5AaR6g1x3qd7OgBFI2EB6erqjFaxGqrtUbwPHIHVuAKneINddqrczYDRt2EB6errYO2Sp7lK9AVLT0vHykOeuMjLQBHcsNihabt+4gavAoZTnz58nJCTEXtn/o5s2jG8HG7ifIx+KGqnuUr0Bbt74Cy+PoHsntBJ79b/Y/9Fw9t1ltlEDg5w0KNqb0/uG5L5Xjkbut7ITkHvWRUlIdZfqDdkzehoYGDgnxufTeoxAwgYKuuqjMyLVXao3QNmyZR2tYGBgkA/G59N6jEDCBiTfHUt1l+oNkJSU5GgFAwODfDA+n9ZjBBKFJDQ0FE3TmDdvnsUlp9u0aYOmaSxevFjfdvDgQbp3707p0qXx8PAgLCyMl156ieTkZIvHSE9PJygoiMDAQNLS0iw6TJ061abzKOJOtvcNqd5gjDgxMHBmjM+n9RidLa3A1dWV5cuX8+yzz5ptT05OZvPmzWbb1qxZQ7du3fjXv/7F6tWrKVu2LAcOHCAuLo7PPvuMLVu25Bm/vGbNGjw8PLh+/Tqff/652ToP9wupIx+keoN9x6mnpWfYbeKorJs3xXagMyh6Mm/epJinp6M1Co0xj4T1GIGEFTRv3pxvvvmGP/74w2xhrJUrVxIREcG2bduA7M47ffv2ZdCgQbz33nt6utDQUFq0aMGjjz5K//792bRpk1n+8fHxNG/enJSUFObPn2+XQCI9PV1kL2Wp3pA9Tt1eM+d5uBU3Rm1YQGoAJHV2SICTv/0m0t2en89/OkbThhU8/vjjlClThi+//NJs+7Jly+jevbv+96JFi7hx44bFVTZ9fHyYOHEimzdv5siRI/r2ixcvsnHjRlq0aEHnzp3Zvn272fu5mTRpElFRUcTFxVGqVCl8fX0ZOnQov/32G23btsXLy4uwsDA2bNig73P27Fl69+5NyZIlcXV1JTQ0lJkzZ+rvx8TEMGDAAEaOHElQUBA+Pj706tWLv/76S0+zYsUKwsPD8fT0xMvLi0aNGrFnzx79/b/++othw4ZRunRpfH19iYqK4tixYwUr4Lsgefinn5+foxUMhCC5rkh1l+rtDMj9VnYgmqbRuXNnVq9erW+7fPky33//PV26dNG37dq1i7CwMLPltXPStGlTAH744Qd92+LFi9E0jaeeeoqnnnoKDw8P5s+ff1efLVu2cOrUKbZv387s2bOZN28eERER9O7dm3379lG1alViYmL09B06dCAtLY0tW7Zw5MgR+vXrx/jx4zlw4ICZR2ZmJjt37mTZsmWsWbOGd999F4A9e/bQrVs3YmJiOHLkCN999x1KKQYNGqTv361bNzZt2sTSpUvZu3cvPj4+REVFcfv27QKUcP5oQu+MQfZqsQZFi+S6ItVdqrczYAQSVtK1a1e2bNnClStXgOw79EaNGlG6dGk9zZUrV/INIgD9vcTERH3b//73P1q2bElAQAC+vr60bduWhQsXWux0mZMPP/yQsLAwnnnmGUqWLEmrVq3o3bs31atXZ+jQoVy6dInExERu3rxJTEwMs2fPpnbt2lSuXJlXX30VFxcXfvnlFzO32bNnExYWRtu2bWnZsiU7d+4EsvuIzJ07l2HDhhEaGkp4eDiDBg3S9z927BgbNmzggw8+oFmzZlStWpX58+fTuXNnm3tGS15xNb/OtQYGuZFcV6S6S/V2BoxAwkoaNWpEcHAwX3zxBZC3WQOyf4yvX7+ebx6mZWuDg4MB2Lt3L4cOHaJr1656mu7du5OcnMzy5cvzzads2bJ455iS1tvbm0qVKul/e97p+HTr1i08PT0ZPnw427ZtY/jw4URFRRESEkJWVpbZj3SlSpUoVqyY/re/v7/eq7lu3bpERUXx+uuv07dvXx577DGGDBmiL01uCigeffRRs7J46623KFOmTL7nURAkzyNhx+l3Df5hSK4rUt2lejsDxrMcK9E0jY4dO7J8+XLatWvHDz/8wGeffWaW5oknnmDFihUkJSVZfDLx/fffA9CwYUMgu5MlwMCBAxk4cKBZ2vnz59OnTx+LLpZ+XPPrS5CSkkLjxo25ffs2Xbt2pWnTpkREROTpsezu7p5nX9PQy82bN9O2bVs6duxIo0aN6N+/P8ePH+e5557L1+d+cfv2bbMARxKXLl3Cx8fHLnkbozYsk5maSjEvL0drFBp71hV7I9VdqrczYAQSNvD000/Tvn17Fi5cSJMmTShZsqTZ+7169WLy5MlMnDiRuXPnmr138+ZNJk+eTJMmTahZsybp6eksXbqUTp06MWXKFLO0s2bN4j//+Q9Hjx6lWrVqNjlv3LiRAwcOcP78eR544AEguykiKyurwHM0zJo1i1atWpkFTl9//TWQHWxUr14dyH7C8uSTTwJw/fp1KleuzMqVK3niiSdsOgepmJ7Y2ANj1IZlpAZA9qwr9kaqu1RvZ8ApAol9mma3FTrvhq1fMpGRkQQGBvLaa6/pHRFzUqJECT755BM6derEtWvXGDlyJGXLluXXX3/l1Vdf5fr166xZswbInjsiOTmZMWPGUKtWLbN8XnrpJeLj45k/fz5vv/22Tc7ly5cH4PPPP6dTp06cPHmS0aNHA9lNHwXNY+3atezatYvSpUuzdu1a3nnnHT2PsLAwOnbsyNChQ5k3bx7BwcG8/PLL+Pv7Ex4ebpO/0bRh8P8ByXVFqrtUb2fA6CNhA5mZmXTu3Jm0tDT+9a9/WUzTvHlz9u7di6urK126dKFq1ao8//zztGjRgp9++klvUoiPj+fhhx+2eLdeuXJl/clHQX/s8+PRRx9l5syZ/Pvf/6Z69eoMHz6cPn360LRpU7Phm3dj8uTJ1K9fn6ioKBo0aMDKlSv53//+B6DnER8fz6OPPkrHjh2JiIggPT2dDRs2WGwyKQy2jvpwJAkJCY5WMBCC5Loi1V2qtzOgFfGUw2eBPEusSX0icfv2bbF3yFLdpXpDdhtszlE99xujaSMvUps27F1X7IlUdzt7y/wAFRDjiYSBgYGBgYGB1ThFHwmpZGZmir07luou1Ruyh/va647HGLVhGamjNuxZV+yNVHep3s6AEUjYgNQfNJDrLtUb/u7oag+MURuWkRoA2bOu2Bup7lK9nQGjacMGJHf8k+ou1Rvg/PnzjlYwEILkuiLVXaq3M2AEElaQnp5O3bp178siVABbt25F0zR+//33+5KfPdi5c6fZmiDWkJyczH/+85/7ZHRvfv31V8LDw8nIyCiyY94NyQuOGRQtkuuKVHep3s6AUXJWMHXqVBo1apRnvgdrefzxx7lw4YI+QVRRUNgmgieffJITJ07YdMzY2FgWLlxoUx6F8a5ZsyZ169bljTfesOmY9wuj/dWgoEiuK1LdpXo7A0YgUUiSk5N5++23GT169H17zO7m5kaZMmWKNCIurPv9GCZ8P/IorPfo0aN54403uHbtms3HthXj0alBQZFcV6S6S/V2CpRSRfk6q5Tam/u1F5QjXtYwffp0Vb9+faWUUunp6Upl/zqqRYsWmaXLuS06Olr1799fjRgxQgUGBipvb2/Vs2dPdf36daWUUlu2bFGASkhIUEoplZycrHr37q38/PxU2bJl1Zw5c1TVqlXVf//7X6WUUnFxcapSpUpmx8u97bffflOdO3dWvr6+qlSpUqp79+7q/Pnz+vsmdxNHjx5VLVu2VL6+vsrPz0917NhRnTlzRimlVIUKFRSgABUZGamf38SJE1VISIgKCQlRFy5cUAcOHFBt2rRR/v7+ytXVVYWFhan//e9/up8pD0DPe/78+SosLEx5eHioWrVqqfj4eDOvXbt2qYYNGyoPDw9VrVo19eGHH+r7z5o1S5UoUULdunVLT//XX38pLy8vtWrVKn1brVq11MyZM/O7pEXGn3/+abe8b966bbe8M1NT7Za3vZHqbs+6Ym+kutvZu6h/a4v05RSjNhootc+e2d/PzNasWUO7du2Awt1hL168mIEDB7Jz505OnjxJt27dqFGjBq+88kqetF26dOHixYts2LABFxcXnnvuOc6cOVPgY924cYMmTZrw+OOPs2PHDjIyMpg8eTLNmjXj559/xs3NLY97r169qF+/PnPnziU1NZWhQ4fSv39/Nm/ezJ49eyhbtixvvfUWffv21ff56KOPWL9+Penp6fj6+lKnTh06dOjA7t27UUrx1ltvMWjQIKKiohg7diwnTpzgzJkzrFy5kuDgYObNm0dcXBxz586lXr167Ny5k+HDs4cwRkdHc/78eVq2bEn37t1ZsGABv/76q74wmMl53LhxrFu3Tp9ZdMWKFXh7e+vXCKBdu3asWbOGsWPHFrgM7YE9+2oYozYsI3XUhrP067EGqe5SvZ0BpwgkpJCVlcXevXt54YUX9L8LSlBQELNnz6ZYsWKEhYXRsmVLdu7cmSfd4cOH2bx5M1u3btVXBV2yZAk1a9Ys8LGWLl3KjRs3iI+P11fKXLp0KSVLlmTFihX07Nkzj/vJkydp1aoVoaGhFC9enMWLF3Px4kXg72XO/f39CQwM1PeJiYmhbt26APz555+MHj2aESNG4HVn3P6ECRP4+OOPOX78OI0bN8bT01NvxgGYNm0acXFxdOnSBcheuvzcuXNMnz6d6Oho5s+fT8mSJfnggw8oVqwY1atXJyEhQV8bpFSpUrRt25bFixfrgcSiRYvo1auXWV+KWrVqMWvWrAKXn724fv06ZcuWdbSGgQAk1xWp7lK9nQEjkCgESUlJZGRk6Kt8urm5FXjfSpUqmS1/7e/vb7FN7tdffwUwW9yqRo0aeVYWvRv79+8nMTERf39/s+2pqakcOXLEovuUKVMYM2YMc+fOpVmzZrRv354ePXrc9TgVK1bU/1+qVCmGDBnCwoUL2b9/PydOnODAgQNA9iRSuUlMTOT8+fOMHTuW2NhYfXtGRgYZGRmkp6fz008/ER4eblZukZGRZvnExMTQs2dPrl69yo0bN9iyZQszZ840SxMcHEx6ejpXrlyhRIkSdz0ne5J7qXYDg/yQXFekukv1dgaMQKIQaHce75p+GNPT0/Hw8MiTztIjMkuLVVlqGjHdzed+715BS85jurm5UbNmTVauXJknXUBAgEX3kSNH0r17d9auXcs333zDqFGjePPNNzlw4EC+C215enrq///jjz9o2LAhISEhdOjQgfbt2/PAAw/wyCOPWNzXdD7vvfceTZo0yfN+8eLFKV68eJ4nJ7k7W7Zv3x5fX19WrFhBcnIytWrVol69emZpTNfL0cO7zp07R9WqVR3qYCADyXVFqrtUb2fAGLVRCIKCgnBzcyMxMRH4O7BwdXXl+vXrejpbhknWrFkTTdPYsWOHvu3333/Xmxkg+0f4r7/+Mtsv5zFr1qzJmTNnCAoKonLlylSuXJlSpUoxevRofvnlFzN3yH7SMmLECG7fvs2AAQP49NNP+fbbbzl69CgHDx7Mk94SS5cu5a+//mLbtm289NJLdOjQgcuXs9dnMwVFOfPw9/cnJCSEs2fP6o6VK1fm22+/5c0338TFxYWHH36Yffv2mT3RyL1CqaurK7169WLVqlWsWrWK6OjoPG6JiYl4eXnleUJT1BTmCZbB/28k1xWp7lK9nQHjiUQh0DSNRx55hP3799O7d2+KF88uvoYNGzJ//nwaNWpEZmYmo0aNsnq57NDQUPr27cvQoUP56KOPKFGiBM8//7zZnXnDhg15+eWXeeedd+jUqRPr169n/fr1lCpVCoDevXszbdo0unXrxuuvv46HhwcvvvgiP/74o97XwuQOUKJECdavX8/p06d5/fXX8fLyIj4+noCAAD1C9/X15fDhw/z555/6cXJSvnx5rl+/zooVK4iIiODgwYOMHDkSQF/63NfXl/Pnz3PmzBnKly/PK6+8wujRo3nwwQdp3rw5u3fvZvTo0YwfPx6AoUOH8tZbbzF06FBGjRrF8ePHmTx5sn4tTMTExNCwYUOUUqxevTqP2/79+4mIiLDqetxPgoKC7Ja3sdaGZbJu3sQlx5MzKdizrtgbqe5SvZ0BI5AoJE899RTLli0Dsh+zFytWjHnz5jFkyBAiIiJ44IEHmDJlik1jkufNm8fo0aPp1KkTrq6ujB8/nu3bt+vvN23alNdee40ZM2YwYcIE2rRpw2uvvcacOXOA7CaHb775hjFjxtCsWTM0TaNhw4Zs3rxZDwJM7pD9yH/dunWMHj2ayMhIbt26RXh4OBs3btTv4l988UUmT57MN998w/79+/M4d+3alR9//JERI0aQkpJC5cqVefXVV3n99dfZs2cPrVu35plnnmH16tVUr16dbdu28dxzz3Hr1i1mzpzJiBEjCAkJYeLEibz44otA9gQxX331FS+88AJ16tShcuXKDB48mGnTppndPdSrV48qVaoQGhpqMcjZsmUL/fv3t/p63C8uXLiAn5+fXfI2Rm1YRmoAZM+6Ym+kukv1dga0wgxhvA+cBS4X5QG5z8M/ExMTeeihh9i1axfVqlUzu7O3J8WLF+fjjz8mJibmvuSXkZFRZO7WcvjwYa5du6aPXoHsESwDBgwgJSVF98/IyKB8+fLMmTOHp59+2iyPgwcP8uSTT3Lu3Dm9f4ijSEpKsutdjxFI5EVqIGHvumJPpLrb2VvmB6iAGH0kCklwcDDPP/887777bqGGfzobEtwTEhJo2rQpn332Gb/99hvfffcdr732Gt27d6d48eKkp6ezfPlynnvuOdzd3enQoUOePN555x3GjBnj8CACIC0tzdEKBkKQXFekukv1dgac+5bUSZk4cSLh4eEcPnxYn0dBGhICiaioKN58801effVVzp07R1BQEE8//bS+doarqyvDhw/H3d2dJUuW5FmH49ChQxw8eJAPP/zQEfp5SElJcbSCgRAk1xWp7lK9nQGjacMGsrKyHD6k0Fqkukv1huw7HkvDhe9L3ukZeLjZ575AaodFkOtuz7pib6S629n7H920YTyRsIH85pGQgFR3qd5g33HqRmdLy0jtIyF5TgOp7lK9nYGivrXL4h8Umd1rbgVnRqq7VG9AbABkUPRIritS3aV6OwNFHUhcBP4xVyvn1M3SkOou1Rtwig6fBjKQXFekukv1dgaKOpB4DXADPPkHPJmQvFqcVHep3oDZ7KQGBndDcl2R6i7V2xko6j4SG4HhQBxQBuHDT3OPEpCEVHep3vD3KqoGBvdCcl2R6i7V2xko6lEbjsBuJ5iQkED58uXtlb1dkeou1Rvs626M2rBMZmoqxe4shCcJo54XPXb2Fv8E/m4YozZsIDU11dEKViPVXao32NfdGLVhGamjNox6XvRI9XYGRDctOBrJ69dLdZfqDbLdDYoWyXVFqrtUb2fACCRs4Ny5c45WsBqp7lK9Qba7QdEiua5IdZfq7QwYgYQNeAlsezUh1V2qN8h2NyhaJNcVqe5SvZ0BI5CwAW9vb0crWI1Ud6neINvdoGiRXFekukv1dgaMzpY2kJiYSGBgoKM1rEKqu1RvsK97WnoG+z8abpe8s27eFNtpUeqoDaOeFz1SvZ0BI5CwgTJlyjhawWqkukv1Bvu6G6M2LCM1ADLqedEj1dsZMJo2bODq1auOVrAaqe5SvUG2u0HRIrmuSHWX6u0MGIGEDaSlpTlawWqkukv1BtnuBkWL5Loi1V2qtzNgBBI2IHncsVR3qd4g292gaJFbVeAjAAAgAElEQVRcV6S6S/V2BoxAwgYkjzuW6i7VG2S7GxQtkuuKVHep3s6A0dnSBnx8fBytYDVS3aV6g33djVEblrl94wauAof1GfW86JHq7QwYgYQNeHh4OFrBaqS6S/UG+7pLHbVh7wDleloaQQIDCaOeFz1SvZ0Bo2nDBi5fvuxoBauR6i7VG2S7S0VqmUv1BrnuUr2dASOQsIGyZcs6WsFqpLpL9QbZ7lKRWuZSvUGuu1RvZ8AIJGwgKSnJ0QpWI9VdqjfIdpeK1DKX6g1y3aV6OwNGIGED6enpjlawGqnuUr1BtrtUpJa5VG+Q6y7V2xnQlNDe2IXAbieYlpYmtoOOVHep3mBf97T0DDzc7NN3OuvmTVw8PcXlDXLri1RvkOtuZ2+Zc8wXEGPUhg2cO3eOqlWrOlrDKqS6S/UG+7obozYsI7W+SPUGue5SvZ0Bo2nDBvz8/BytYDVS3aV6g2x3qUgtc6neINddqrczYAQSNlC8uNwHOlLdpXqDbHepSC1zqd4g112qtzNgBBI2kJyc7GgFq5HqLtUbZLtLRWqZS/UGue5SvZ0BI5CwgZCQEEcrWI1Ud6neINtdKlLLXKo3yHWX6u0MGM9ybODSpUti52eX6i7VG+zrLnWtDXuP2pBaX6R6g1x3qd7OgBFI2EBWVpajFaxGqrtUb7CvuzFqwzJS64tUb5DrLtXbGTCaNmxA8qMwqe5SvUG2u1SklrlUb5DrLtXbGTACCRtISEhwtILVSHWX6g2y3aUitcyleoNcd6nezoARSNhAQECAoxWsRqq7VG+Q7S4VqWUu1Rvkukv1dgaMQMLAwMDAwMDAaozOljZw9epVSpcu7WgNq5DqLtUb7OtujNqwjNT6ItUb5LpL9XYGjEW7bCA1NRUvLy97ZW9XpLpL9Qb7uxujNvIitb5I9Qa57nb2/kcv2mU0bdjA+fPnHa1gNVLdpXqDbHepSC1zqd4g112qtzNgBBI24OIit/ikukv1BtnuUpFa5lK9Qa67VG9nwCg5G5DcnibVXao3yHaXitQyl+oNct2lejsDRiBhA5IfhUl1l+oNst2lIrXMpXqDXHep3s6AMWrDBgIDAx2tYDVS3aV6g33djVEblpFaX6R6g1x3qd7OgBFI2EBGRoajFaxGqrtUb7Cvu7HWhmWk1hep3iDXXaq3M2A0bdjA9evXHa1gNVLdpXqDbHepSC1zqd4g112qtzNgBBI2UKFCBUcrWI1Ud6neINtdKlLLXKo3yHWX6u0MGIGEDZw7d87RClYj1V2qN8h2l4rUMpfqDXLdpXo7A0YgYQNubm6OVrAaqe5SvUG2u1SklrlUb5DrLtXbGTCmyLaB69ev4+fnZ6/s7YpUd6neYF/3tPQMPNzs03faniMr7D1qQ2p9keoNct3t7P2PniLbGLVhAxcuXBD5gQG57lK9wb7uxqgNy0itL1K9Qa67VG9nwGjasIGSJUs6WsFqpLpL9QbZ7lKRWuZSvUGuu1RvZ8AIJGwgLS3N0QpWI9VdqjfIdpeK1DKX6g1y3aV6OwNGIGEDKSkpjlawGqnuUr1BtrtUpJa5VG+Q6y7V2xkwAgkbkDzuWKq7VG+Q7S4VqWUu1Rvkukv1dgaMURs2cOzYMapWrWqv7O2KVHep3mBfd2PUhmWk1hep3iDX3c7exqgNA8t4eHg4WsFqpLpL9Qb7uhujNiwjtb5I9Qa57lK9nQGjacMGAgICHK1gNVLdpXqDbHepSC1zqd4g112qtzNgBBI2cPHiRUcrWI1Ud6neINtdKlLLXKo3yHWX6u0MGIGEDQQHBztawWqkukv1BtnuUpFa5lK9Qa67VG9nwAgkbODGjRuOVrAaqe5SvUG2u1SklrlUb5DrLtXbGTA6W9pAamqqoxWsRqq7VG+wr3taegb7Pxpul7yzbt60W6dIe4/akFpfpHqDXHep3s6AMfzTBtLS0sT29JXqLtUb7O9ujNrIi9T6ItUb5Lrb2fsfPfzTaNqwAcnr10t1l+oNst2lIrXMpXqDXHep3s6AEUjYgJeXl6MVrEaqu1RvkO0uFallLtUb5LpL9XYGjEDCBry9vR2tYDVS3aV6g2x3qUgtc6neINddqrczYAQSNpCYmOhoBauR6i7VG2S7S0VqmUv1BrnuUr2dAaOzpQ1cu3YNf39/e2VvV6S6S/UG+7oba21YRmp9keoNct3t7P2P7mxpDP+0gatXr4r8wIBcd6neYF93Y60Ny0itL1K9Qa67VG9nwGjasIG0tDRHK1iNVHep3iDbXSpSy1yqN8h1l+rtDBiBhA1IXr9eqrtUb5DtLhWpZS7VG+S6S/V2BoxAwgYkjzuW6i7VG2S7S0VqmUv1BrnuUr2dASOQsAEfHx9HK1iNVHep3iDbXSpSy1yqN8h1l+rtDBidLW1A4jSwJqS6S/UG+7oba21YRmp9keoNct2lejsDRiBhA5cvXyYoKMjRGlYh1V2qN9jX3Ri1YRmp9UWqN8h1l+rtDBhNGzZQtmxZRytYjVR3qd4g210qUstcqjfIdZfq7QwYgYQNJCUlOVrBaqS6S/UG2e5SkVrmUr1BrrtUb2fACCRsID093dEKViPVXao3yHaXitQyl+oNct2lejsDxhTZNmDn9evtilR3qd5gX3e7TpGdloaLnbztmTfIrS9SvUGuu529jSmyDSxz7tw5qlat6mgNq5DqLtUb7Otu786W9sKeQQTIrS9SvUGuu1RvZ8Bo2rABPz8/RytYjVR3qd4g210qUstcqjfIdZfq7QwYgYQNFC8u94GOVHep3iDbXSpSy1yqN8h1l+rtDBiBhA0kJyc7WsFqpLpL9QbZ7lKRWuZSvUGuu1RvZ8AIJGwgJCTE0QpWI9VdqjfIdpeK1DKX6g1y3aV6OwPGsxwbuHTpktj52aW6S/UG+7rbc4psyUitL1K9Qa67VG9nwAgkbCArK8vRClYj1V2qN9jXXeqoDXsjtb5I9Qa57lK9nQGjacMGJD8Kk+ou1Rtku0tFaplL9Qa57lK9nQEjkLCBhIQERytYjVR3qd4g210qUstcqjfIdZfq7QwYgYQNBAQEOFrBaqS6S/UG2e5SkVrmUr1BrrtUb2fACCQMDAwMDAwMrMbobGkDV69epXTp0o7WsAqp7lK9wb7uxqgNy0itL1K9Qa67VG9nwFi0ywZSU1Px8vKyV/Z2Raq7VG+wv7sxaiMvUuuLVG+Q625n73/0ol1G04YNnD9/3tEKViPVXao3yHaXitQyl+oNct2lejsDRiBhAy4ucotPqrtUb5DtLhWpZS7VG+S6S/V2BoySswHJ7WlS3aV6g2x3qUgtc6neINddqrczYAQSNiD5UZhUd6neINtdKlLLXKo3yHWX6u0MGKM2bCAwMNDRClYj1V2qN9jX3Ri1YRmp9UWqN8h1l+rtDBiBhA1kZGQ4WsFqpLpL9Qb7uhtrbVhGan2R6g1y3aV6OwNG04YNXL9+3dEKViPVXao3yHaXitQyl+oNct2lejsDRiBhAxUqVHC0gtVIdZfqDbLdpSK1zKV6g1x3qd7OgBFI2MC5c+ccrWA1Ut2leoNsd6lILXOp3iDXXaq3M2AEEjbg5ubmaAWrkeou1Rtku0tFaplL9Qa57lK9nQFjimwbuH79On5+fvbK3q5IdZfqDfZ1v3U7A3dXo+90bqTWF6neINfdzt7GFNkGlrlw4YKjFaxGqrtUb7CvuxFEWEZqfZHqDXLdpXo7A8YTCQMDAwMDA/tiPJEwMDAwMDAwMLCEEUgYGBgYGBgYWI0RSBgYGBgYGBhYjcMCCU3T6mua9qGmaUc1TUvVNO26pmk7NE0bpmma0/Yc+/rrr9mzZ4/Djh8fH0+VKlVwd3endOnSnDhxIt+0x48f5/PPPzfbpmkadevWtbdmkdCkSRM0TePq1auOVrGKq1evomkaTZo0ua/5xsTEoGkaBw4csGp/W+qIpTrnTHTq1AlN0zh79qyjVZyCpUuXcvr0af3v+Ph4NE3jnXfeKZLj79mzh6+//rpQ+wwaNIgOHTrYySgv33//PS1atMDX1xdPT08ee+wxVq5caTHtjh07aNWqFSVLlsTf359WrVqxdevWPOk0Tdumadq/C+qgadpWTdOUpmkBVp+IHSnyQELTNBdN0yYDe4Fo4AgwB/gMKAe8D3yraZpnUbvdi3nz5hEVFeWwVeKOHDnCgAEDuHz5MkOHDqVPnz75zsZ28OBBateuzQ8//FDElkVHTEwMcXFxeHh4OFrFqejUqRNxcXGUKVPGqv3j4uJ47rnnCr3f/4c6908iNjaWXr16mU0NXbduXeLi4njsscfsfvx169bx2GOPcfjw4QLvs2XLFuLj45k5c6Ydzf5m48aNNGvWjB07dtCtWzcGDhzImTNn6Ny5M3Pnzs2TtnHjxuzdu5euXbvSt29fDhw4QLNmzdA0rXuurMcCozRNq19AlXjgNSDN5pOyA464858ATAR2AV2UUvqvsqZp7sACoDfZBZe78B3KpUuXHHr8AwcOkJWVxbBhw5g6depd0165coX09PQiMnMMMTExjlZwSjp16kSnTp2s3n/SpElW7ff/oc79k7D0fVa3bt0ie2KZmJhIVlZWgdNnZGQwePBgevXqRbVq1exo9jdjx45F0zS+++47wsPDAXjppZeoU6cOsbGxREdH4+3tTVZWFgMGDMDPz48DBw7w4IMPAjBhwgRq165NcnLyLE3TViilMgCUUrs1TVsHzAceuZeHUirebid5HyjSJxKapoUBrwKJQJucQQSAUuoW8AxwDuiqaVr1ovRzdm7dugVAyZIlHWxiYGBgULQsX76ckydPMnLkyCI5XlpaGocOHaJ27dp6EAHwwAMP0K5dO1JSUjh06BAAp0+fxtfXl+joaD2IMKWNjIwEKAuE5jrE+0ADTdNa2flU7I9SqshewFSy53V49R7p2gMxQHCu7d2BH4AbQAqwA+iRK03onWOsvrNNJy4uTgFq1apV+rYKFSqoyMhIdfjwYdW+fXvl5+enfHx8VJs2bdSBAwf0dJGRkepOvvrLxMaNG1WzZs1UcHCw8vDwULVq1VLTp09Xt27dUgXh2LFjqnfv3qpUqVLK1dVVVaxYUY0bN05dvXrVzDP38ePi4izmZzrPnK8tW7YolV1Aqk6dOmrnzp2qefPmysvLS5UoUUJ17txZnTlzJk9eFy5cUEOGDFEhISHKzc1NhYaGqvHjx6vr16+bpYuMjFQVKlRQ69atUxUqVFCenp6qa9eu+vv/+9//VGRkpAoICFCurq6qTJkyqlevXurUqVNm+VSoUEE1atRIHTx4UEVGRipPT0/1wAMPqGHDhqmkpKQ8xwTUlStXzLYvW7ZMNWzYUHl7eytfX1/VrFkztXnz5jzntmfPHtWuXTtVtmxZ5e7urqpUqaJiY2PVtWvXLJZrbn755RfVp08fVa5cOeXq6qp8fX3V448/rpYvX54n7ZkzZ/Rr7OPjo/71r3+pgwcPKkBFRkbq6f773/8qQG3dulW9/vrrKjQ0VHl4eKi6deuqDRs2KKWUWrBggapWrZry9PRUtWrVUp9//rnZsaKjoxWg9u/frx/bVF+++OILFR4erjw8PFRwcLAaOHCgSkxMNNvfVEdyMnv2bNWgQQPl4+OjfH191RNPPKGWLVumv3+3OqeUUvv27VMdO3ZUgYGBysPDQ9WpU0fNmzdPZWVl5Tl2dHS0mjZtmvL391f+/v7q7bff1t8v6LXNyMhQ//73v1VYWJjy8PBQtWvXVitWrFAdO3ZUgMW6nhPT+fz8889q5MiRqmTJksrPz081b95cbd++PU/6rKwsNW/ePFWvXj3l4eGhAgICVIcOHdRPP/1kls50fZctW6ZatWql3N3d1YMPPpjnc2DCdO1efvlltWzZMlWjRg3l4eGhwsLC1JtvvqkyMzPz7FOQz1ru75MKFSqY+c2aNcsszxMnTuj1183NTVWrVk1Nnz5dpaenm6UzfQ8kJCSonj17qsDAQOXp6akaN25sVh9MdTTn617XJDw8XFWrVi3P9oJ+hyul8hzT0sv0vZqVlaW8vb1V6dKl85xnixYtFJDvdTORmZmpatasqYAMoIQy/61yAS4AG3Nut/QCtt7xC7jzd5M7f8cA/YFfyG72+B14E/C6V57381XUgcS+OycfYcW+b97Z9wLw0Z3XhTvb3siRrtCBRMWKFVVAQIB69NFH1dixY1X79u0VoAICAtSff/6plMr+gJl+uLp3765Xtu+//165ubmpBx54QA0fPlyNGzdO1a1bVwGqf//++VYwE7t27VLe3t7KxcVFdezYUY0aNUo99thjClDVqlXTfzxnzZqlfwlGRUWpuLg4sw9mTrZs2aJ/UCMiIlRcXJz+IQWUv7+/cnd3V82bN1fjx49XTZs2VYAqX768SklJ0fM5d+6cKleunNI0TT311FMqNjZWRUVFKUDVq1fPLG1kZKTy8fFRPj4+qnfv3mrIkCFq9uzZSimlxowZo/84vfDCC2rUqFGqfv36+jFTU1PNrsdDDz2kSpQooerVq6fGjRunGjdurABVs2ZN9ddff5kdM3cgMXHiRAWo0NBQNWzYMDV8+HBVunRp5eLiohYtWqSnO3bsmPL391clSpRQgwcPVrGxsfpxmjVrds/rtnv3buXp6akCAgLUgAED1Isvvqi6dOmiihcvrgD15Zdf6mkTEhJU2bJllaZpqmPHjmrkyJGqSpUqqkyZMvkGEnXr1lUlS5ZUw4cPVzExMapYsWLKzc1NjRw5Unl7e6sBAwaooUOH6nUn5w9WfoFE/fr1lYuLi3rqqafU+PHj9Xr6+OOPm51b7kBixowZ+v5jxoxRI0aM0N0XLlx4zzr31VdfKXd3d+Xr66uio6PVuHHjVO3atRWgBg0alOfYpUuXVn5+fmrkyJGqW7duaseOHYW6tkop1adPHwWoGjVqqOeff161adNGaZqmSpcuXahAon79+iogIEANGzZM9evXT3l6eio3Nze1ceNGs/R9+/bV6+gLL7ygBg0apPz9/ZWHh4fatGlTnutbunRpvX537tw5X4+c107TNNWhQwf1wgsvqCpVquhBV04K+lmbNWuWqlOnjgLUs88+qwcOlgKJffv2KX9/f+Xm5qZ69OihYmNj1eOPP64A1bp1a5WRkaGnjYyMVEFBQSo0NFTVqFFDjRo1SvXs2VO5uLgoNzc3dejQIaWUUqtWrcrzfZb7hiAnJ0+eVIB6/vnn87xX0O9w03W91yvn9+ro0aMVoPr166cSEhLUlStX1PTp0xWgOnbsmK9venq6+uWXX1T37t1NAcp7yvLv2kIgCwiy9H6OdPkFEnuBdGAp8G/g5J3tS+6W3/1+FXUgcenOSZYo5H6N7+z3EzmeUgDBdyIxBTyprAwkADVs2DCzu6NBgwYpQM2bN++u+3fu3FkB6vTp02aVqG7duqpYsWJ3vbvNyMhQVapUUcWLF1fr1683ey82NjZPMJLf3YIltmzZYvGDd6ds1LRp08y2mz7UK1eu1Le1bdtWaZqm1q5da5b23XffVYAaN26cvs30oz569GiztL///rtycXFRTz75pNkXjil/wOxL2XQ9nnrqKbP0I0aMMLtbyHlM0xfQ7t27laZpqkmTJurGjRt6usuXL6vKlSsrLy8v/UvF9IWb+262Xbt2CtC/8PIjKipKFS9eXB0+fNhs+2effaYA1bNnT31bv379FKDi4+P1bSkpKapJkyb5BhJ+fn7q3Llz+vaXXnpJAapYsWJmd1nx8fEKUOPHj9e35RdIcOdO2ER6errpbkkdOXJE3547kAgKClKVKlVSt2/f1rclJCQod3d39cgjj+jbLNW5GzduqODgYFWqVCmzH+/MzEzVpUsXBah169aZHRtQa9asMSvXwlzbzZs36z9QaWlpetr333+/wHe/ps+6n5+fOnnypL59165dqnjx4qpixYr604Bly5YpQPXq1cusjE6fPq0CAwNVSEiI/nTSdH3LlStndh75kfPazZw5U9+ekpKi33CYfvgK+1nLXU9y+pm+Y7KyslStWrWUh4eH2rt3r1meo0aNUoCaM2eOvs30mezYsaPZXfy0adMUoGJjY/M91t34+OOPFZAnYFSqcN/hhSUzM1O9+uqrStM0/ToAqk+fPmY3QLkpV66cnvbOb0QxZfm3beSddE9bej9HuvwCiQygYY50/sCfwG3A52553s9XUY/aMA1d+auQ+8Xc+XesUirRtPHO/1+882d/W8RiY2PRtL9nMW3bti3APYeJmToL/fjjj/o2V1dX1q9fT1JS0l0XgdmxYwcnTpygZ8+etG7d2uy91157jZCQEJYsWaL3jbhfeHp6MnbsWLNtpuFUpqFgFy5cYP369bRt25Z27dqZpR0+fDjly5cnPj4+T96dO3c2+9vDw4NFixbx7rvvUqxYMbP37rQd8ueff5pt1zSNmTNnmqWfMmUKPj4+LFmyJN/z+s9//oNSipkzZ+Ll5aVvDwoKIjY2ltTUVJYtWwb8fd1yD+WNj48nMTGRmjVr5nscgFGjRrFkyRKqVzfvxmMaymk6p/T0dFauXEnNmjWJjo7W03l7ezNjxox883/66afN2lobNWoEQIsWLahTp46+PSIiArh3PQWoWLEiXbt21f92dXWlRYsW99w/KyuLxMREs2GC5cqV4+jRo2zbtu2ux1yzZg2JiYmMGzeO0NBQfbuLiwuvv/46AP/973/N9vH09NQ/fyYKc22XLl0KwNSpU3F3d9fTDhs2rNCd9EaMGEGlSpX0vyMiIujRowenT59m586dACxYsACAd955h+LF/+6//tBDDzFkyBDOnz/PN998Y5ZvmzZtzM7jXlSoUIEXXnhB/9vb21vvcG36TFjzWbsXu3fv5tChQwwYMIAGDRqYvTdlyhTc3NzyXD+AMWPG4Orqqv9d0O/T/Pjpp58AqFGjRr5prP0Ovxtffvklc+fOJSgoiIEDBzJkyBAefPBBPv3007sOke3YsSOjRo2idu3arFixAmC1pmmWhpf9euffBhbeKwjfKaV2mv5QSl0ju8m/ONmjIIuEoh61kUR2p5MSZHe4LCh1yX78s93Ce6ZtdSy8VyA8PDwoX7682TZ/f3+Ae/6IDxo0iNWrV9OjRw8mTpxImzZtaNOmDc2aNbvnsrSmcf5PPvlknvfc3d0JDw9n9erVHD161OzHw1YefPDBPG5BQUEApKSkANkfXKUUSUlJFnvxu7m5kZCQwPnz5wkJCdG3P/TQQ3ny7dWrF1lZWRw6dIgjR45w+vRpDh48yLfffgtAZmam2T5ly5YlLCzMbJu/vz9hYWH89NNPpKamWvwS3rdvHwArVqxg7dq1Zu/9/vvvwN9lHh0dzbx584iNjeW9997Tr1urVq3w9va2UGrmREVFAXDx4kUOHjzIqVOnOHr0KNu3bzc7p1OnTpGSksIjj+TtmP3II4+YfdnmpHLlymZ/m5xyl69p6GtBgs3cZQoFq+fPPvssM2bMoHr16oSHh9OmTRvatWtn8ZxyY7om+/bts1iPihUrlme+i/Lly+f5ISzMtT148CDFihWzOPrg8ccf5+jRo/f0NmH6Ac7Jo48+yuLFizl48CCNGjVi3759eHh4MGfOnDxpTcc6cOCAWUCe+zrei0aNGpkFKSYPyD5fsO6zdi9M5X7q1CmL18/X15eDBw+ilDL7Ebf0+YWC1VNLmAKg/DqaF/Q7vCAjkpo0aUKTJk04c+YMXbt2pVy5cuzcuZPSpUsD8Ndff9GmTRsmTJhAnTp18gS9AO+//z6QPdKkX79+LF26tD0wAsg9bvXynX+D7ylmmeMWtl2786+7hffsQlEHEqfJDiQqc5dAQtM0f7I7i5iWY/MD0pRSecaWKaWuaZqWChQ8vM9FzruWHA6m/O+6b5s2bdiyZQszZ87k22+/Zfbs2cyePZvAwEAmTZrEiBEj8t3XNH7bVOFz88ADDwCQmppaoPMoKHebd8F0vqZJnnbt2sWuXbvyTZ+cnGwWSHh65p3+Y+XKlbz44ov65Fk+Pj40aNCAOnXq8O233+Yp45z55cQ0L8K1a9csBhIm57vd6ScnJwNQp04ddu3axfTp01m3bh0fffQRH330Ed7e3jz//PNMnTrV7IsxN7/99hsjR45kzZo12Y/2XFwICwvjiSeeYP/+/fo5XblyBcj+ws1NsWLF8r32+QUzlupqQbG2nk+fPp0qVarwwQcf8OOPP7J7924mTZpE1apVmTt3Ls2aNct3X9M1+fTTT/NNY7omJizVocJc2ytXruDp6ZnnhxcgMDAw3/0tYaku5qyHJreMjAxee+21e7qZsHSOhfXw9fXFy8tL94DCf9buhancN2zYwIYNG/JNl5KSYlbHc9e1gn6f5ofpHPN7ilPQun23a5STJk2asGTJEm7fvs3EiRP1IAKyy/3tt98mIiKC+Ph4i4GEieLFizNz5kzTU7KO5A0kbtz5t0SBxPJiKTIznXCRLRRW1E0bppp4r+Eug4E/NE2bcufvvwAvS7N63Xlc5En20w74uxDznNv9/kE2ERkZydq1a0lKSmL9+vUMGzaM9PR0Ro4cyfr16/Pdz/TBy2+CK9OPkOlpQVHi4+MDwMSJE+/aNla7du275rN79266du3KrVu3WLp0KSdPnuT69ets3bpVf6yem5s3b1rcbvpSy688fHx8KFasGOnp6fn63nnMCGQHE5999hnJycls2bKF8ePH4+XlxfTp0/nggw/yPSelFO3atePLL79kwoQJ7Nmzh5SUFI4cOZJnfo8SJbK/H3J+2efM58aNG3m2OxuaptG/f39+/PFHLl68yJIlS+jSpQvHjx+nQ4cOXL58Od99TfVo06ZN+V6TpKSkfPfPmU9Br22JEiVITU3l9u3befIxPXErKJbqoqkemu6OfXx8KF++/F0/J2+99VahjlsQj1u3bnHz5k3dw5rP2r0wXb8FCxbc9fwsBR2G5aMAACAASURBVMr3E1MAaOlzVBgK0t5vemqRkJAAkKf5EtCbPn/77TcA/vjjD1atWmXW/Gfizg3hbcDS4xTTb5rlLz0hFHUg8QnZPUyH33nqkAdN07yAQXf+NDUsmp59PmFhlyfIjrxMbU2mpxZ5bulOnTplhbKZW55t7777LhMnTsw+oLc3rVu35v3339dnPbtbG7Lp0avpcXhOsrKy2L59Oz4+PvnOXllY18Lw8MMPA7B3716L78fFxTFjxox7TkD06aefkpWVxdy5c+nR4//aO/MwLYpr/3/OsA2LjDKAokF2IldEFMGLQQSiJLiwGiIiCogRREYUgcHlBxhQ0ATFeNVIQBQ1oCKaiBsuqBGR30XcEOSqgCKgyCKrS+DcP071O/322+86wyK3v8/zPv129emu7VTVqapzTl1Eo0aNYmlbsWIFkDhLWbVqVUKHsXv3bt5//31OOeWUpFtGLVq0YO/evSxbtizh2eLFiykuLo7Vx8MPP8ywYcNQVSpWrEiHDh2YPHlybDBKVW8ffPABH330ET179mTChAmcdtppsRlmME+NGzemoKCARYsWJXzn448/Tio0HSrwtrYeeughAGrXrs3FF1/ME088wYABA9i9e3ds/zqM51Lx0ZYtWxg+fDiPPPJI2nRkU7etWrVi3759oStpyfg5GcLc4Xu6EZ5+SosWLVi3bh0bN25MoJ0/fz433XRTbPshV4Sl45133kFVY+nItq1l0kekqr+ffvqJESNG8Je//CX7DGUYv4c6deoApBRayxreKsSqVYm7B96Kj7c69dprr9GzZ8/Q7S3nubMCEDYAecLFl6VP8cHDARUkVPVz4E6s8F4QkTr+5064eBRoAvxTVd9wj2a6620iUstHX4uSpaJZ7voNsBVoIyK1Pdply5Yxf/78UqXf28/2D54vvvgiEydOTOi0PAWfVEJAu3btaNy4MU899RTPPfdc3LOxY8fy5Zdf0rt375yWs8PSmg0aNGhA+/btef7553nyySfjns2aNYtbbrmFF154Ia0eiLeNEvSi98orr/DYY48BJMwcf/zxR2644YZYp6eqjBkzhl27djFwYHKdWs/T5bXXXhvn9nfHjh0MGTKEyZMnx/aIFy9ezD333JNwLkQm9eblKai4tmXLFkaOHBmXpwoVKnDxxRfz2WefMWXKlLg8jhkzJmkchwqOOOIIpk6dyo033piwPL927VqgpKzCeK5Hjx5Ur16dyZMnJ3TIo0aNYurUqXz66adp05FN3V522WWICMXFxezYUaLXPXv27KwFiTvuuIMNGzbE7hctWsSjjz5Kq1atYoNs//79UVWuvvrquLxv2LCBwYMHc9ttt5V6xv7OO+8wZ86c2P2OHTsYM2YMeXl5MSXebNtaJn1E+/btadCgAdOnT48JUB4mTZrElClTYnoU2SKbPqp58+YALF++PA1l2eHCCy9ERJg4cWKcAPP9998zatQoAPr06QOYYme1atWYNm1a3PlHu3bt8m9vzwiJprm7lk7SPNg4UOYh3g8ohxWoYg405gKTgUcwIUAxBcojA+/92T3bgLkVfQBY78ImBWg9nxNrRowYEbP/9vwEBM0/CwoKNIgwUzbP1O6kk07S4uJi3bNnjy5ZskTz8/M1Pz9f+/Xrp8XFxdq1a1cVEW3WrFmcr4UwvPXWW1qtWrWYH4nrrrsuZtbVrFmzOCdM2ZhLrVmzRgEtLCzUkSNHxswZIdHZkKrZdRMwr1y5cqXWqlVLAe3SpYuOHDlSu3btqnl5eVqjRg1dvnx5jDaZc6hly5ZphQoVtFKlSnrppZfq6NGjtUuXLpqXl6e1a9dWQG+99dYYfb169bRChQpapUoVbdu2rV577bXatm1bBbRjx44JNuvBOIuKimLmdVdeeaUWFRVp3bp1FdDBgwfH6FavXq2FhYVarlw57dWrlxYXF+tFF10Uc+Dz1VdfJS3bvXv3aps2bRTQdu3a6ejRo/Xyyy/XwsJCrVq1qlapUkWbNm0ao9+yZYs2bdpUAe3cubMOHz5cmzdvrscee6zm5+eHmn8G6ziZOa9nHui3aU9m/hlm9x5m0hzkkbvvvlsBrVOnjl511VV6/fXXa+vWrRXQfv36xeiS8dzjjz+u5cuX1ypVqmjfvn115MiRsfJr3bp1nG+QZPypmnndqqqOHDlSAW3YsKEWFRVpjx49VES0UaNGWZl/FhQU6NFHH61DhgzRvn37aqVKlbSgoECXLl0ao923b592795dAW3atKkOGzZMhwwZooWFhQropEmTYrTZtGHVkrorKChQEdGePXtqUVGRNmzYUAG9+eabY7TZtrVx48bFeHjcuHFJ0/fmm29q1apVtXz58tqrVy8dNWqUdurUSQFt0KCBrl+/PkabrB8I48GFCxcqmF+Q0aNHp2xz69evVxHRAQMGJDzLpg/PFuPHj1dAa9WqpUOGDNFhw4Zp48aNYybefnPTmTNnqojoEUccoYMGDdKhQ4dqgwYNPDPQ+zR8PJyHmXDWCnvuo1tIuPnnXSG0M92zlqm+WZa/Ay5I+DLbGXgKc6CxB9juBIgrSW5z2xd4G1NQ2eYKN8H+FltGGg+sqVixop544ok6ffr02GCZqyCxZ88e7d27t1apUkWrV6+uK1euVFXVJUuWaNeuXeO8Pw4fPly//fbbhO+GYcWKFdqnTx+tVauWVqpUSZs2bao33XRTXAermn0nNGHCBK1Zs6ZWrlxZZ8yYoarZCRKqql988YVeccUVsbzVq1dPL7vssgSPbsk6EFXVBQsW6BlnnKHVq1ePOZqaMGGCbtiwQfPy8rRdu3YxWq8+3n77bW3btq3m5+drgwYNdOzYsXE+AVLFOWvWLG3btm2snlq3bq0zZsxI8AK4cuVK7du3r9arVy/mVGzgwIFx/huSYcOGDdq/f3897rjjtHLlytqkSRO95JJLdOXKlbFBxe9/YNOmTTp48GCtU6eOVq5cWc8++2xdsWKFFhQUHPKChKrq7Nmz9YwzztDCwkLNz8/XFi1a6JQpU+L8JqiG85yq6qJFi/SCCy6IebY84YQT9Oabb07ws5JKkFDNvG5VzffASSedpPn5+dq4cWOdPn26XnPNNVkJEjNnztQrrrhCjzzySK1Ro4b26tUrwXeIqvmEmTp1qrZs2VIrV66sNWrU0DPPPDOuXFVzFyS6deumM2bM0CZNmmjlypX11FNPDfWpkE1b27Rpk55zzjman5+vNWrU0B07diRN3/Lly7VPnz5au3ZtrVSpkjZq1EiLiop048aNcXTZCBL79u3ToUOHavXq1bVq1aq6YMGClGXRpk0brVu3bkJd709BQlX1ySef1Hbt2mnVqlVjXmbvueeeBK+sqlb+HTt2jNG2bt3a8x8TNp5VBLYAz4c9D9Ae0oKEuIgPZxz2GTycUL9+fbZt2/azPRo8wuGBcePGMX78eObNm1eqA9BKizVr1tCgQQO6devG008/fdDScShg9uzZ9OnTh5deeolzzjnnYCcnWyQohIhIb+zU67NV9ZUDn6SywwE/RjxChAgRIkTIFr1796Zp06ZMmzbtYCelrHAF8M7PXYiASJCIECFChAg/A+Tl5XHXXXcxd+5cPvjgg4OdnFJBRNoDnYDh6Wh/DogEiQgRIkSI8LNAly5d6N+/P8XFxemJD21MAu5U1eTe/n5GiHQkIkSIECFChP2LA+Zl8mDgQLvIPhg4rCswQoQIESJEOJiItjYiRIgQIUKECDkjZ0FCRGaKiIpIhwzp1zj64O97EVkrIrNEpFngnf5J3vHe+0pE5onIf2YRX/A3LiRP/t9eEdkpIh+LyBQRCT1RSkQWOvr6SZ6fJSKPisinLu1bReRVEekrPl+xIlI/w3R7v7TlLyLlRWS0iHwiIjtE5G2n7HNYwFdvicc97p/4+ohIw/3w3fdEJO1WnI/XEs6e2Q9p8rejuinoyovIZke3MMe4vPZ+yCigHWjeCsR9uog87OrgexHZICJviMggEcnu1K8DBFdW76WnPLQgIgtc2v+RgmaQo7n6QKbt54CDsbURPH4tH2gBXAJ0F5EzVTXIiK9jDjn8OBI4HegOnC8iHVU17JjxdMe9Bb8L8BCwxv0vDxS4uK4F+otIZ1XNyNeuiFQC7gEGYYePPYd586wNXIB59DxfRPqq6j7M0VYwzS2xk+PCymEN6fFnoAh41cXfH3hJRNqo6s9b/dnwNFYOiYcdlDFEZDIwCjhlf8d1CKIHcHeSZ52A7I7WjBAKEcnDvPNei3n/fQH4BCvfTsA0YISIdFfVTw5aQg8TuMlhJ2A3cK6I1NGSk6cjZIJcPVlR4j2rQ4b0ayy6pM9vcN972RfW34WNS/HeLY5mUTbx5ZInzO5XsQHrqCSex+oHwv/mwp8BagSeVQdecc8np0hX2nJI8W5VYC/w35Qo13YniVe06Jcxj5S51zjscDrNgM7jtSPLOg0hca3BPMluBxamoHsAE5Q1FV2auDw+H36w6/lA1HeKOO9wcb4B/CLwrBwmYOwFNgFHH+wyCqRPgfcOdjqyTPNol+6x7npDErpB7vnVBzvNh9rvUNKRuAs7arWj2NHgmWKCe6+t2Mmh+w2qOg24DziaDOx/RaQjcDl2MunvVDXu1CNV3Q78DtiJnYi6P84LPxbbwtqkrjVQcgpd9f0QX4TDDz8B84F2IpJwFLKIlMOE038e6IQdbhCRU4ERwP8A56rqOv9zVd2rqndig15NILejNyP40Q/4FhPgdgAD/dvNEdLjkBEkVHU3dmpnHnBUFu/9CHhnTqc+irJs8Cd3vSgD2svd9XaXzgQ44WKIo/0pjKaU+AxYC3QWkTYurMhdM/a569srPkpE7hORjW7fdqmI9AqhLxCR20XkMxH5UUS+djoiTQN03r74WSJSLCKrRWSPiCwTkd84moEiskJEdovIhyJyYZK0tXT3np7JOBHpKiJL3De/EZFpSQbDS53uwVaX3g0uvQ19NGuAy9ztMnfvPRMRGSwi77q4torIP0QkYQtERCqLyK1u73uPiCzOUWfleDEdoZ1OP+GxQHr7uXKYEJKGKmL6Mm9lGNdcbDbcLeTZWUAt4MmQZ4hIJRG5QUzP6AeX1mdE5LRMIhaRY0TkXhFZ595fLSKTRSThSE0RqSkid/r4aJWITBSRaj6aUB0TH9+kbReZ8IujU8efN4jINve7NsWnizBLs0mqujMF3R3YikRPETk6kP5s+L69iDwrIt+KyHciskhEEupYRM4R0yPY7r75rohcJbYNk66sMq5/MV2bMa7e9rh3BorITS5v9R3vbheRL0QSB3wRmeFom2SQtlbAicACNwb9A2gEdEz3rnv/XyKy0qXrSVeG20RkjogUivWXf3Plu8Xl+/jAN0REBojI6z5+Wi+mN1g/QLtORF4WkRNFZL6Lb4erw5NC0nemWB+x0X13i4i8JCJnhdDWFpG7pKRfWiUifxSRqmkLohTLQTMp262N6sA+bE+wogvrT/qtjVaOZm028ZUmT8BXjq6mL2whga0NYLMLK9XyYyblkOb9Hu79L7EtFsWcoeRSNv/tyvZuYLqrr31AZx9tIbDS0b8NTMGElr2Y0Hd6SN6WYR3jX4AHsRPxfgCmYis2fwP+y/3fC5wSkraW7r6+u1/qaJ/BTphd5sLfCuTNOy32PeyY+ynuXQW+ACo7uuGORoH78S3BAw+78I/cNx7A9F32AJ18dHk+XnnHxfWmK8ctmfCs7/0NrpzvwDpABb4Gjnd0VbEZ1mch37jY0V+ZQbvd5r61G5gfQnMvdnJvIYGtDUwH6k0X/iG28jjb5fdHoFsIL/jL9XiMb/e5epyE6Qwo8C5Q1Ud7jEuvYvpAf6Jk6/BloHyg/IInDHt883Qy3sqGXxyttxX6HcbLc4C2Kcp7nXunThZt8vIc+f4SrJ1tB2a5vHzpaAf46Ia5sG2Y/th/YRMUdXUpgfy+57vPuP4d/VOO9n1Mt+tpd+/FV9/RPeju2wfez3dl/XaG/dpU951u7v58d/9YCG3C1gZ20ORG7CTqRcDtwGIfz73r8v1n4CVK2r2/zO6ihJ+nuHrw6mwNUCnAH//j6mIx1vbnO9rNQKGPtpfjg6+wNjoZeN7R/gSc5KM9DuNdxdrMn4DX3P2LJDlIM/Z+JoWdhok7ZEi/htSChFeYT4Z0LOMCtIIpW56LnR6qwMCw+IBxKX7FueQJWOLo/BWxkHhGr+zuv8u1jNOVQxbvH4Vtr6j7XVqK+n6H+M7bG5Bm+8Kmu7A/Br5xLjYgrPIY05e373ADoAu/1YX/GzjZF34ZAZ0SkgsSim0peXQVsIFegRN8DWgvpshaLpBer4F2ThaXC/udC3sUN1i58AZY415HiXA8wNFOB/J8tLd7ac6gLjxeWwTk+8Kv9NLhC3vIhZ0ekrcfCOj6JGm329z/p7AB4Ajf8zxMoLkfa5NKvCBxswt7MFA2p2KCyVageoAXhgfSuQ84L5CuIkd7uy/s4eD7LvyvLrxnoPyyFiRy4BePDy/IoF6rOtrtGbZJb29/Yg58fxQ2GH0NNPXR1sQGnm/dew2xQWct0DCQVk9I6xfIr1+QyKb+eznaeUAFH+1QX768/rWju78vUCZeW7wqg/IrjwnAWylpnxVc3veQqAeXTJBQ4HFKdNAqUCIQvhHIyxsuvIm7P97x06vE9weCDeBK/ETE++5dgbTNcOGDfGGfuvzVCtB6+oi3+MIeC+bNhXt9edeUZZkJwyaphJnkIEiQOJhPoWRg/pr4GX1/HwMl+20DrksRX8p3c8kTJRL2r3xhC4ln9Drufl2uZRxSDuNyePccbKb/b+Bz952/lqK++wXCvcFjsbuviHUQa/wNw0f/hL+MfXl7MEB3ngt/IRB+ggufE5K2oCARNhP3BNbfuvtCTBhKUKbDrDMUuCRZXC7MmyHXCvnGBPfsPHf/EjYw1g7QVXK8rBnUhcdrZ4U8W4kN9pXcfSdHO9VHUwsbHOZm2G49QaKv+9ZFvuftXdivCRckPsOUNY8I+banVNg/wAvDfW1oH/BsyLt52AzqG1/57QRWhdDWAybiVgIonSCRLb8o1h5Szugc7bFk0WdQovz91xz43qvLBMVCoLfLy1GUCAIDQ+hODKlvJV6QyKb+vVW1RiF17a1w1ndh4nhzE/ECyjPYSkdhML6Q+L3Vh+mB8PtdeFEgPJUg8asA7TwXfmEg3FvNOsfd13R10SIkfd6A729voStWwIUufIK7Lwf09Oo7QHuGo73f3Vd2PPpxCG1DrA87PfjM/zsY5p9jA/e7sA7hbuAODSgXOfjNHqtjUucvMNPJP6jqnmSRqer+UJrx9mZT7WFudteM9T3KGiJyOvAstrzdHhMklgJ/EJG3sdnqJ5jkep46zkmDVYF7Tz+lkrv+EmPMf6mZswbxL4zpTybelPXTAN0ud10dCP8+EF82aU1Ir6puBh4TkTwRaQ40wxrPycDZjrZcmnhauXQNDdmyPcFdW2Iz1pOBL1T1Gz+Rqv4gIkuxgT8TKLZtFMQSrA5OwJaHX8OWq3uLyHWquhf4PTYbm5VhXB6exTrpntjyNFhdbsLqMk5nQUyHoSG2pL4j5Hv/Aq7HyiQMp2IDRqH4/L348CNQV8x8rwCbJSeUiaquBW5Mka+MkSO/fOnKPR22umumPiK8vetNgfC0fE9JmYeV1+Pefynxn/FGCN1yEdlGkvrLof5bA5tV9TM/karuc/3VL31hKiKPYPX6G2C+iNQAugDPuXpKh0vd9e+B8Eex1b3LSW7uHERO/Zeqfgs8GuCnRphLhGT8tFMTzVOD/dpebAURp2fR3H33PyjR//C+2wTjuTBe+By4KRgeRJkJEo7huockZFzgPpeBfaH/OyJyM+YP4RKsAA+YgxCn3FMP68jXJKNT1R9F5CvgOEljlywitYF/a8CqowwwEVsh6K2qi1xcvTDB7F6s820CfJKhEAG2HB6Da9BQ4orcswT5jnCsd9eghc2uIGFYfFki7F0vn34nYD2xvXdPOWsnJnC9jzXmdDx7JNaWgkKyH56PhaOw5cYwZFP/WzVcgdfrsKtBXIc7ButAXsbazWasDWUMVf1ORF4Guoj5R/GEiqdVdW+IEJUrL3jwlCH/0/2SoYYvru0p6MoEOfBL0omOH6q6R0Q2AHVEpKYbZFLhP9x1bSA8E773JjjpyiuTOmxcinehpP5rYhObVLR+PIwJEn0wIb03tq2QVkAWU7S9wN0uCOFdgBZivnaWpPsepei/xJTHb6OkHHdiumgfYhOLYOIy7ddOxnRAznJBP2Fb3P8f491seSEpytJqoyXWkQZ/ZQ5V3YUxzdfYLPDK/RFPEjTHOrjlqpqsgXh4wV07p6EbC2wSkStKm7gA2mAS/qtegNppc8MwCfQuFzytDOP0BrJQD6CUMG0mM4b9Drdq8wQmyffBGnN1Ve2ADbqZYCc265QUvxGOdismwIWhWpLwMFQP01jHlschXih5yF17i0g9zLnanCSCSDrMxdLZGRvcj8PKLwyl5QVvxe+Pacr2Qx9tgiUHQEDz3Ot0g/1fWvPxMuKXVPAsRsKsY/zpKI/pHO0lN7PbpOXlrCy8SWYmdZis/rKt/+0kN0lPCFfVVZjCYTcn2PbG2tezSb7hR29MMXMJpkMT/L3u6AZl8K2cISJnYPoV5TFLwEYYP3XE9CZy/W4BsAAbA67DVjiqqeop2CTSj2zaTijKTJBQ1Zlhjbysvh8S39eY2STAlKCZzH7EUHd9LANarwMf7WuYcRCRYzAGUkx5qSzxPXCkiMRtr6jqA5SY6m2hROApC3zi4m3tGncQnpnj8jKMszS4CGsHV6nqbFX9zLc647ls9/Nx2MrNB8AvXF3GQUTOE5EJbnYANnOtG2ICVo7svGWWD9KLSAXgNJyuQCzB5v1wCbYnfL4LznZbw8MzmL5ND0w5bjO2fZIANT8pq4GmIlIrhCQdL3heV0PNREVkvJjJcEWM737EOs4g3XHAThF5wAV5AlSwg2yUJB1+ZMsv2eI+rHxvdoNBMhRhA/Q/VDUXj64fumtCeWHbDXuciaDnZbhdkEhEGmN6LKH1l0P9L8XaUZ0Q2tPD4sBWJaphgteZwOOqmskqpretcY2qDg7+KFGKvigj88fc0Qfjl8GqOkdVPy8jfjob04Waqqp3quqHvolD8LsrMZ4Lazv1sLYTFD7icMj4kcgFqjoP2weqgjXA/QoR6Qv8AVtmuycdvaq+iZl7NQPmBjsG12DmYkuz97r9qLLEU9g+2O3+2auInIkpYeLi/ptkYA+eCVwj/js2M45z9S0iv8X25z/FLA4OBXh7lkf7A0Xk15hSHdhyqQfP14ffZ8lMrFHe4wY17xt1MMWtMZTMzma66xQ38HsYGUxDBhjrBBAPozDdoYdC9uQfxjr9kcCnbmUqa7i959cxgaQHME9V/53ilZnY6tedfmFazPHSMEzBNHRGraqrsb35LpLoO6Qf8P8wZbIfVfV7rC01C1nZu8FdvRWDle7qCVWIOcEbmSIfHrLll6zgVlcmYtunL0rgfBMxDMGsfDZTMrHJFk9jy/HXuMHC+34NTD9gBzbbfwQbZG6QeB8lVTEzUDDeSoaZZF7/D2Lt6A4/X4vIJZj+RBhmY4Lh7WSo9+Py8StMKTW0HTjeex2bpf8+3TdLgWT81NkXby78lOy79TEF2th33Qr/POAkERkQ+M4Yd0252nY4HCNehElfvxWRPqoapziTREnLj42qen8grL+UHIZVDluCa4spf20GuidRHgrDQGwpuyvwpYj8E9O8rY8pBh2BVWImnVi2uBHbFx8EnCgiizCFpXOxJcDOmM1yP2yZr3cZxTsKa6ij3axmEaZ01RXroC7JQidjf2MO5knwXpfWDdgy4G8wM7DamKa+h6/c9c8i8rKqjsc6y67YDP1DEXkRa1u93bvFnpCoqo+7QfF3wFIReQXTfu+E7XXXIzN8jyl5LnHfaIkJhysJV476O2YhVY/SbznOxaw0alGyKpgMt2Nl2Rfbc34V69y6Y4PG793MNRn+gFlJPSEiz2NmjL/EhIAtwFU+2uuxmfMDTo/hI2yW1R7T4/CUCGdgA/BUsQP/vsVmtN+RfK/bQ7b8kgvGY7PhscAnLt+rsL7i15gi7SrMIiCnMyFUdYuIDMUG72ViTrh2YsqzdTBT2R+Az0VkBLbX/q6PrgvWpmeraqrBO5v6n431RX2x/uo1bOvofKxsa2JbOf58bHV9ai/gc1XNxMGatxrxaBq6B4EOWP85I4Pv5oLZmH+av4pIJ8wnxclY31wafnoDM2IY4HTwPsRMTbthFhoEvnsdZs0xw/VPH2Nbl+0wlwxPpYxNMzAzCvtRxn4kkrzTnwzMHjFlS8V0Jo7yx5fB772QPPl/+7DBbxmmYBXqXIokZ21oiSnOhZgzkNWYssxWbA/r92VVDkneLcQ0j7/EJPe12GrK0e75MdjMo2+G9R1m9hZXji7sKMzUycvvOqwxBk27vLwFbf87uPCgvXR90pvoJdD4aMe5Z919YWcDb2EDyRbMMcyNrmz2Am/6aGtiJpx7MKGymq+Oixyf7HbP3vDHE+CHUdhg8D22hH8BzvlOBnW6EJvJNXVp2Y0pcN5PCrM3TLlS8fkDyLDdBs2kvXLZTLzpXYL5pwuvjM2CVjpe+BrbFz4lQJeMF+piDr7WuffXuDpPyIdL2/2YwPeTo/0jPqc+jq4zJuDucenx/GBsS8VbOfBLQtvIouxbYPpLK1wdf+146kp8vlxStY1UfO/LyyuYfsIel69zQ97/rY9uJ7ZVNgifY6UUfUFG9e+jnYj1Uz9g2x59MQFOCeFvTGBXYHyG5er5HmqShq6Ky69iiq2pzD+rBd59xIU3D4R75uDnh/DidqxNLQWKsa2rfcBrPtp1wLchaT3bffdPvrCm2CT1a1dnH2P6EcdggsVOoIqP/lisna3H2s5qTKitlKqca9Ie3gAAAUFJREFUVDXmQCPC/2GISJ6Gm2pGOEzgtq7WAmtU9cyDnZ4IEYJw2zjfacgKlYi8junKVNPAoCUit2JL8E1UNWiGGeEA4GetIxGhbBAJEf8nMAjTnyhLC50IEcoSo4HvJHAOhIi0xZbYF4YIEb/A/D28FgkRBw/RikSECIcxRGQOtsR5MmbZ0EJV98fhcBEilApOAfNtnNdVbHuqAaZP8QPmmXSFo+2LHafeGDMN7aCqCU6zIhwYRCsSESIc3vgGU05cgh1MFAkREQ5JqOq7mILfc5jy8QjMpHMO0MoTIhzWYULGbuzguUiIOIiIViQiRIgQIUKECDkjWpGIECFChAgRIuSMSJCIECFChAgRIuSMSJCIECFChAgRIuSMSJCIECFChAgRIuSMSJCIECFChAgRIuSMSJCIECFChAgRIuSM/wUMxdhajGVIlAAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 540x720 with 4 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "font_size_legend = 15\n",
    "font_size_data = 16\n",
    "font_size_axis_label = 18\n",
    "font_size_tick_params = 18\n",
    "font_size_title_minor = 20\n",
    "font_size_title_major = 22\n",
    "\n",
    "figure = plt.figure(figsize=(7.5, 10))\n",
    "gs = figure.add_gridspec(nrows=3, ncols=2)\n",
    "gsA = gs[:,:].subgridspec(3, 2, height_ratios = [1, 20, 1], wspace=.00, hspace=0.0)\n",
    "\n",
    "# axA = Figure 3A. Comparison of therapy counts per patient, unique strategy and overlapping strategies\n",
    "# axA_top = legend, all columns and top two rows\n",
    "# axA_left = I-PREDICT, first three columns and then middle 14 rows\n",
    "# axA_right = MOAlmanac, second three columns and then middle 14 rows\n",
    "# axA_bottom = title, all columns and bottom two rows\n",
    "\n",
    "axA_top = figure.add_subplot(gsA[0, :])      # legend, all columns and top two rows\n",
    "axA_left = figure.add_subplot(gsA[1, 0])     # I-PREDICT, first three columns and then middle 14 rows\n",
    "axA_right = figure.add_subplot(gsA[1, 1])    # MOAlmanac, second three columns and then middle 14 rows\n",
    "axA_bottom = figure.add_subplot(gsA[2, :])   # title, all columns and bottom two rows\n",
    "\n",
    "#axA_left.annotate('', (0, 0.45), (0.36, 0.45), ha='right', va='center', size=25,\n",
    "#                   arrowprops=dict(arrowstyle='->', fc='k', ec='k', linewidth=2))\n",
    "#axA_top.annotate('Patients', (5, -5), (5, -5), ha='right', va='center', size=25,\n",
    "#                   arrowprops=dict(arrowstyle='->', fc='k', ec='k', linewidth=2))\n",
    "\n",
    "p_left = (data_s\n",
    "          .loc[:, ['study_overlap', 'study_not_overlap']]\n",
    "          .plot(kind='barh', stacked=True, ax=axA_left, width=1, \n",
    "                fontsize = font_size_data, \n",
    "                color=(purple, blue), edgecolor='white', zorder=3))\n",
    "\n",
    "p_right = (data_s\n",
    "          .loc[:, ['almanac_overlap', 'almanac_not_overlap']]\n",
    "          .plot(kind='barh', stacked=True, ax=axA_right, width=1, \n",
    "                fontsize = font_size_data, \n",
    "                color=(purple, red), edgecolor='white', zorder=3))\n",
    "\n",
    "for ax in [axA_bottom, axA_top]:\n",
    "    remove_ticks(ax, labeltop=False)\n",
    "\n",
    "for ax in [axA_left, axA_right]:\n",
    "    remove_ticks(ax, labeltop=True)\n",
    "    ax.grid(linestyle='--', linewidth=0.5, alpha=0.3, color='black', zorder=0)\n",
    "    ax.get_yaxis().set_visible(False)\n",
    "    ax.set_xticks([2, 4, 6, 8])\n",
    "    ax.set_xticklabels([2, 4, 6, 8])\n",
    "    ax.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "    \n",
    "axA_left.set_xlim(9, 0)\n",
    "axA_right.set_xlim(0, 9)\n",
    "\n",
    "axA_left.set_xlabel('# of therapies given\\nin I-PREDICT', \n",
    "                    fontsize = font_size_axis_label)\n",
    "axA_right.set_xlabel('# of therapies nominated by\\nMOAlmanac', \n",
    "                     fontsize = font_size_axis_label)\n",
    "axA_left.xaxis.set_label_position('top')\n",
    "axA_right.xaxis.set_label_position('top')\n",
    "\n",
    "#axA_left.text(-1, 60, 'Patients', rotation=90, fontsize = font_size_title_minor)\n",
    "\n",
    "for ax in [axA_left, axA_right, axA_top, axA_bottom]:\n",
    "    remove_spines(ax)\n",
    "\n",
    "title = 'Counts of therapies administered per patient (n=83) in\\n I-PREDICT & nominated by Molecular Oncology Almanac'\n",
    "axA_bottom.text(0.5, 0, title, fontsize=font_size_title_minor, \n",
    "                horizontalalignment='center', verticalalignment='center')\n",
    "\n",
    "legend_elements = [Patch(facecolor=blue, label='I-PREDICT\\n(unique strategy)'), \n",
    "                   Patch(facecolor=purple, label='Involved in an\\noverlapping strategy'),\n",
    "                   Patch(facecolor=red, label='MOAlmanac\\n(unique strategy)')]\n",
    "\n",
    "axA_left.legend(handles=legend_elements, \n",
    "               frameon=True, bbox_to_anchor=(0.8, 0.45),\n",
    "               fontsize = font_size_legend,  \n",
    "               ncol=1, facecolor='white', edgecolor='white')\n",
    "axA_right.get_legend().remove()\n",
    "\n",
    "filename = 'clinical-trial-comparison-summary'\n",
    "for suffix in ['svg', 'png']:\n",
    "    outname = '../../figures/{}.{}'.format(filename, suffix)\n",
    "    plt.savefig(outname, format=suffix)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Therapies by evidence for those (stacked bar charts)\n",
    "We plot the evidence level for overlapping and and unique strategy when comparing I-PREDICT (`data_a0`) and the Molecular Oncology Almanac (`data_a1`)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "idx_overlap = therapies['included-in-overlapping-strategy'].fillna(0.0).eq(1.0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Strategy of overlapping and unique therapies for I-PREDICT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "column = 'study-evidence-strongest'\n",
    "overlap = 'Involved in common therapeutic strategy with\\nMolecular Oncology Almanac'\n",
    "unique = 'I-PREDICT\\n(unique therapeutic strategy)'\n",
    "percent = 'percent agree'\n",
    "\n",
    "therapies[column] = (therapies[column]\n",
    "                     .str.replace('No citation', 'Not based on molecular features'))\n",
    "\n",
    "data = pandas.DataFrame(columns = {overlap, unique}, index=therapies[column].dropna().unique())\n",
    "data[unique] = therapies[~idx_overlap][column].value_counts()\n",
    "data[overlap] = therapies[idx_overlap][column].value_counts()\n",
    "data[percent] = (data[overlap]\n",
    "                 .divide(data[unique].add(data[overlap]))\n",
    "                 .round(2)\n",
    "                 .multiply(100)\n",
    "                 .fillna(0)\n",
    "                 .astype(int)\n",
    "                 .astype(str) + '%')\n",
    "\n",
    "for index in data.index:\n",
    "    if len(data.loc[index, 'percent agree']) == 2:\n",
    "        data.loc[index, 'percent agree'] = ' ' + data.loc[index, 'percent agree']\n",
    "        \n",
    "order = ['Clinical trial', 'Clinical evidence', 'Preclinical', 'Inferential', \n",
    "         'Citation listed not applicable', 'Not based on molecular features']\n",
    "data = data.reindex(order)\n",
    "data = data.loc[:, [overlap, unique, percent]]\n",
    "\n",
    "data_a0 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Clinical trial                     92\n",
       "Preclinical                        21\n",
       "Not based on molecular features    14\n",
       "Citation listed not applicable      7\n",
       "Clinical evidence                   3\n",
       "Inferential                         2\n",
       "Name: study-evidence-strongest, dtype: int64"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies['study-evidence-strongest'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Strategy of overlapping and unique therapies for Molecular Oncology Almanac"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "column = 'almanac-evidence-strongest'\n",
    "overlap = 'Involved in common therapeutic strategy\\nwith I-PREDICT'\n",
    "unique = 'Molecular Oncology Almanac\\n(unique therapeutic strategy)'\n",
    "percent = 'percent agree'\n",
    "\n",
    "data = pandas.DataFrame(columns = {overlap, unique}, index=therapies[column].dropna().unique())\n",
    "data[unique] = therapies[~idx_overlap][column].value_counts()\n",
    "data[overlap] = therapies[idx_overlap][column].value_counts()\n",
    "data[percent] = (data[overlap]\n",
    "                 .divide(data[unique].add(data[overlap]))\n",
    "                 .round(2)\n",
    "                 .multiply(100)\n",
    "                 .fillna(0)\n",
    "                 .astype(int)\n",
    "                 .astype(str) + '%')\n",
    "\n",
    "for index in data.index:\n",
    "    if len(data.loc[index, 'percent agree']) == 2:\n",
    "        data.loc[index, 'percent agree'] = ' ' + data.loc[index, 'percent agree']\n",
    "order = ['FDA-Approved', 'Guideline',  'Clinical trial', 'Clinical evidence', 'Preclinical', 'Inferential']\n",
    "data = data.reindex(order)\n",
    "\n",
    "data = data.loc[:, [overlap, unique, percent]]\n",
    "data_a1 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Preclinical          66\n",
       "Clinical trial       33\n",
       "FDA-Approved         24\n",
       "Clinical evidence    21\n",
       "Guideline            20\n",
       "Inferential          10\n",
       "Name: almanac-evidence-strongest, dtype: int64"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[column].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Counts\n",
    "We create scatter plots comparing the molecular features targeted, therapeutic strategies, and specific therapies targeted and highlighted by the study and our methodology. Values from I-PREDICT will appear on the x-axis with Molecular Oncology Almanac on the y. Data tables will need to have additional columns for label display, which can be manually tweaked as needed for visualization."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Therapeutic strategies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "therapies['strategy'] = therapies['strategy'].str.replace(' inhibition', '')\n",
    "ipredict = therapies[~therapies['study-evidence-strongest'].isnull()]['strategy'].value_counts()\n",
    "almanac = therapies[~therapies['almanac-evidence-strongest'].isnull()]['strategy'].value_counts()\n",
    "strategy_list = therapies['strategy'].unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = strategy_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b0 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Specific therapies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "ipredict = therapies[~therapies['study-evidence-strongest'].isnull()]['therapy'].value_counts()\n",
    "almanac = therapies[~therapies['almanac-evidence-strongest'].isnull()]['therapy'].value_counts()\n",
    "therapies_list = therapies['therapy'].unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = therapies_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b1 = data.copy(deep=True)\n",
    "data_b1.index = data_b1.index.str.capitalize()\n",
    "data_b1.rename(\n",
    "    index={'Amg 510': 'AMG 510', 'Pd-l1 antagonist': 'PD-L1', 'Epz015666': 'EPZ015666'},\n",
    "    inplace=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Molecular features targeted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "ipredict = features[features['ipredict_targeted'].eq(1)]['feature'].value_counts()\n",
    "almanac = features[features['sensitive_predictive_implication'].notnull()]['feature'].value_counts()\n",
    "features_list = features['feature'].sort_values().unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = features_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "\n",
    "data.rename(index={'CDKN2A': 'CDKN2A/B'}, inplace=True)\n",
    "data.drop('CDKN2B', inplace=True)\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b2 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Generate figure"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "a0_replace_dict = {\n",
    "    'Citation listed not applicable': 'Citation listed\\nnot applicable',\n",
    "    'Not based on molecular features': 'Not based on\\nmolecular features'\n",
    "}\n",
    "\n",
    "b0_replace_dict = {\n",
    "    'targets KRAS G12C': 'targets\\nKRAS G12C'\n",
    "    \n",
    "}\n",
    "\n",
    "data_a0.rename(index=a0_replace_dict, inplace=True)\n",
    "data_b0.rename(index=b0_replace_dict, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1080 with 5 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "font_size_legend = 15\n",
    "font_size_data = 16\n",
    "font_size_axis_label = 18\n",
    "font_size_tick_params = 18\n",
    "font_size_title_minor = 20\n",
    "font_size_title_major = 22\n",
    "\n",
    "figure = plt.figure(figsize=(20, 15), constrained_layout=True)\n",
    "gs = figure.add_gridspec(nrows=2, ncols=6)\n",
    "\n",
    "# ax2: Comparison of therapies (I-PREDICT) with unique and shared strategies per patient by evidence level\n",
    "ax2 = figure.add_subplot(gs[0, 0:3])\n",
    "p2 = data_a0.plot(kind='bar', color=[purple, blue], stacked=True, fontsize=font_size_data, rot=45, ax=ax2)\n",
    "label_by_height(data_a0, ax2)\n",
    "\n",
    "plt.tick_params(axis=\"both\", which=\"both\", \n",
    "                bottom=False, top=False, left=True, right=False,    \n",
    "                labelbottom=True, labeltop=False, labelleft=True, labelright=False) \n",
    "plt.xticks(horizontalalignment='right')\n",
    "plt.legend(frameon=False, fontsize=font_size_legend, loc=0)\n",
    "\n",
    "ax2_limit = 105 # roundup(data_a0.iloc[:, :2].sum(axis=1).max(), 5)\n",
    "ax2.set_ylim([-1, ax2_limit])\n",
    "\n",
    "value = therapies[therapies['study-evidence-strongest'].notnull()].shape[0]\n",
    "title = 'Therapies administered to patients in\\nI-PREDICT (n={}) by evidence'.format(value)\n",
    "ax2.set_title(title, fontsize=font_size_title_minor)\n",
    "\n",
    "# ax3: Comparison of therapies (MOAlmanac) with unique and shared strategies per patient by evidence level\n",
    "ax3 = figure.add_subplot(gs[0, 3:])\n",
    "p3 = data_a1.plot(kind='bar', color=[purple, red], stacked=True, fontsize=font_size_data, rot=45, ax=ax3)\n",
    "label_by_height(data_a1, ax3)\n",
    "\n",
    "plt.tick_params(axis=\"both\", which=\"both\", \n",
    "                bottom=False, top=False, left=True, right=False,    \n",
    "                labelbottom=True, labeltop=False, labelleft=True, labelright=False) \n",
    "plt.xticks(horizontalalignment='right')\n",
    "plt.legend(frameon=False, fontsize=font_size_legend, loc=2)\n",
    "\n",
    "ax3_limit = 105 # roundup(data_a1.iloc[:, :2].sum(axis=1).max(), 5)\n",
    "ax3.set_ylim([-1, ax3_limit])\n",
    "\n",
    "value = therapies[therapies['almanac-evidence-strongest'].notnull()].shape[0]\n",
    "title = 'Therapies highlighted by Molecular Oncology Almanac\\n(n={}) for I-PREDICT patients by evidence'.format(value)\n",
    "ax3.set_title(title, fontsize=font_size_title_minor)\n",
    "\n",
    "# ax4: Scatter of therapeutic strategies\n",
    "ax4 = figure.add_subplot(gs[1, :2])\n",
    "p4 = data_b0.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax4, color=green)\n",
    "\n",
    "ax4_limit = 30 # roundup(int(max(data_b0['study'].max(), data_c0['almanac'].max())), 5)\n",
    "p4_line = plt.plot(range(0, ax4_limit), range(0, ax4_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "#for idx in data_b0.index:\n",
    "#    display_label(data_b0, ax4, 9, 9, idx)\n",
    "    \n",
    "display_label(data_b0, ax4, 9, 9, 'targets\\nKRAS G12C', add_x=0, add_y=2)\n",
    "display_label(data_b0, ax4, 9, 9, 'PI3K/AKT/mTOR', add_x=-2, add_y=-2)\n",
    "display_label(data_b0, ax4, 9, 9, 'PRMT5', add_x=0, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'CDK4/6', add_x=-2, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'EGFR', add_x=1, add_y=-1)\n",
    "display_label(data_b0, ax4, 9, 9, 'MEK', add_x=1, add_y=0)\n",
    "display_label(data_b0, ax4, 9, 9, 'VEGF/VEGFR', add_x=-5, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'PD-1/PD-L1', add_x=0, add_y=-2)\n",
    "display_label(data_b0, ax4, 9, 9, 'ER signaling', add_x=0, add_y=1)\n",
    "\n",
    "ax4.set_ylabel('Molecular Oncology Almanac\\n(# of patients)', fontsize = font_size_axis_label)\n",
    "ax4.set_xlabel('', fontsize = font_size_axis_label)\n",
    "ax4.set_ylim([-1, ax4_limit])\n",
    "ax4.set_xlim([-1, ax4_limit])\n",
    "ax4.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Therapeutic strategies'\n",
    "ax4.set_title(title, fontsize = font_size_title_minor, y = 1.05)\n",
    "\n",
    "# ax5: Scatter of therapies\n",
    "ax5 = figure.add_subplot(gs[1, 2:4])\n",
    "p5 = data_b1.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax5, color=green)\n",
    "\n",
    "ax5_limit = 30 # roundup(int(max(data_c1['study'].max(), data_c1['almanac'].max())), 5)\n",
    "p5_line = plt.plot(range(0, ax5_limit), range(0, ax5_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "#for idx in data_b1.index:\n",
    "#    display_label(data_b1, ax5, 6, 6, idx)\n",
    "    \n",
    "display_label(data_b1, ax5, 6, 6, 'AMG 510', add_x=0, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Pictilisib', add_x=1, add_y=0)\n",
    "display_label(data_b1, ax5, 6, 6, 'EPZ015666', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Palbociclib', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Everolimus', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Trametinib', add_x=1, add_y=0)\n",
    "display_label(data_b1, ax5, 6, 6, 'Nivolumab', add_x=1, add_y=0)\n",
    "display_label(data_b1, ax5, 6, 6, 'Pembrolizumab', add_x=1, add_y=1)\n",
    "\n",
    "ax5.set_ylabel('', fontsize = font_size_axis_label)\n",
    "ax5.set_xlabel('I-PREDICT (# of patients)', fontsize = font_size_axis_label)\n",
    "ax5.set_ylim([-1, ax5_limit])\n",
    "ax5.set_xlim([-1, ax5_limit])\n",
    "ax5.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Therapies'\n",
    "ax5.set_title(title, fontsize = font_size_title_minor, y = 1.05)\n",
    "\n",
    "# ax6: Scatter of features\n",
    "ax6 = figure.add_subplot(gs[1, 4:])\n",
    "p6 = data_b2.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax6, color=orange)\n",
    "\n",
    "ax6_limit = 30 #roundup(int(max(data_b2['study'].max(), data_b2['almanac'].max())), 5)\n",
    "p6_line = plt.plot(range(0, ax6_limit), range(0, ax6_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "#for idx in data_b2.index:\n",
    "#    display_label(data_b2, ax6, 7.5, 7.5, idx)\n",
    "\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'ATM', add_x=0, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'EGFR', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'CDKN2A/B', add_x=-1, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'PIK3CA', add_x=-4, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'KRAS', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'ERBB2', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'TP53', add_x=0, add_y=1.5)\n",
    "\n",
    "ax6.set_ylabel('', fontsize = font_size_axis_label)\n",
    "ax6.set_xlabel('', fontsize = font_size_axis_label)\n",
    "ax6.set_ylim([-1, ax6_limit])\n",
    "ax6.set_xlim([-1, ax6_limit])\n",
    "ax6.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Molecular features'\n",
    "ax6.set_title(title, fontsize=font_size_title_minor, y = 1.05)\n",
    "\n",
    "for ax in [ax2, ax3, ax4, ax5, ax6]:\n",
    "    remove_spines(ax)\n",
    "    \n",
    "fig_label_x = 0.01\n",
    "fig_label_y_a = 0.98\n",
    "fig_label_y_b = 0.45\n",
    "font_size_lg = 25\n",
    "\n",
    "plt.figtext(fig_label_x, fig_label_y_a, 'a', fontsize=font_size_lg)\n",
    "plt.figtext(fig_label_x, fig_label_y_b, 'b', fontsize=font_size_lg)\n",
    "\n",
    "filename = 'clinical-trial-comparison'\n",
    "for suffix in ['svg', 'png']:\n",
    "    outname = '../../figures/{}.{}'.format(filename, suffix)\n",
    "    plt.savefig(outname, format=suffix)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary\n",
    "1. What strategies are shared and not shared?\n",
    "2. How many patients do we observe a shared therapeutic strategy?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### What items are shared or not shared?\n",
    "1. The most common shared strategies are PI3K/AKT/mTOR inhibition and HER2 inhibition, followed by immunotherapy. \n",
    "2. I-PREDICT favors VEGF/VEGFR inhibition by targeting TP53 variants\n",
    "3. Molecular Oncology Almanac commonly recommends PRMT5 based on CDKN2A/B loss\n",
    "\n",
    "There is likely opportunity to note, perhaps in the discussion, that there is variability as to how the two approaches arrive at the same therapeutic strategy. For example, PI3K/AKT/mTOR us recommended more recent HER2 inhibitors."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ER signaling     9\n",
       "PI3K/AKT/mTOR    9\n",
       "PD-1/PD-L1       7\n",
       "EGFR             5\n",
       "MET              4\n",
       "CDK4/6           4\n",
       "BRAF             3\n",
       "MEK              3\n",
       "PARP             2\n",
       "Chemotherapy     1\n",
       "RET              1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "idx_shared = therapies['included-in-overlapping-strategy'].eq(1)\n",
    "idx_almanac = therapies['almanac-evidence-strongest'].notnull()\n",
    "idx_study = therapies['study-evidence-strongest'].notnull()\n",
    "\n",
    "therapies[idx_shared].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "VEGF/VEGFR         25\n",
       "MEK                13\n",
       "PD-1/PD-L1         10\n",
       "NSAID               5\n",
       "PI3K/AKT/mTOR       5\n",
       "ER signaling        5\n",
       "CDK4/6              3\n",
       "PARP                3\n",
       "MET                 2\n",
       "EGFR                2\n",
       "targets BCR-ABL     1\n",
       "Wee-1               1\n",
       "BET                 1\n",
       "IGF                 1\n",
       "Hedgehog            1\n",
       "Antineoplastic      1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~idx_shared & idx_study].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>feature</th>\n",
       "      <th>feature_type</th>\n",
       "      <th>alteration_type</th>\n",
       "      <th>alteration</th>\n",
       "      <th>patient_id</th>\n",
       "      <th>ipredict_targeted</th>\n",
       "      <th>score_bin</th>\n",
       "      <th>sensitive_predictive_implication</th>\n",
       "      <th>resistance_predictive_implication</th>\n",
       "      <th>prognostic_predictive_implication</th>\n",
       "      <th>...</th>\n",
       "      <th>resistance_therapy_name</th>\n",
       "      <th>resistance_therapy_type</th>\n",
       "      <th>resistance_description</th>\n",
       "      <th>resistance_citation</th>\n",
       "      <th>resistance_url</th>\n",
       "      <th>prognostic_score_bin</th>\n",
       "      <th>favorable_prognosis</th>\n",
       "      <th>prognostic_description</th>\n",
       "      <th>prognostic_citation</th>\n",
       "      <th>prognostic_url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Frameshift</td>\n",
       "      <td>p.R209fs*6</td>\n",
       "      <td>105</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R273H</td>\n",
       "      <td>140</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Nonsense</td>\n",
       "      <td>p.R306*</td>\n",
       "      <td>20</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R175H</td>\n",
       "      <td>34</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R282W</td>\n",
       "      <td>39</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.V157F</td>\n",
       "      <td>48</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Frameshift</td>\n",
       "      <td>p.H178fs*3</td>\n",
       "      <td>59</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R248W</td>\n",
       "      <td>66</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Insertion</td>\n",
       "      <td>p.M160_A161insAIYK</td>\n",
       "      <td>84</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Nonsense</td>\n",
       "      <td>p.Q165*</td>\n",
       "      <td>84</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Deletion</td>\n",
       "      <td>p.P250_I251del</td>\n",
       "      <td>88</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R248Q</td>\n",
       "      <td>9</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R273H</td>\n",
       "      <td>A008</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Frameshift</td>\n",
       "      <td>p.K373fs*22+</td>\n",
       "      <td>A009</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R248Q</td>\n",
       "      <td>A009</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.K132N</td>\n",
       "      <td>A012</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.Y205F</td>\n",
       "      <td>A021</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>469</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R175H</td>\n",
       "      <td>A033</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Frameshift</td>\n",
       "      <td>p.P191fs*15</td>\n",
       "      <td>A038</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - Low</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.V197G</td>\n",
       "      <td>A045</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>...</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability - High</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>20 rows  27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    feature     feature_type alteration_type          alteration patient_id  \\\n",
       "18     TP53  Somatic Variant      Frameshift          p.R209fs*6        105   \n",
       "101    TP53  Somatic Variant        Missense             p.R273H        140   \n",
       "165    TP53  Somatic Variant        Nonsense             p.R306*         20   \n",
       "204    TP53  Somatic Variant        Missense             p.R175H         34   \n",
       "212    TP53  Somatic Variant        Missense             p.R282W         39   \n",
       "251    TP53  Somatic Variant        Missense             p.V157F         48   \n",
       "278    TP53  Somatic Variant      Frameshift          p.H178fs*3         59   \n",
       "286    TP53  Somatic Variant        Missense             p.R248W         66   \n",
       "307    TP53  Somatic Variant       Insertion  p.M160_A161insAIYK         84   \n",
       "308    TP53  Somatic Variant        Nonsense             p.Q165*         84   \n",
       "315    TP53  Somatic Variant        Deletion      p.P250_I251del         88   \n",
       "321    TP53  Somatic Variant        Missense             p.R248Q          9   \n",
       "379    TP53  Somatic Variant        Missense             p.R273H       A008   \n",
       "386    TP53  Somatic Variant      Frameshift        p.K373fs*22+       A009   \n",
       "387    TP53  Somatic Variant        Missense             p.R248Q       A009   \n",
       "404    TP53  Somatic Variant        Missense             p.K132N       A012   \n",
       "439    TP53  Somatic Variant        Missense             p.Y205F       A021   \n",
       "469    TP53  Somatic Variant        Missense             p.R175H       A033   \n",
       "495    TP53  Somatic Variant      Frameshift         p.P191fs*15       A038   \n",
       "523    TP53  Somatic Variant        Missense             p.V197G       A045   \n",
       "\n",
       "     ipredict_targeted                         score_bin  \\\n",
       "18                   1  Investigate Actionability - High   \n",
       "101                  1  Investigate Actionability - High   \n",
       "165                  1  Investigate Actionability - High   \n",
       "204                  1  Investigate Actionability - High   \n",
       "212                  1  Investigate Actionability - High   \n",
       "251                  1  Investigate Actionability - High   \n",
       "278                  1  Investigate Actionability - High   \n",
       "286                  1  Investigate Actionability - High   \n",
       "307                  1   Investigate Actionability - Low   \n",
       "308                  1  Investigate Actionability - High   \n",
       "315                  1   Investigate Actionability - Low   \n",
       "321                  1  Investigate Actionability - High   \n",
       "379                  1  Investigate Actionability - High   \n",
       "386                  1  Investigate Actionability - High   \n",
       "387                  1  Investigate Actionability - High   \n",
       "404                  1  Investigate Actionability - High   \n",
       "439                  1  Investigate Actionability - High   \n",
       "469                  1  Investigate Actionability - High   \n",
       "495                  1  Investigate Actionability - High   \n",
       "523                  1  Investigate Actionability - High   \n",
       "\n",
       "    sensitive_predictive_implication resistance_predictive_implication  \\\n",
       "18                               NaN                 Clinical evidence   \n",
       "101                              NaN                 Clinical evidence   \n",
       "165                              NaN                 Clinical evidence   \n",
       "204                              NaN                 Clinical evidence   \n",
       "212                              NaN                 Clinical evidence   \n",
       "251                              NaN                 Clinical evidence   \n",
       "278                              NaN                 Clinical evidence   \n",
       "286                              NaN                 Clinical evidence   \n",
       "307                              NaN                 Clinical evidence   \n",
       "308                              NaN                 Clinical evidence   \n",
       "315                              NaN                 Clinical evidence   \n",
       "321                              NaN                 Clinical evidence   \n",
       "379                              NaN                 Clinical evidence   \n",
       "386                              NaN                 Clinical evidence   \n",
       "387                              NaN                 Clinical evidence   \n",
       "404                              NaN                 Clinical evidence   \n",
       "439                              NaN                 Clinical evidence   \n",
       "469                              NaN                 Clinical evidence   \n",
       "495                              NaN                 Clinical evidence   \n",
       "523                              NaN                 Clinical evidence   \n",
       "\n",
       "    prognostic_predictive_implication  ... resistance_therapy_name  \\\n",
       "18                          Guideline  ...            Lenalidomide   \n",
       "101                 Clinical evidence  ...            Lenalidomide   \n",
       "165                         Guideline  ...            Lenalidomide   \n",
       "204                 Clinical evidence  ...            Lenalidomide   \n",
       "212                 Clinical evidence  ...            Lenalidomide   \n",
       "251                 Clinical evidence  ...            Lenalidomide   \n",
       "278                         Guideline  ...            Lenalidomide   \n",
       "286                 Clinical evidence  ...            Lenalidomide   \n",
       "307                         Guideline  ...            Lenalidomide   \n",
       "308                         Guideline  ...            Lenalidomide   \n",
       "315                         Guideline  ...            Lenalidomide   \n",
       "321                 Clinical evidence  ...            Lenalidomide   \n",
       "379                 Clinical evidence  ...            Lenalidomide   \n",
       "386                         Guideline  ...            Lenalidomide   \n",
       "387                 Clinical evidence  ...            Lenalidomide   \n",
       "404                 Clinical evidence  ...            Lenalidomide   \n",
       "439                 Clinical evidence  ...            Lenalidomide   \n",
       "469                 Clinical evidence  ...            Lenalidomide   \n",
       "495                         Guideline  ...            Lenalidomide   \n",
       "523                 Clinical evidence  ...            Lenalidomide   \n",
       "\n",
       "    resistance_therapy_type  \\\n",
       "18         Targeted therapy   \n",
       "101        Targeted therapy   \n",
       "165        Targeted therapy   \n",
       "204        Targeted therapy   \n",
       "212        Targeted therapy   \n",
       "251        Targeted therapy   \n",
       "278        Targeted therapy   \n",
       "286        Targeted therapy   \n",
       "307        Targeted therapy   \n",
       "308        Targeted therapy   \n",
       "315        Targeted therapy   \n",
       "321        Targeted therapy   \n",
       "379        Targeted therapy   \n",
       "386        Targeted therapy   \n",
       "387        Targeted therapy   \n",
       "404        Targeted therapy   \n",
       "439        Targeted therapy   \n",
       "469        Targeted therapy   \n",
       "495        Targeted therapy   \n",
       "523        Targeted therapy   \n",
       "\n",
       "                                resistance_description  \\\n",
       "18   More frequent with complex karyotypes and del(...   \n",
       "101  More frequent with complex karyotypes and del(...   \n",
       "165  More frequent with complex karyotypes and del(...   \n",
       "204  More frequent with complex karyotypes and del(...   \n",
       "212  More frequent with complex karyotypes and del(...   \n",
       "251  More frequent with complex karyotypes and del(...   \n",
       "278  More frequent with complex karyotypes and del(...   \n",
       "286  More frequent with complex karyotypes and del(...   \n",
       "307  More frequent with complex karyotypes and del(...   \n",
       "308  More frequent with complex karyotypes and del(...   \n",
       "315  More frequent with complex karyotypes and del(...   \n",
       "321  More frequent with complex karyotypes and del(...   \n",
       "379  More frequent with complex karyotypes and del(...   \n",
       "386  More frequent with complex karyotypes and del(...   \n",
       "387  More frequent with complex karyotypes and del(...   \n",
       "404  More frequent with complex karyotypes and del(...   \n",
       "439  More frequent with complex karyotypes and del(...   \n",
       "469  More frequent with complex karyotypes and del(...   \n",
       "495  More frequent with complex karyotypes and del(...   \n",
       "523  More frequent with complex karyotypes and del(...   \n",
       "\n",
       "                                   resistance_citation  \\\n",
       "18   National Comprehensive Cancer Network. Myelody...   \n",
       "101  National Comprehensive Cancer Network. Myelody...   \n",
       "165  National Comprehensive Cancer Network. Myelody...   \n",
       "204  National Comprehensive Cancer Network. Myelody...   \n",
       "212  National Comprehensive Cancer Network. Myelody...   \n",
       "251  National Comprehensive Cancer Network. Myelody...   \n",
       "278  National Comprehensive Cancer Network. Myelody...   \n",
       "286  National Comprehensive Cancer Network. Myelody...   \n",
       "307  National Comprehensive Cancer Network. Myelody...   \n",
       "308  National Comprehensive Cancer Network. Myelody...   \n",
       "315  National Comprehensive Cancer Network. Myelody...   \n",
       "321  National Comprehensive Cancer Network. Myelody...   \n",
       "379  National Comprehensive Cancer Network. Myelody...   \n",
       "386  National Comprehensive Cancer Network. Myelody...   \n",
       "387  National Comprehensive Cancer Network. Myelody...   \n",
       "404  National Comprehensive Cancer Network. Myelody...   \n",
       "439  National Comprehensive Cancer Network. Myelody...   \n",
       "469  National Comprehensive Cancer Network. Myelody...   \n",
       "495  National Comprehensive Cancer Network. Myelody...   \n",
       "523  National Comprehensive Cancer Network. Myelody...   \n",
       "\n",
       "                                        resistance_url  \\\n",
       "18   https://www.nccn.org/professionals/physician_g...   \n",
       "101  https://www.nccn.org/professionals/physician_g...   \n",
       "165  https://www.nccn.org/professionals/physician_g...   \n",
       "204  https://www.nccn.org/professionals/physician_g...   \n",
       "212  https://www.nccn.org/professionals/physician_g...   \n",
       "251  https://www.nccn.org/professionals/physician_g...   \n",
       "278  https://www.nccn.org/professionals/physician_g...   \n",
       "286  https://www.nccn.org/professionals/physician_g...   \n",
       "307  https://www.nccn.org/professionals/physician_g...   \n",
       "308  https://www.nccn.org/professionals/physician_g...   \n",
       "315  https://www.nccn.org/professionals/physician_g...   \n",
       "321  https://www.nccn.org/professionals/physician_g...   \n",
       "379  https://www.nccn.org/professionals/physician_g...   \n",
       "386  https://www.nccn.org/professionals/physician_g...   \n",
       "387  https://www.nccn.org/professionals/physician_g...   \n",
       "404  https://www.nccn.org/professionals/physician_g...   \n",
       "439  https://www.nccn.org/professionals/physician_g...   \n",
       "469  https://www.nccn.org/professionals/physician_g...   \n",
       "495  https://www.nccn.org/professionals/physician_g...   \n",
       "523  https://www.nccn.org/professionals/physician_g...   \n",
       "\n",
       "                 prognostic_score_bin favorable_prognosis  \\\n",
       "18    Investigate Actionability - Low                 0.0   \n",
       "101  Investigate Actionability - High                 0.0   \n",
       "165   Investigate Actionability - Low                 0.0   \n",
       "204  Investigate Actionability - High                 0.0   \n",
       "212  Investigate Actionability - High                 0.0   \n",
       "251  Investigate Actionability - High                 0.0   \n",
       "278   Investigate Actionability - Low                 0.0   \n",
       "286  Investigate Actionability - High                 0.0   \n",
       "307   Investigate Actionability - Low                 0.0   \n",
       "308   Investigate Actionability - Low                 0.0   \n",
       "315   Investigate Actionability - Low                 0.0   \n",
       "321  Investigate Actionability - High                 0.0   \n",
       "379  Investigate Actionability - High                 0.0   \n",
       "386   Investigate Actionability - Low                 0.0   \n",
       "387  Investigate Actionability - High                 0.0   \n",
       "404  Investigate Actionability - High                 0.0   \n",
       "439  Investigate Actionability - High                 0.0   \n",
       "469  Investigate Actionability - High                 0.0   \n",
       "495   Investigate Actionability - Low                 0.0   \n",
       "523  Investigate Actionability - High                 0.0   \n",
       "\n",
       "                                prognostic_description  \\\n",
       "18   Mutations in TP53 correlated with shorter over...   \n",
       "101  Missense mutation in any codon except P47S or ...   \n",
       "165  Mutations in TP53 correlated with shorter over...   \n",
       "204  Missense mutation in any codon except P47S or ...   \n",
       "212  Missense mutation in any codon except P47S or ...   \n",
       "251  Missense mutation in any codon except P47S or ...   \n",
       "278  Mutations in TP53 correlated with shorter over...   \n",
       "286  Missense mutation in any codon except P47S or ...   \n",
       "307  Mutations in TP53 correlated with shorter over...   \n",
       "308  Mutations in TP53 correlated with shorter over...   \n",
       "315  Mutations in TP53 correlated with shorter over...   \n",
       "321  Missense mutation in any codon except P47S or ...   \n",
       "379  Missense mutation in any codon except P47S or ...   \n",
       "386  Mutations in TP53 correlated with shorter over...   \n",
       "387  Missense mutation in any codon except P47S or ...   \n",
       "404  Missense mutation in any codon except P47S or ...   \n",
       "439  Missense mutation in any codon except P47S or ...   \n",
       "469  Missense mutation in any codon except P47S or ...   \n",
       "495  Mutations in TP53 correlated with shorter over...   \n",
       "523  Missense mutation in any codon except P47S or ...   \n",
       "\n",
       "                                   prognostic_citation  \\\n",
       "18   National Comprehensive Cancer Network. Myelody...   \n",
       "101  National Comprehensive Cancer Network. Myelody...   \n",
       "165  National Comprehensive Cancer Network. Myelody...   \n",
       "204  National Comprehensive Cancer Network. Myelody...   \n",
       "212  National Comprehensive Cancer Network. Myelody...   \n",
       "251  National Comprehensive Cancer Network. Myelody...   \n",
       "278  National Comprehensive Cancer Network. Myelody...   \n",
       "286  National Comprehensive Cancer Network. Myelody...   \n",
       "307  National Comprehensive Cancer Network. Myelody...   \n",
       "308  National Comprehensive Cancer Network. Myelody...   \n",
       "315  National Comprehensive Cancer Network. Myelody...   \n",
       "321  National Comprehensive Cancer Network. Myelody...   \n",
       "379  National Comprehensive Cancer Network. Myelody...   \n",
       "386  National Comprehensive Cancer Network. Myelody...   \n",
       "387  National Comprehensive Cancer Network. Myelody...   \n",
       "404  National Comprehensive Cancer Network. Myelody...   \n",
       "439  National Comprehensive Cancer Network. Myelody...   \n",
       "469  National Comprehensive Cancer Network. Myelody...   \n",
       "495  National Comprehensive Cancer Network. Myelody...   \n",
       "523  National Comprehensive Cancer Network. Myelody...   \n",
       "\n",
       "                                        prognostic_url  \n",
       "18   https://www.nccn.org/professionals/physician_g...  \n",
       "101  https://www.nccn.org/professionals/physician_g...  \n",
       "165  https://www.nccn.org/professionals/physician_g...  \n",
       "204  https://www.nccn.org/professionals/physician_g...  \n",
       "212  https://www.nccn.org/professionals/physician_g...  \n",
       "251  https://www.nccn.org/professionals/physician_g...  \n",
       "278  https://www.nccn.org/professionals/physician_g...  \n",
       "286  https://www.nccn.org/professionals/physician_g...  \n",
       "307  https://www.nccn.org/professionals/physician_g...  \n",
       "308  https://www.nccn.org/professionals/physician_g...  \n",
       "315  https://www.nccn.org/professionals/physician_g...  \n",
       "321  https://www.nccn.org/professionals/physician_g...  \n",
       "379  https://www.nccn.org/professionals/physician_g...  \n",
       "386  https://www.nccn.org/professionals/physician_g...  \n",
       "387  https://www.nccn.org/professionals/physician_g...  \n",
       "404  https://www.nccn.org/professionals/physician_g...  \n",
       "439  https://www.nccn.org/professionals/physician_g...  \n",
       "469  https://www.nccn.org/professionals/physician_g...  \n",
       "495  https://www.nccn.org/professionals/physician_g...  \n",
       "523  https://www.nccn.org/professionals/physician_g...  \n",
       "\n",
       "[20 rows x 27 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vegf_patients = therapies[therapies['strategy'].eq('VEGF/VEGFR')]['patient_id'].astype(str).tolist()\n",
    "features[features['feature'].eq('TP53') & features['ipredict_targeted'].eq(1) & features['patient_id'].astype(str).isin(vegf_patients)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "targets KRAS G12C    18\n",
       "PI3K/AKT/mTOR        14\n",
       "PRMT5                13\n",
       "MDM2-p53              7\n",
       "FGFR                  7\n",
       "PD-1/PD-L1            6\n",
       "CDK4/6                6\n",
       "ATR                   5\n",
       "PARP                  5\n",
       "Proteasome            5\n",
       "CTLA-4                5\n",
       "Aurora kinase         4\n",
       "targets BCR-ABL       3\n",
       "EGFR                  3\n",
       "ER signaling          2\n",
       "BRAF                  2\n",
       "MEK                   1\n",
       "ALK                   1\n",
       "IDH1                  1\n",
       "IDH2                  1\n",
       "Antineoplastic        1\n",
       "JAK                   1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~idx_shared & idx_almanac].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "pictilisib    17\n",
       "azd8186        4\n",
       "everolimus     3\n",
       "mk-2206        3\n",
       "alpelisib      1\n",
       "sirolimus      1\n",
       "Name: therapy, dtype: int64"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[idx_almanac & therapies['strategy'].eq('PI3K/AKT/mTOR')]['therapy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>34</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>73</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>101</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>102</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>119</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id    therapy study-evidence-strongest almanac-evidence-strongest  \\\n",
       "39          34  epz015666                      NaN                Preclinical   \n",
       "84          73  epz015666                      NaN                Preclinical   \n",
       "116        101  epz015666                      NaN                Preclinical   \n",
       "119        102  epz015666                      NaN                Preclinical   \n",
       "138        119  epz015666                      NaN                Preclinical   \n",
       "\n",
       "     included-in-overlapping-strategy strategy  study-gave-as-matched-therapy  \\\n",
       "39                                  0    PRMT5                            NaN   \n",
       "84                                  0    PRMT5                            NaN   \n",
       "116                                 0    PRMT5                            NaN   \n",
       "119                                 0    PRMT5                            NaN   \n",
       "138                                 0    PRMT5                            NaN   \n",
       "\n",
       "    study-citations-used-for-patient comment-on-study-citation substrategy  \n",
       "39                               NaN                       NaN         NaN  \n",
       "84                               NaN                       NaN         NaN  \n",
       "116                                2                       NaN         NaN  \n",
       "119                              NaN                       NaN         NaN  \n",
       "138                              NaN                       NaN         NaN  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[therapies['strategy'].eq('PRMT5')].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2     CDKN2A\n",
       "3     CDKN2B\n",
       "6     CDKN2A\n",
       "7     CDKN2B\n",
       "39    CDKN2A\n",
       "Name: feature, dtype: object"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "features[features['sensitive_therapy_name'].eq('EPZ015666')]['feature'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### How many patients observe a shared therapeutic strategy?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(38,)"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[idx_shared]['patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(83,)"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies['patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.4578313253012048"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[idx_shared]['patient_id'].drop_duplicates().shape[0] / therapies['patient_id'].drop_duplicates().shape[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(41,)"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies.loc[therapies['study-evidence-strongest'].dropna().index, 'therapy'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(40,)"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies.loc[therapies['almanac-evidence-strongest'].dropna().index, 'therapy'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(31,)"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies['strategy'].dropna().drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "non_standard = therapies[~(therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline', '']))]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    98\n",
       "1    32\n",
       "Name: included-in-overlapping-strategy, dtype: int64"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts = non_standard['included-in-overlapping-strategy'].value_counts()\n",
    "non_standard_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    0.753846\n",
       "1    0.246154\n",
       "Name: included-in-overlapping-strategy, dtype: float64"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts.divide(non_standard_counts.sum())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "130"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>7</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>9</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>15</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>19</td>\n",
       "      <td>pictilisib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>A043</td>\n",
       "      <td>neratinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TKI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>A043</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>A044</td>\n",
       "      <td>everolimus</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>A045</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>A045</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>130 rows  10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id     therapy study-evidence-strongest  \\\n",
       "2            5    nutlin-3                      NaN   \n",
       "5            7     amg 510                      NaN   \n",
       "7            9     amg 510                      NaN   \n",
       "9           15    nutlin-3                      NaN   \n",
       "11          19  pictilisib                      NaN   \n",
       "..         ...         ...                      ...   \n",
       "290       A043   neratinib                      NaN   \n",
       "291       A043     amg 510                      NaN   \n",
       "295       A044  everolimus                      NaN   \n",
       "298       A045     amg 510                      NaN   \n",
       "299       A045   epz015666                      NaN   \n",
       "\n",
       "    almanac-evidence-strongest  included-in-overlapping-strategy  \\\n",
       "2                  Preclinical                                 0   \n",
       "5               Clinical trial                                 0   \n",
       "7               Clinical trial                                 0   \n",
       "9                  Preclinical                                 0   \n",
       "11                 Preclinical                                 0   \n",
       "..                         ...                               ...   \n",
       "290          Clinical evidence                                 1   \n",
       "291             Clinical trial                                 0   \n",
       "295          Clinical evidence                                 0   \n",
       "298             Clinical trial                                 0   \n",
       "299                Preclinical                                 0   \n",
       "\n",
       "              strategy  study-gave-as-matched-therapy  \\\n",
       "2             MDM2-p53                            NaN   \n",
       "5    targets KRAS G12C                            NaN   \n",
       "7    targets KRAS G12C                            NaN   \n",
       "9             MDM2-p53                            NaN   \n",
       "11       PI3K/AKT/mTOR                            NaN   \n",
       "..                 ...                            ...   \n",
       "290       ER signaling                            NaN   \n",
       "291  targets KRAS G12C                            NaN   \n",
       "295      PI3K/AKT/mTOR                            NaN   \n",
       "298  targets KRAS G12C                            NaN   \n",
       "299              PRMT5                            NaN   \n",
       "\n",
       "    study-citations-used-for-patient comment-on-study-citation substrategy  \n",
       "2                                NaN                       NaN         NaN  \n",
       "5                                NaN                       NaN         NaN  \n",
       "7                                NaN                       NaN         NaN  \n",
       "9                                NaN                       NaN         NaN  \n",
       "11                               NaN                       NaN         NaN  \n",
       "..                               ...                       ...         ...  \n",
       "290                              NaN                       NaN         TKI  \n",
       "291                              NaN                       NaN         NaN  \n",
       "295                              NaN                       NaN         NaN  \n",
       "298                              NaN                       NaN         NaN  \n",
       "299                              NaN                       NaN         NaN  \n",
       "\n",
       "[130 rows x 10 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    107\n",
       "1     63\n",
       "Name: included-in-overlapping-strategy, dtype: int64"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard = therapies[(therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline']) | therapies['almanac-evidence-strongest'].isnull())]\n",
    "standard['included-in-overlapping-strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2</td>\n",
       "      <td>crizotinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1</td>\n",
       "      <td>I could not get access to this article; howeve...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>7</td>\n",
       "      <td>gemcitabine</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>7</td>\n",
       "      <td>nab-paclitaxel</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>9</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Inferential</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3</td>\n",
       "      <td>Citation 3 describes VEGF inhibition showing e...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>19</td>\n",
       "      <td>trametinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>MEK</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4</td>\n",
       "      <td>Citation 4 describes targeting KRAS indirectly...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>22</td>\n",
       "      <td>pertuzumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>7,8,9,10</td>\n",
       "      <td>Citations look at combination of pertuzumab wi...</td>\n",
       "      <td>HER2 antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>22</td>\n",
       "      <td>trastuzumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>7,8,9,10</td>\n",
       "      <td>Citations look at combination of pertuzumab wi...</td>\n",
       "      <td>HER2 antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>22</td>\n",
       "      <td>ado-trastuzumab emtansine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HER2 antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>26</td>\n",
       "      <td>OX40 agonist in clinical development</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>26</td>\n",
       "      <td>PD-L1 antagonist</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>28</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>30</td>\n",
       "      <td>vemurafenib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>1.0</td>\n",
       "      <td>14,15</td>\n",
       "      <td>Citations 14 (trial) and 15 (review) look at t...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>30</td>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>30</td>\n",
       "      <td>trametinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>MEK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>34</td>\n",
       "      <td>lenvatinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>34</td>\n",
       "      <td>erdafitinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>FGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FGFR</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>34</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>47</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>18</td>\n",
       "      <td>Citation 18 covers a trial of 151 patients rec...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>47</td>\n",
       "      <td>ipilimumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>0</td>\n",
       "      <td>CTLA-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>47</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>48</td>\n",
       "      <td>sorafenib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6</td>\n",
       "      <td>Citatons further look into efficacy of VEGF in...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>51</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16,17,19</td>\n",
       "      <td>Citation 19 is a review focused on olaparib fo...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>51</td>\n",
       "      <td>alpelisib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>53</td>\n",
       "      <td>sulindac</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NSAID</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19,20,21</td>\n",
       "      <td>Citation 21 looks at overall response of sulin...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>61</td>\n",
       "      <td>everolimus</td>\n",
       "      <td>Citation listed not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>22</td>\n",
       "      <td>Citation 22 is a case report of a patient with...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>73</td>\n",
       "      <td>cabozantinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1</td>\n",
       "      <td>I could not get access to this article; howeve...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>73</td>\n",
       "      <td>ivosidenib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>IDH1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>74</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>Citation listed not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4</td>\n",
       "      <td>Tamoxifen is FDA approved for ER+ breast cance...</td>\n",
       "      <td>SERM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>86</td>\n",
       "      <td>dual p70S6K/Akt Inhibitor in clinical development</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23,24,25</td>\n",
       "      <td>Citation 23 is a review of targeting PI3K/AKT/...</td>\n",
       "      <td>akt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>91</td>\n",
       "      <td>Wee-1 inhibitor in clinical development</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Wee-1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>26,27</td>\n",
       "      <td>Citation 26 looks at efficacy of Wee-1 inhibit...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>92</td>\n",
       "      <td>ceritinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>IGF</td>\n",
       "      <td>1.0</td>\n",
       "      <td>28,29,30</td>\n",
       "      <td>Citation 28 is a review of EWSR1 fusions, in w...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>97</td>\n",
       "      <td>dasatinib</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>targets BCR-ABL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>99</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,4,20,21,31,32,33,34,35,36</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>112</td>\n",
       "      <td>bosutinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>targets BCR-ABL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>118</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>119</td>\n",
       "      <td>vismodegib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Hedgehog</td>\n",
       "      <td>1.0</td>\n",
       "      <td>37</td>\n",
       "      <td>Citation 37 reviews inhibiting hedgehog pathwa...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>120</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4,11,12,13,38</td>\n",
       "      <td>Citation 38 describes how activation of KRAS a...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>127</td>\n",
       "      <td>dual p70S6K/Akt Inhibitor in clinical developm...</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>24,25</td>\n",
       "      <td>Citation 24 is a trial testing a dual p70S6K/A...</td>\n",
       "      <td>akt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>132</td>\n",
       "      <td>durvalumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>135</td>\n",
       "      <td>osimertinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1,40,41</td>\n",
       "      <td>This is a glioblastoma patient with many EGFR ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>155</td>\n",
       "      <td>enasidenib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>IDH2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>157</td>\n",
       "      <td>BET Inhibitor in clinical development</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>BET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>43,44</td>\n",
       "      <td>Citations look at efficacy of inhibitors in pr...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>A001</td>\n",
       "      <td>crizotinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4</td>\n",
       "      <td>Citation 4 does not discuss targeting c-MET an...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>A003</td>\n",
       "      <td>carboplatin</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>1.0</td>\n",
       "      <td>45,46</td>\n",
       "      <td>Clinical trials testing efficacy of PARP inhib...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>A003</td>\n",
       "      <td>veliparib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PARP</td>\n",
       "      <td>1.0</td>\n",
       "      <td>45,46</td>\n",
       "      <td>Clinical trials testing efficacy of PARP inhib...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>A008</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,7,8,9,10</td>\n",
       "      <td>Citations look at combination of pertuzumab wi...</td>\n",
       "      <td>TKI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>A009</td>\n",
       "      <td>ramucirumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17</td>\n",
       "      <td>Citatons further look into efficacy of VEGF in...</td>\n",
       "      <td>vegf</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>A010</td>\n",
       "      <td>fulvestrant</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23,47</td>\n",
       "      <td>Citation 47 describes landscape of ESR1 varian...</td>\n",
       "      <td>SERD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>A011</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>18,20,21,23,48,49,50</td>\n",
       "      <td>Citation 18 covers a trial of 151 patients rec...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>A021</td>\n",
       "      <td>exemestane</td>\n",
       "      <td>Citation listed not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23,52</td>\n",
       "      <td>Citations discuss PI3K/AKT/mTOR and pazopanib....</td>\n",
       "      <td>Aromatase inhibition</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>A021</td>\n",
       "      <td>pazopanib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>23,52</td>\n",
       "      <td>Citation 52 is a review that discusses trial a...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>A035</td>\n",
       "      <td>atezolizumab</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17,18</td>\n",
       "      <td>This seems to be made based on citation 18's c...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>A037</td>\n",
       "      <td>azacitidine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>0</td>\n",
       "      <td>Antineoplastic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>A041</td>\n",
       "      <td>anastrozole</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>1.0</td>\n",
       "      <td>7,8,9,10</td>\n",
       "      <td>Citations look at combination of pertuzumab wi...</td>\n",
       "      <td>Aromatase inhibition</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>A042</td>\n",
       "      <td>Irinotecan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Antineoplastic</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>A042</td>\n",
       "      <td>denosumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>A044</td>\n",
       "      <td>cyclophosphamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>A044</td>\n",
       "      <td>dacarbazine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>A044</td>\n",
       "      <td>vincristine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id                                            therapy  \\\n",
       "0            2                                         crizotinib   \n",
       "1            5                                        palbociclib   \n",
       "3            7                                        gemcitabine   \n",
       "4            7                                     nab-paclitaxel   \n",
       "6            9                                        bevacizumab   \n",
       "10          19                                         trametinib   \n",
       "16          22                                         pertuzumab   \n",
       "17          22                                        trastuzumab   \n",
       "18          22                          ado-trastuzumab emtansine   \n",
       "23          26               OX40 agonist in clinical development   \n",
       "24          26                                   PD-L1 antagonist   \n",
       "26          28                                          nivolumab   \n",
       "28          30                                        vemurafenib   \n",
       "29          30                                         dabrafenib   \n",
       "30          30                                         trametinib   \n",
       "36          34                                         lenvatinib   \n",
       "40          34                                        erdafitinib   \n",
       "41          34                                           olaparib   \n",
       "54          47                                      pembrolizumab   \n",
       "56          47                                         ipilimumab   \n",
       "57          47                                          nivolumab   \n",
       "58          48                                          sorafenib   \n",
       "60          51                                           olaparib   \n",
       "63          51                                          alpelisib   \n",
       "66          53                                           sulindac   \n",
       "72          61                                         everolimus   \n",
       "83          73                                       cabozantinib   \n",
       "85          73                                         ivosidenib   \n",
       "87          74                                          tamoxifen   \n",
       "92          86  dual p70S6K/Akt Inhibitor in clinical development   \n",
       "101         91            Wee-1 inhibitor in clinical development   \n",
       "103         92                                          ceritinib   \n",
       "109         97                                          dasatinib   \n",
       "110         99                                        palbociclib   \n",
       "126        112                                          bosutinib   \n",
       "134        118                                          erlotinib   \n",
       "137        119                                         vismodegib   \n",
       "140        120                                          cetuximab   \n",
       "157        127  dual p70S6K/Akt Inhibitor in clinical developm...   \n",
       "159        132                                         durvalumab   \n",
       "162        135                                        osimertinib   \n",
       "182        155                                         enasidenib   \n",
       "189        157              BET Inhibitor in clinical development   \n",
       "194       A001                                         crizotinib   \n",
       "199       A003                                        carboplatin   \n",
       "200       A003                                          veliparib   \n",
       "211       A008                                           afatinib   \n",
       "218       A009                                        ramucirumab   \n",
       "222       A010                                        fulvestrant   \n",
       "224       A011                                      pembrolizumab   \n",
       "238       A021                                         exemestane   \n",
       "239       A021                                          pazopanib   \n",
       "264       A035                                       atezolizumab   \n",
       "270       A037                                        azacitidine   \n",
       "277       A041                                        anastrozole   \n",
       "281       A042                                         Irinotecan   \n",
       "283       A042                                          denosumab   \n",
       "292       A044                                   cyclophosphamide   \n",
       "293       A044                                        dacarbazine   \n",
       "294       A044                                        vincristine   \n",
       "\n",
       "            study-evidence-strongest almanac-evidence-strongest  \\\n",
       "0                     Clinical trial                  Guideline   \n",
       "1                     Clinical trial                  Guideline   \n",
       "3    Not based on molecular features                        NaN   \n",
       "4    Not based on molecular features                        NaN   \n",
       "6                        Inferential                        NaN   \n",
       "10                    Clinical trial                        NaN   \n",
       "16                    Clinical trial                        NaN   \n",
       "17                    Clinical trial                        NaN   \n",
       "18                               NaN               FDA-Approved   \n",
       "23   Not based on molecular features                        NaN   \n",
       "24   Not based on molecular features                        NaN   \n",
       "26   Not based on molecular features                        NaN   \n",
       "28                    Clinical trial                        NaN   \n",
       "29                               NaN               FDA-Approved   \n",
       "30                               NaN               FDA-Approved   \n",
       "36                       Preclinical                        NaN   \n",
       "40                               NaN               FDA-Approved   \n",
       "41                               NaN               FDA-Approved   \n",
       "54                    Clinical trial                        NaN   \n",
       "56                               NaN                  Guideline   \n",
       "57                               NaN                  Guideline   \n",
       "58                    Clinical trial                        NaN   \n",
       "60                    Clinical trial                        NaN   \n",
       "63                               NaN               FDA-Approved   \n",
       "66                       Preclinical                        NaN   \n",
       "72    Citation listed not applicable                        NaN   \n",
       "83                    Clinical trial                        NaN   \n",
       "85                               NaN               FDA-Approved   \n",
       "87    Citation listed not applicable                        NaN   \n",
       "92                    Clinical trial                        NaN   \n",
       "101                      Preclinical                        NaN   \n",
       "103                   Clinical trial                        NaN   \n",
       "109  Not based on molecular features                        NaN   \n",
       "110                   Clinical trial                        NaN   \n",
       "126                              NaN               FDA-Approved   \n",
       "134  Not based on molecular features                        NaN   \n",
       "137                   Clinical trial                        NaN   \n",
       "140                      Preclinical                        NaN   \n",
       "157                   Clinical trial                        NaN   \n",
       "159  Not based on molecular features                        NaN   \n",
       "162                      Preclinical               FDA-Approved   \n",
       "182                              NaN               FDA-Approved   \n",
       "189                      Preclinical                        NaN   \n",
       "194                   Clinical trial                        NaN   \n",
       "199                   Clinical trial                        NaN   \n",
       "200                   Clinical trial                        NaN   \n",
       "211                   Clinical trial                        NaN   \n",
       "218                   Clinical trial                        NaN   \n",
       "222                      Preclinical                        NaN   \n",
       "224                   Clinical trial               FDA-Approved   \n",
       "238   Citation listed not applicable                        NaN   \n",
       "239                   Clinical trial                        NaN   \n",
       "264                Clinical evidence                        NaN   \n",
       "270                              NaN                  Guideline   \n",
       "277                   Clinical trial                        NaN   \n",
       "281                              NaN                        NaN   \n",
       "283                              NaN                        NaN   \n",
       "292                              NaN                        NaN   \n",
       "293                              NaN                        NaN   \n",
       "294                              NaN                        NaN   \n",
       "\n",
       "     included-in-overlapping-strategy         strategy  \\\n",
       "0                                   1              MET   \n",
       "1                                   1           CDK4/6   \n",
       "3                                   0              NaN   \n",
       "4                                   0              NaN   \n",
       "6                                   0       VEGF/VEGFR   \n",
       "10                                  0              MEK   \n",
       "16                                  1     ER signaling   \n",
       "17                                  1     ER signaling   \n",
       "18                                  1     ER signaling   \n",
       "23                                  0              NaN   \n",
       "24                                  1       PD-1/PD-L1   \n",
       "26                                  0       PD-1/PD-L1   \n",
       "28                                  1             BRAF   \n",
       "29                                  1             BRAF   \n",
       "30                                  1              MEK   \n",
       "36                                  0       VEGF/VEGFR   \n",
       "40                                  0             FGFR   \n",
       "41                                  0             PARP   \n",
       "54                                  1       PD-1/PD-L1   \n",
       "56                                  0           CTLA-4   \n",
       "57                                  1       PD-1/PD-L1   \n",
       "58                                  0       VEGF/VEGFR   \n",
       "60                                  0             PARP   \n",
       "63                                  0    PI3K/AKT/mTOR   \n",
       "66                                  0            NSAID   \n",
       "72                                  0    PI3K/AKT/mTOR   \n",
       "83                                  1              MET   \n",
       "85                                  0             IDH1   \n",
       "87                                  0     ER signaling   \n",
       "92                                  1    PI3K/AKT/mTOR   \n",
       "101                                 0            Wee-1   \n",
       "103                                 0              IGF   \n",
       "109                                 0  targets BCR-ABL   \n",
       "110                                 0           CDK4/6   \n",
       "126                                 0  targets BCR-ABL   \n",
       "134                                 0             EGFR   \n",
       "137                                 0         Hedgehog   \n",
       "140                                 0             EGFR   \n",
       "157                                 1    PI3K/AKT/mTOR   \n",
       "159                                 0       PD-1/PD-L1   \n",
       "162                                 1             EGFR   \n",
       "182                                 0             IDH2   \n",
       "189                                 0              BET   \n",
       "194                                 0              MET   \n",
       "199                                 1     Chemotherapy   \n",
       "200                                 1             PARP   \n",
       "211                                 1     ER signaling   \n",
       "218                                 0       VEGF/VEGFR   \n",
       "222                                 0     ER signaling   \n",
       "224                                 1       PD-1/PD-L1   \n",
       "238                                 0     ER signaling   \n",
       "239                                 0       VEGF/VEGFR   \n",
       "264                                 0       PD-1/PD-L1   \n",
       "270                                 0   Antineoplastic   \n",
       "277                                 1     ER signaling   \n",
       "281                                 0   Antineoplastic   \n",
       "283                                 0              NaN   \n",
       "292                                 0              NaN   \n",
       "293                                 0              NaN   \n",
       "294                                 0              NaN   \n",
       "\n",
       "     study-gave-as-matched-therapy study-citations-used-for-patient  \\\n",
       "0                              1.0                                1   \n",
       "1                              1.0                                2   \n",
       "3                              0.0                   Not applicable   \n",
       "4                              0.0                   Not applicable   \n",
       "6                              1.0                                3   \n",
       "10                             1.0                                4   \n",
       "16                             1.0                         7,8,9,10   \n",
       "17                             1.0                         7,8,9,10   \n",
       "18                             NaN                              NaN   \n",
       "23                             0.0                   Not applicable   \n",
       "24                             0.0                   Not applicable   \n",
       "26                             0.0                   Not applicable   \n",
       "28                             1.0                            14,15   \n",
       "29                             NaN                              NaN   \n",
       "30                             NaN                              NaN   \n",
       "36                             1.0                      2,5,6,16,17   \n",
       "40                             NaN                              NaN   \n",
       "41                             NaN                              NaN   \n",
       "54                             1.0                               18   \n",
       "56                             NaN                               18   \n",
       "57                             NaN                               18   \n",
       "58                             1.0                            2,5,6   \n",
       "60                             1.0                         16,17,19   \n",
       "63                             NaN                              NaN   \n",
       "66                             1.0                         19,20,21   \n",
       "72                             1.0                               22   \n",
       "83                             1.0                                1   \n",
       "85                             NaN                              NaN   \n",
       "87                             1.0                                4   \n",
       "92                             1.0                         23,24,25   \n",
       "101                            1.0                            26,27   \n",
       "103                            1.0                         28,29,30   \n",
       "109                            0.0                   Not applicable   \n",
       "110                            1.0      2,4,20,21,31,32,33,34,35,36   \n",
       "126                            NaN                              NaN   \n",
       "134                            0.0                   Not applicable   \n",
       "137                            1.0                               37   \n",
       "140                            1.0                    4,11,12,13,38   \n",
       "157                            1.0                            24,25   \n",
       "159                            0.0                   Not applicable   \n",
       "162                            1.0                          1,40,41   \n",
       "182                            NaN                              NaN   \n",
       "189                            1.0                            43,44   \n",
       "194                            1.0                                4   \n",
       "199                            1.0                            45,46   \n",
       "200                            1.0                            45,46   \n",
       "211                            1.0                   2,5,6,7,8,9,10   \n",
       "218                            1.0                      2,5,6,16,17   \n",
       "222                            1.0                            23,47   \n",
       "224                            1.0             18,20,21,23,48,49,50   \n",
       "238                            1.0                            23,52   \n",
       "239                            1.0                            23,52   \n",
       "264                            1.0                   2,5,6,16,17,18   \n",
       "270                            NaN                              NaN   \n",
       "277                            1.0                         7,8,9,10   \n",
       "281                            0.0                   Not applicable   \n",
       "283                            0.0                   Not applicable   \n",
       "292                            0.0                   Not applicable   \n",
       "293                            0.0                   Not applicable   \n",
       "294                            0.0                   Not applicable   \n",
       "\n",
       "                             comment-on-study-citation           substrategy  \n",
       "0    I could not get access to this article; howeve...                   NaN  \n",
       "1    Citation 2 describes clinical trials of CDK4 i...                   NaN  \n",
       "3                                                  NaN                   NaN  \n",
       "4                                                  NaN                   NaN  \n",
       "6    Citation 3 describes VEGF inhibition showing e...                   NaN  \n",
       "10   Citation 4 describes targeting KRAS indirectly...                   NaN  \n",
       "16   Citations look at combination of pertuzumab wi...         HER2 antibody  \n",
       "17   Citations look at combination of pertuzumab wi...         HER2 antibody  \n",
       "18                                                 NaN         HER2 antibody  \n",
       "23                                                 NaN                   NaN  \n",
       "24                                                 NaN                   NaN  \n",
       "26                                                 NaN                   NaN  \n",
       "28   Citations 14 (trial) and 15 (review) look at t...                   NaN  \n",
       "29                                                 NaN                   NaN  \n",
       "30                                                 NaN                   NaN  \n",
       "36                                          VEGF/VEGFR                   NaN  \n",
       "40                                                FGFR                   NaN  \n",
       "41                                                 NaN                   NaN  \n",
       "54   Citation 18 covers a trial of 151 patients rec...                   NaN  \n",
       "56                                                 NaN                   NaN  \n",
       "57                                                 NaN                   NaN  \n",
       "58   Citatons further look into efficacy of VEGF in...                   NaN  \n",
       "60   Citation 19 is a review focused on olaparib fo...                   NaN  \n",
       "63                                                 NaN                   NaN  \n",
       "66   Citation 21 looks at overall response of sulin...                   NaN  \n",
       "72   Citation 22 is a case report of a patient with...                   NaN  \n",
       "83   I could not get access to this article; howeve...                   NaN  \n",
       "85                                                 NaN                   NaN  \n",
       "87   Tamoxifen is FDA approved for ER+ breast cance...                  SERM  \n",
       "92   Citation 23 is a review of targeting PI3K/AKT/...                   akt  \n",
       "101  Citation 26 looks at efficacy of Wee-1 inhibit...                   NaN  \n",
       "103  Citation 28 is a review of EWSR1 fusions, in w...                   NaN  \n",
       "109                                                NaN                   NaN  \n",
       "110  Citation 2 describes clinical trials of CDK4 i...                   NaN  \n",
       "126                                                NaN                   NaN  \n",
       "134                                                NaN                   NaN  \n",
       "137  Citation 37 reviews inhibiting hedgehog pathwa...                   NaN  \n",
       "140  Citation 38 describes how activation of KRAS a...                   NaN  \n",
       "157  Citation 24 is a trial testing a dual p70S6K/A...                   akt  \n",
       "159                                                NaN                   NaN  \n",
       "162  This is a glioblastoma patient with many EGFR ...                   NaN  \n",
       "182                                                NaN                   NaN  \n",
       "189  Citations look at efficacy of inhibitors in pr...                   NaN  \n",
       "194  Citation 4 does not discuss targeting c-MET an...                   NaN  \n",
       "199  Clinical trials testing efficacy of PARP inhib...                   NaN  \n",
       "200  Clinical trials testing efficacy of PARP inhib...                   NaN  \n",
       "211  Citations look at combination of pertuzumab wi...                   TKI  \n",
       "218  Citatons further look into efficacy of VEGF in...                  vegf  \n",
       "222  Citation 47 describes landscape of ESR1 varian...                  SERD  \n",
       "224  Citation 18 covers a trial of 151 patients rec...                   NaN  \n",
       "238  Citations discuss PI3K/AKT/mTOR and pazopanib....  Aromatase inhibition  \n",
       "239  Citation 52 is a review that discusses trial a...                   NaN  \n",
       "264  This seems to be made based on citation 18's c...                   NaN  \n",
       "270                                                NaN                   NaN  \n",
       "277  Citations look at combination of pertuzumab wi...  Aromatase inhibition  \n",
       "281                                                NaN                   NaN  \n",
       "283                                                NaN                   NaN  \n",
       "292                                                NaN                   NaN  \n",
       "293                                                NaN                   NaN  \n",
       "294                                                NaN                   NaN  "
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard.drop_duplicates(['therapy', 'almanac-evidence-strongest'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2</td>\n",
       "      <td>crizotinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1</td>\n",
       "      <td>I could not get access to this article; howeve...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>15</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>22</td>\n",
       "      <td>ado-trastuzumab emtansine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HER2 antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>30</td>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   patient_id                    therapy study-evidence-strongest  \\\n",
       "0           2                 crizotinib           Clinical trial   \n",
       "1           5                palbociclib           Clinical trial   \n",
       "8          15                palbociclib           Clinical trial   \n",
       "18         22  ado-trastuzumab emtansine                      NaN   \n",
       "29         30                 dabrafenib                      NaN   \n",
       "\n",
       "   almanac-evidence-strongest  included-in-overlapping-strategy      strategy  \\\n",
       "0                   Guideline                                 1           MET   \n",
       "1                   Guideline                                 1        CDK4/6   \n",
       "8                   Guideline                                 1        CDK4/6   \n",
       "18               FDA-Approved                                 1  ER signaling   \n",
       "29               FDA-Approved                                 1          BRAF   \n",
       "\n",
       "    study-gave-as-matched-therapy study-citations-used-for-patient  \\\n",
       "0                             1.0                                1   \n",
       "1                             1.0                                2   \n",
       "8                             1.0                                2   \n",
       "18                            NaN                              NaN   \n",
       "29                            NaN                              NaN   \n",
       "\n",
       "                            comment-on-study-citation    substrategy  \n",
       "0   I could not get access to this article; howeve...            NaN  \n",
       "1   Citation 2 describes clinical trials of CDK4 i...            NaN  \n",
       "8   Citation 2 describes clinical trials of CDK4 i...            NaN  \n",
       "18                                                NaN  HER2 antibody  \n",
       "29                                                NaN            NaN  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard = therapies[therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline'])]\n",
    "standard.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "How many therapies does moalmanac highlight on average, that were not administered?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    74.000000\n",
       "mean      2.108108\n",
       "std       1.360576\n",
       "min       1.000000\n",
       "25%       1.000000\n",
       "50%       2.000000\n",
       "75%       3.000000\n",
       "max       6.000000\n",
       "Name: patient_id, dtype: float64"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~therapies['almanac-evidence-strongest'].isnull() & therapies['study-evidence-strongest'].isnull()]['patient_id'].value_counts().describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "moalmanac-paper",
   "language": "python",
   "name": "moalmanac-paper"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
